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Abstract 
 
Cancer, a generic group of diseases, can affect distant sites of the human 
body to cause sever health consequences. According to the World Health 
Organization, 9.8 million people died from cancer in 2015 worldwide, about 
1600 people per day. More seriously, the number of new cases is expected to 
increase 70% by 2030 to cause 12 million deaths globally. Early detection, 
accurate diagnosis and effective treatment are crucial in increasing cancer 
survival rates and reducing patients’ suffering. In particular, precise cancer 
positioning that can guide surgery, chemotherapy and radiotherapy has 
important clinical significance in successful treatment. The nanotechnology-
based diagnosis (e.g. QD/QR-bioconjugate probes) and/or treatment of 
different cancers have received great attention, which is growing to be a 
promising field in medical research. Over the past 20 years, not only have QD 
based probes been widely used in developing immunoassays, cellular 
labeling, cellular imaging, tissue imaging and in vivo imaging, but also being 
extended to researches such as the drug target and drug delivery system. 
And this thesis is composed of two parts: 
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Part I 
An ultra-efficient ligand-exchange protocol (UCEP) to render commercial 
hydrophobic QDs completely water-soluble using >50-fold less of the air-
stable lipoic acid (LA) based functional ligands with a rapid in situ reduction by 
tris(2-carboxylethyl phosphine, TECP) has been developed. The resulting 
water-soluble QDs are compact (Dh <10 nm), bright (retaining >90% of 
original fluorescence), resisting nonspecific adsorption and displaying good 
stabilities in biological buffers even with high salt contents (e.g. 2 M NaCl), 
making them well-suited for cell imaging and ratiometric biosensing. A DHLA-
zwitterion capped QD prepared by the UCEP is readily biofunctionalized with 
hexa-histidine (His8)-tagged small antibody mimetic proteins (also known as 
Affimers), allowing for rapid, ratiometric detection of its target protein down to 
5 pM via the QD-sensitized Förster resonance energy transfer (FRET) 
readout signal. Moreover, compact biotin functionalized QDs are prepared by 
a facile, one-step cap-exchange process for ratiometric quantitation detection 
of 5 pM protein such as NeutrAvidin as well as for fluorescence imaging of 
target model cancer cells. 
Part II 
A stable, water-soluble rod-shaped fluorescence semiconductor nanocrystal 
(CdSe/CdS core/shell quantum rod, QR) was made by an efficient cap 
exchange protocol as described in Part I. However, in most cases the 
24 
 
fluorescence of the cap-exchanged QR was almost quenched, hindering their 
biomedical applications. Herein I have solved this problem by discovering a 
simple method that allows for efficient recovery of the QR quantum yield, 
making them suitable for biological applications. The resulting water-soluble 
QRs are compact (Dh < 20 nm), bright (recovering to >67% of original 
fluorescence), resisting nonspecific adsorption and displaying good stabilities 
in biological buffers, making them well-suited for ratiometric biosensing. After 
tris(2-carboxylethyl phosphine, (TECP) reduction, a dihydrolipoic acid-
zwitterion ligand (DHLA-ZW) capped QR was self-assembled with (His8)-
tagged anti-yeast SUMO non-antibody binding proteins (nABPs), allowing for 
ratiometric detection of its target protein down to 5 pM by the QR-sensitized 
Förster resonance energy transfer (FRET) signal. Furthermore, compact 
biotin functionalized QRs are prepared by a facile, one-step cap-exchange 
process for ratiometric quantitation of labelled neutravidin down to 5 pM. Such 
sensitivity is among the very best for QR-FRET based biosensors.  
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Chapter 1 General introduction 
1.1 Abstract 
Fluorescent semiconductor nanocrystals, also known as quantum dots (QDs) 
or quantum rods (QRs), are a new type of fluorescent nanomaterials which 
have a number of advantageous properties compared to other fluorescent 
materials such as fluorescent proteins and organic dyes. These include 
excellent optical and chemical stability, high fluorescent quantum yield, broad 
absorption and size-tunable, narrow symmetric emission 1-5. QDs are mostly 
composed of group IIB/VIA (e.g. CdSe) or IIIA /VA (e.g. InP, GaAs) elements, 
and are commonly have sizes of 1-10 nm, which are comparable to or smaller 
than the typical exciton (electron-hole pair) Bohr radius of the corresponding 
materials, leading to strong quantum confinement 6, 7. QRs are rod shape 
semiconductor nanocrystals with diameters ranging from 2 to 10 nm and with 
lengths ranging from 5 to 100 nm8. Compared to the spherical QDs, QRs 
have several attractive properties that make them potentially better probes for 
some biomedical application than QDs. For example, QRs have larger 
absorption cross section,9 faster radiative decay rate10 and a bigger stokes 
shift11 and can be functionalized with more binding moieties. Furthermore, 
QRs have higher extinction coefficient and hence have higher brightness for 
individual particle. These unique properties make QRs highly desirable for 
certain biological applications and bring in new possibilities for biological 
imaging. 
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Most high quality QDs are prepared by using organometallic precursors in 
high-boiling point coordinating solvents under high temperatures. They are 
naturally capped with hydrophobic ligands, such as trioctylphosphine (TOP), 
trioctylphosphine oxide (TOPO) and/or long chain fatty amines, making them 
insoluble in aqueous solutions and are therefore biologically incompatible. In 
1998, the Nie and Alivisatos’ research groups first addressed the 
biocompatibility problem independently by using ligand exchange and silica 
shell encapsulation, respectively, to make the QDs water-soluble and 
subsequently conjugated with specific bio-molecules as novel bioimaging 
probes2, 3. Nie’s group used a thioglycolic acid (TGA) capped water-soluble 
CdSe/ZnS QD further conjugated with the protein transferrin for specific cell 
labelling. The transferrin conjugated QD could be recognized by cell surface 
transferring receptors and entered into cells effectively via receptor mediated 
endocytosis. This work demonstrated that QDs could be used to probe the 
specific ligand-receptor bindings inside living cells2, 3. Similar to QDs, high 
quality QRs are also synthesized to be only soluble in organic solvents12. In 
2007, the Alivisatos’ research groups design a method to transfer QRs into 
aqueous medium and make them bio-functional by surface silanization8. 
However, for most biological and analytical applications, the QDs should be 
carefully chosen and designed. Through specific modification of the surface 
capping ligands by approaches such as ligand exchange, silica encapsulation 
and amphiphilic polymer or lipid micelle encapsulation, the QDs can be made 
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stable, water-soluble and biocompatible2, 3, 13. QD-based fluorescent probes 
which have strong fluorescence with excellent photo-stability are therefore 
extremely well-placed for these studies. Over the past 20 years, not only have 
QD based probes been widely used in developing immunoassays, cellular 
labeling, cellular imaging, tissue imaging and in vivo imaging, but also being 
extended to researches such as the drug target and drug delivery system14. 
Despite such great developments, there are still significant challenges, 
especially for biomedical and clinical applications. For instance, the so called 
“blinking” which is a well-known phenomenon that limits the stability 
of quantum dot-based devices such as solar cells and light-emitting diodes. 
that can make tracking and trafficking studies unreliable. Moreover, most high 
qualities QDs contain heavy metal (e.g. Cd, Hg) and hence toxicity and 
cytotoxicity arising from the leaked heavy metals at physiological environment 
can limit their in vivo applications. Therefore significant further researches are 
still needed. 
In this chapter, the quantum confinement effect and optical properties of 
QDs/QRs in comparison with organic dyes will be discussed first. Then 
several strategies for preparation, surface modification and bioconjugation of 
QDs/QRs will be introduced. After that, the principle and applications of FRET 
based QDs will be illustrated. And finally the background aims of my project 
will be introduced. 
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1.2 Distinct properties of semiconductor of QDs/QRs 
as fluorophores 
1.2.1 Quantum confinement effect of QDs 
As we all know, crystalline inorganic solids are divided into three classes: 
metal, semiconductors and insulators. The overlap of atomic orbitals forms 
continuous electronic energy levels called band structures, where electron-
filled and empty bands are called valence and conduction bands, respectively. 
For metals, there is no band-gap separating the valence and conduction 
bands, electrons can move freely; whereas in semiconductors the 
valency/conduction bands are separated by a small band gap, while for 
insulators, the electron distributions are the same as semiconductors, but the 
band gap is much larger. All bulk semiconductor materials have defined 
valence and conduction bands, and the band-gap is specific for each 
semiconductor material. The QD fluorescence emission occurs when an 
electron excited to the conduction band and rapidly relaxed to the lowest 
energy level of the conduction band, returns to and recombines with a 
positively charged hole in the valence band. This gives the emission photon 
with energy exactly matching that of the band-gap. However, for QDs, the 
band-gap is not only dependent on the material but also on the size of the 
particles. This is because as the size of the QD decreases, there are fewer 
atoms (hence orbitals) in the dot to form the conduction and valence bands, 
leading to a greater band-gap (see Figure. 1-1). As a result, the biggest QD 
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has lowest band-gap (hence lowest energy, longest wavelength, red 
fluorescence), the middle QD has median band-gap (green) fluorescence and 
the smallest one has highest energy blue (hence highest energy, shortest 
wavelength, blue fluorescence) emission15, 16.  Therefore different sized QDs 
produce their specific, distinct coloured emissions. Moreover, electrons at any 
valence band levels can be excited to any levels in the conduction band upon 
absorption of a photon, giving a rather broad absorption. These unique 
absorption and emission characteristics allow a single excitation wavelength 
to excite different coloured QDs at same time (see Figure 1-3), yet each still 
producing its specific distinct coloured emissions, making QDs extremely well-
suited for multiplexed assays and imaging/tracking studies16. 
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Figure 1-1: Schematic representation of the band gaps of a semiconductor 
bulk material (left) and three different sized QDs. For QDs, the wavelength of 
emitted light is strongly dependent on the particle size16. 
1.2.2 Optical properties of QDs and QRs 
Another unique optical property of QDs is that their absorption and emission 
spectra are strongly dependent on the QD sizes, which can be finely 
controlled by changing the reaction time and temperature during synthesis17, 
18. As the reaction time increase, the QDs will grow bigger and bigger. Hence 
different coloured QDs can be easily prepared by simply changing the QD 
growth time. For example, a 1.8 nm size CdSe QD emits a blue light, but a 7 
nm CdSe QD emits a red light. Therefore, by using a range of different sized 
CdSe QDs, it is possible to cover all the colours of visible range of spectrum 
(see Figure. 1-2). Moreover, different sized QDs can be simultaneously used 
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to detect and track several different molecules simultaneously by conjugating 
each specific ligand to a specific coloured QD19. 
 
 
 
Figure 1-2: Ten distinguishable emission colours of CdSe/ZnS core/shell QDs 
excited with a near-UV lamp. From left to right (blue to red), the emission 
maxima are located at 443, 473, 481, 500, 518, 543, 565, 587, 610, and 655 
nm respectively19. 
 
And Figure 1-3 shows the typical absorption and emission spectra of different 
sized CdSe/ZnS core/shell QDs, which all have broad absorption, different 
coloured QDs can be excited by a single excitation UV wavelength. 
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Figure 1-3: Typical absorption spectra (left) and emission spectra (right) of 
CdSe/ZnS core/shell QDs. The Figure is taken from Evident technologies: 
http://www.evidenttech.com 
 
 
Besides spherical QDs, the rod-shaped QRs made of CdSe with different 
aspect ratios (length to diameter ratio) have also been prepared (Figure 1-4). 
Interestingly, by tuning the aspect ratio, the QR fluorescence can also be 
systematically tuned (Figure 1-5)20. 
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Figure 1-4: TEM images of four CdSe rod samples20. 
 
Figure 1-5:  Photoluminescence spectra of 3.7 (±0.2) nm wide CdSe quantum 
rods with lengths of 9.2, 11.5, 28.0, and 37.2 nm, respectively (from left to 
right), excited at 450 nm20.  
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In comparison, traditional organic fluorescent dyes tend to have relatively 
narrow absorptions and board asymmetric emissions. As a result, they can 
only be efficiently excited by a narrow range of specific lights, and therefore 
different coloured traditional fluorophores normally cannot be excited by a 
single light source. Moreover, the excitation light can also lead to irreversible 
oxidation of organic fluorescence dye, resulting in quick disappearance of 
fluorescence (or photobleaching), thus organic dyes tend to fade over time. 
Such drawbacks can seriously limit their applications in cell tracking/trafficking 
studies that require long term observations21. 
In contrast, QDs are made of solid inorganic nanocrystals which are much 
more robust against photo-oxidation (especially for those coated with a thick 
inorganic shell, e.g. core/shell QD). Moreover, the extremely high quantum 
yield (QY) (up to 100%) and large extinction coefficient make QDs up to 100 
times as bright as organic dyes with 1000 times higher photo-stability over 
organic dyes. These properties are very important for detecting and marking 
bio-molecule long-term interaction in living cells22, because the large molar 
extinction coefficients (e.g. 105-107 M-1cm-1), resisting photobleaching and 
chemical degradation, and two-photo absorption cross sections (103-104 GM) 
are much larger than fluorescent dyes23. 
In addition, the combination of using different materials and different particle 
sizes allows the preparation of various QDs with emission covering the whole 
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visible to near infrared region of spectrum (ca. 0.4-2.0 µm). This enables the 
use of different QD spectral signature at the same time, making specific 
detection of bio-molecules or cells easily recognizable. These advantages 
have enabled the QD being one of the most powerful fluorescent probes with 
very broad biomedical applications2. 
 
1.3 Synthesis, surface modification and 
bioconjugation of QDs and QRs 
1.3.1 QD synthesis methods 
A basic structure of a QD is comprised of a semiconductor core of hundred to 
thousand atoms, and coated with organic molecules (ligands) to promote 
solubility and prevent aggregation. The core where fluorescence comes from 
is typically composed of semiconductor material, such as CdSe. The core only 
QDs are directly capped with organic ligands and usually have low quantum 
yield and limited resistance to photo bleaching and chemical oxidation. Murray 
et al.17 used Cd(CH3)2 and (TMS)2Se as the reaction precursors, which were 
added into TOPO ligand solvent at 350 °C with stirring. By controlling the 
growth temperature, they prepared CdSe core QDs with sizes ranging from 
2.4 to 13 nm. The fluorescence quantum efficiency of the QDs was typically 
~10%. Following on from this work, Peng et al.18 obtained rod shape CdSe 
QDs (also named as quantum rod, QR) by changing the concentration of 
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precursors and the proportion of ligand. The quantum yield for luminescence 
in as grown rods is approximately 1% at room temperature, and is increased 
by a factor of 5 when a shell of a larger-bandgap material (CdS or ZnS) is 
grown on the core, as has been done with the QDs. Such quantum yields 
could be sufficient for biological labelling experiments, but are well below the 
maximum of 80% they have observed in dots. When thicker shells are grown 
on the QRs, the quantum yields are further decreased, which is likely due to 
cracking or strain at the core-shell interface. Besides, since Te2- is more easily 
oxidized than Se2-, it is generally harder to make CdTe QDs as compared to 
CdSe or CdS. Dmitri et al.24 used laurylamine (DDA) to replace TOPO as 
reacting solvent and obtained highly luminescent CdTe QDs with an 
impressive fluorescence quantum efficiency of up to 65%. Its emission 
spectrum can cover from red to green range of the visible spectra range. 
Sanser et al.25 used a mixed solvent of DDA and TOP and prepared different 
size CdTe QDs under different temperatures. They found that at higher 
reaction temperature, the faster the QD growth rate and the longer the 
fluorescence life time. Peng et al.26 has improved the QD synthesis method by 
using CdO to replace Cd(CH3)2 as the precursor, and ethylphosphonic acid 
(HPA) and tetradecylphosphonic acid (TDPA) as the ligands. They have 
prepared high quality CdTe, CdSe, and CdS QDs in technical grade (90% 
purity) TOPO solvent. This synthetic method did not use organometallic 
cadmium in the reaction, and therefore greatly reducing the possibility of 
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environment pollution caused by the organometallic compounds. Qu et al.27 
also used the CdO precursor to prepare high quality CdSe QDs which 
displayed rather impressive fluorescence quantum efficiency (up to 85%) with 
narrow emission half-width of only 23 nm. On the basis of the above studies, 
they have optimised the alternative routes toward high quality CdSe QDs by 
using different scale of ligand, precursor and solvent28. As the QD synthesise 
methods improved, some reagents (oleic acid and ODE) which were cheaper 
and more environmentally friendly have been successfully used to replace the 
expensive and toxic organic reagents (TOPO and TOP)29, 30. Over the past 
few years, a few greener routes to synthesise high quality QDs have been 
reported. These include the use of liquid paraffin wax as well as olive oil to 
replace the TOPO and ODE solvent, presumably because liquid paraffin wax 
and olive oil are much cheaper. For example, Sapra et al.31 used olive oil as 
solvent and ligand and successfully synthesised highly mono-disperse CdSe 
QDs, while Dai et al.32 used liquid paraffin wax as solvent and ligand to 
prepare high quality ZnSe QDs. 
 
1.3.1.1 QD synthesis in organic phase  
Normally, several different methods have been developed to synthesis QDs: 
(1) high temperature organometallic approach using organometallic 
precursors and nonpolar organic solvents under inert atmosphere, (2) low 
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temperature aqueous approach by using convenient air-stable precursors. 
The most often used one is the organometallic approach. This is often done in 
high boiling point organic solvents at 250-300 0C by adding organometallic 
precursors in a coordinating solvent, under which the precursor pyrolyse 
quickly to form tiny crystal nucleus. The crystal nucleus gradually grows into 
QDs with time at the growing temperature. As the QD grows into a certain 
size, the surface curvature is reduced; allowing the coordination ligands to 
bind strongly onto the QD surface to block further growth as temperature is 
lowered, making them stable and well-dispersed in solvent. The precursors 
used here are typically metal alkyl compounds such as dimethyl cadmium. 
The ligands are typically trioctylphosphine (TOP), trioctylphosphine oxide 
(TOPO), and long chain amines (e.g. lauryl amine, DDA). This method can 
produce QDs with high fluorescence quantum yield, well-controlled and 
uniform sizes and core/shell structure. This is the most widely used approach 
to produce high quality QDs. It has been successfully used to synthesise 
group 12-16 (e.g. CdSe, CdS and CdSe/ZnS) QDs. Figure 1-6 shows the 
schematic procedures of the high temperature route to synthesise CdSe/ZnS 
core/shelled QDs33. 
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Figure 1-6: High-temperature coordinating solvent synthesis of colloidal CdSe 
quantum dots. For a typical reaction, a three-necked flask is placed in a 
heating mantle and equipped with a thermocouple and temperature controller. 
A cadmium precursor (e.g. cadmium oxide or cadmium acetate) is dissolved 
in the tri-n-octylphosphine oxide (TOPO) coordinating solvent in an inert 
atmosphere (argon or nitrogen flow). Under continuous stirring at high 
temperature (∼320 °C), a selenium precursor dissolved in tri-n-octylphospine 
(TOP) is swiftly injected into the flask, initiating rapid nucleation of CdSe 
nanoparticles. Nucleation ceases quickly, partially due to the quick decrease 
in temperature (to ∼290 °C) caused by the injection of the room-temperature 
solution, and particle growth ensues. When the desired size has been 
obtained, the solution may then be cooled (∼220 °C) to prevent further 
particle growth. A passivating layer of ZnS may then be grown epitaxially by 
injection of zinc and sulfur precursors dissolved in TOP. Upon cooling to room 
temperature, these core-shell QDs may be isolated via precipitation33. 
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The advantages of this method are that the QDs synthesized can be made of 
different layers of semiconductor materials (i.e. with core/shell structures) and 
coated with hydrophobic ligands to provide colloidal stability and surface 
passivity. Besides, a wide size range of QDs can be readily prepared by 
controlling the reaction time with each size nearly mono-disperse and the 
resulting QDs are highly crystalline with high quantum yields (e.g. > 80%). Its 
disadvantages include the use of toxic reagents, high costs, and low safety of 
operating procedures33. 
 
1.3.1.2 QD synthesis in the aqueous phase 
Another approach is based on the aqueous synthetic route. Rajh et al.34 first 
reported the preparation of CdTe core QDs coated by hydrosulfide group. 
Since then, the use of hydrosulfide based small molecule protective agents to 
make water soluble QDs has been improved gradually. The aqueous phase 
preparation methods usually use  Zn2+, Cd2+ or Hg2+ as the metal precursor, 
and Se2- or Te2- as anion precursor and functional thiol containing small 
molecules as the protective ligands, for instance, 2-mercaptoethanol, 
thioglycolic acid (TGA), mercaptoethylamine, glutathione (GSH), cysteine etc. 
Through reflux heating, the precursors first nucleate and then gradually grow 
into QDs which are capped with the thiol-containing ligands.  
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Figure 1-7: (A) CdTe QDs were synthesized via aqueous synthetic route in 
which Cd2+ ions and NaHTe were reacted in the presence of dithiol-
functionalized ionic liquid (dTFIL). The control experiment with the use of 
mercaptoacetic acid (MAA) as a capping ligand was also conducted for 
comparison. (B) Absorption and photoluminescence spectra of IL-capped 
CdTe QDs with respect to the reaction time. PL spectra were recorded with an 
excitation at 470 nm. (C) Fluorescence images of dTFIL-capped CdTe QDs at 
different reaction times. All solutions were excited with a hand-held UV lamp. 
(D) Illustration of dTFIL-capped CdTe QD with estimated dimensions35. 
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Figure 1-7 shows an effective method for aqueous synthesis of highly 
luminescent and stable CdTe QD by using thiol-functionalized ionic liquid as 
capping ligand molecules. The photoluminescence quantum yield of dithiol-
functionalized ionic liquid (dTFIL) capped CdTe nanocrystals reached up to 
∼40%. The luminescent property was maintained for 8 weeks without obvious 
change of physical appearance, making it an attractive method to make 
functional QDs directly from the water phase35. 
QDs prepared by the aqueous synthetic method possess several merits: (1) 
the use of water as solvent; (2) use of inorganic salt as the reaction precursor; 
(3) the synthetic procedure is simple; (4) the QDs are readily water-soluble 
and can be applied to bio-system directly; (5) the QDs are capped with 
functional ligands, allowing for easy functionalisation and bioconjugation35. 
However, most of these QDs (except for CdTe and HgTe) tend to have 
relatively low quantum yield and relatively large particle size poly-diversity and 
low crystallinity. Moreover, since the core is directly exposed to the outside 
environment (this approach is not suitable for making high quality core/shell 
QDs)35, their fluorescence is often sensitive to environmental changes, which 
can significantly restrict their applications. 
43 
 
 
Figure 1-8: Chemical structures of thiol capping ligands that have been used 
in the synthesis of QDs in the aqueous phase36. 
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Figure 1-8 shows a wide range of thiol containing compounds that have been 
successfully used as the capping ligands in the aqueous QD synthetic 
approach36. 
To increase the quantum yield and solve the problems outlined above, Guo et 
al.37 changed the formulation of cadmium precursor and optimized the ratios 
between the protective agent and Cd2+, and prepared a TGA coated CdTe QD 
with a QY as high as 50%. Using similar method, Rogach et al.38 further 
improved the QY of the CdTe QD to 60%. While Li et al.39 carefully 
investigated how the reaction conditions affected the preparation of 
mercaptopropanoic acid (MPA) coated CdTe QDs. They found that the pH 
and concentration of cadmium precursor solution strongly affected the QY of 
the resulting QD, with pH = 8.00 and 1.25 mM cadmium precursor 
concentration being optimum for the QD synthesis, under which the resulting 
CdTe QD exhibited a high QY of 67%. Their results indicated that the MPA 
ligand on the QD surface not only decreased the surface defects but also 
prevented the continuous growth of the QD. Zhao et al.40 studied how the 
Cd/Te ratio affected the luminescence property of QDs.  They found that the 
higher the Cd/Te ratio, the better passivation of the QD surface. In addition, 
Chen et al.41 made a mercaptamine coated CdTe QD where they have used 
the amino functional group of the mercaptamine to conjugate the DNA 
molecules directly. After DNA conjugation, the fluorescence intensity and 
photo-stability were found to have improved dramatically, allowing it to be 
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used in imaging of living organism. Jiang et al.42 prepared a CdS QD using 
glutathione (GSH) as protective agent. They found that increasing the reaction 
temperature decreased the reaction time dramatically while increased the QY 
up to 36%. In addition, Yang et al.43 used a mixed glutathione (GSH) and 
cysteine (molar ratio = 1:3) as the protecting agents for QD synthesis. Since 
GSH and cysteine both contain amino- and carboxylic acid- groups which are 
charged and therefore offering good water solubility. The resulting CdTe QD 
displayed a highly impressive QY of as high as 70%, which is so far the 
highest for the CdTe QDs prepared by the aqueous synthetic route. Liu et al.44 
developed a one-step method to make ZnSxCd1-xSe mixed QDs using 
cysteine as the protecting agent in an aqueous solution. They found that after 
exposure to the ultra-violet light, cysteine decomposed to give S which 
subsequently bound to the QD surface, leading to a QD surface 
reconstruction and significantly increased QY to 26.5%. Last but not the least, 
Deng et al.45 chose three different kinds of protecting agents (MPA, TGA, 
GSH) to make ZnSe and ZnxCd1-xSe QDs in the water phase. They found 
that the protective agents had significant impact on the growth speed and final 
size of the QDs.  
In addition to the approaches mentioned above, a number of other aqueous 
based synthetic methods, such as the hydrothermal growth,46 microwave 
assisted reaction and so on, have also been developed to make water-soluble 
QDs47.  
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Despite a number of different synthesis methods have been developed to 
prepare QDs to be directly soluble in water or in organic phase, some further 
developments are still needed; 1) the elements used to synthesis the QDs are 
mostly toxic, which can limit their use in living organisms; 2) the route to 
synthesise the QDs in organic phase often needs high temperature, oxygen-
free environment and organic solvent which can cause environmental 
pollution; 3) some synthesis procedure can be dangerous when using 
organometallic precursors; 4) the hydrophobic QDs should be surface 
modified before biological application; 5) the route to synthesise QDs in the 
water phase often produces low QY with limited stability under biological 
conditions, which can limit their use in biosensing and biomedical applications. 
 
1.3.2 Structure of core/shell QDs 
To date, most experiments often use core/shell QDs capped with hydrophobic 
TOPO surface ligands, which have high QY and can be made biocompatible 
after surface modification. Figure 1-9 shows typical structures of CdSe/ZnS 
core/shelled QDs coating with TOPO ligands. 
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Figure 1-9: (A) an illustration of the structure of a core-shell QD. The core is 
coated with an inorganic shell, which is further coated by a layer of organic 
ligands. The Figure is taken from Evident technologies: 
http://www.evidenttech.com. (B) Schematic structure of a CdSe/ZnS 
core/shell QD. High-quality QDs are normally stabilized by a layer of 
coordinative organic ligands, such as TOP (trioctylphosphine) or TOPO 
(trioctylphosphine oxide), which make them strongly hydrophobic and only 
soluble in nonpolar organic solvents. 
 
The photo physical properties of QDs are strongly dependent on their surface 
properties; the presence of defects can seriously affect their fluorescence 
quantum efficiency. Core-only QDs usually have relatively low fluorescence 
quantum yield and limited resistance to photo-bleaching and chemical 
oxidation. If the defects only exist on the surface, then the QDs need to be 
capped by organic ligands to passivate the surface. However, organic ligands 
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can only passivate anionic but not cationic defects. Meanwhile the use of 
inorganic material shell can not only eliminate both anionic and cationic 
surface defects but also allow the formation a new type of core/shell QD48. 
Coating the QD core with another layer of lattice matching higher band-gap 
inorganic material shell can significantly improve the stability of the QDs. In 
this case, the exciton carriers are restricted within the core only upon photo-
excitation, and thereby significantly improving fluorescence quantum yields12, 
49-51, resistance against photo-oxidation52, 53, and chemical and thermal 
stability54. For example, Hines et al,55 and Bawendi et al6, have used Zn(CH3)2, 
ZnEt2 and (TMS)2S as precursors to prepare CdSe/ZnS core/shell QDs, 
where the capping a ZnS shell not only can eliminate dangling bond(s) on the 
QD surface, but also confine the exciton carriers to the fluorescence core only, 
leading to significantly improved fluorescence quantum efficiency to around 
40-50%. After that, Reissue et al49, first used CdO as metal precursor added 
in a specifically scale HDA/TOPO coordinating solvent  to prepare the CdSe 
core QD, and then used zinc stearate to coat the core QD with a ZnSe shell, 
yielding a CdSe/ZnSe core/shell QD with impressive fluorescence quantum 
efficiencies of  60-85%. Thereafter, Mekis et al56, used Cd(Ac)2 as metal 
precursor in HDA-TOPO-TDPA mixed solvent to prepare the CdSe core QD 
first, and then added H2S gas into CdSe QD solution to obtain high 
luminescent CdSe/CdS core/shell QDs with adjustable fluorescence spectrum 
from green to red. Pron’s group further made new core/shell/shell 
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CdSe/ZnSe/ZnS and CdSe/CdS/ZnS QDs57-59 which can offer higher stability 
against photo-oxidation and higher QYs than the normal core/shell QDs. 
 
Figure 1-10: Schematic representation of energy-level alignment by selection 
core and shell materials, leading to the formation of different QD types. (A) 
Type I QD where both electron and hole are confined in the core; (B) Type II 
QD with localization the electron in the shell; (C) Type II QD with localization 
of the hole in the shell. (D) Quasi-Type II QD with localization of the electron 
in both and the core and shell. (E) Inverse-Type I QD with localization of both 
carriers in the shell23. 
 
So far, many types of core/shell QDs or core/shell/shell QDs made of II-VI, IV-
VI, and III-V semiconductors have been prepared with different relative core 
and shell band energy and band gaps. As Figure 1-10 shows, there are four 
types of energy level alignments in core/shell QDs. For the Type I QDs (a 
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typical example CdSe/ZnS, where the shell valency and conduction bands are 
lower and higher than the corresponding core material), the core band gap is 
located within the shell band gap, therefore, the exciton carriers are fully 
confined within the core, the recombination probability of electron- hole pair is 
significantly increased, while the non-radiative decay is greatly suppressed. 
As a result, the QY is greatly increased. Any changes to the shell do not affect 
its fluorescence too much. For example, Hines and Guyot et al,55 prepared the 
CdSe/ZnS QD first by coating with a 3 nm thick ZnS shell on the core (QY up 
to 50%). Type I configuration is most used in biological application because it 
offers the best confinement of exciton. For other three types, (Type II and 
inverse Type I) the electron and/or hole are located either in the core or in the 
shell. The exciton recombines across the core/shell interface; the energy of 
emission is less than the band gap of either the core or shell. It will offer lower 
absorption coefficients and increase photoluminescence (PL) decay times. 
Because of different semiconductor materials (ZnSe, CdS, or ZnS) have 
different energy gap, and have different absorption coefficients. The 
absorption coefficient determines how far into a material light of a particular 
wavelength can penetrate before it is absorbed. Furthermore, surface 
modifications like ligand exchange will form new surface traps. With the 
excited electrons being spread out of the core/shell structure, the 
fluorescence properties of such QDs are strongly dependent on surface 
properties, because surface traps can greatly reduce the QD fluorescence. 
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1.3.3 Surface modification of QDs and QRs 
1.3.3.1 Surface modification of QDs 
All QDs prepared are coated with a layer of hydrophobic or hydrophilic ligands 
which control the QDs’ solvent dispersibility, effective volume, surface charge 
and function. The ligands control the QD’s solubility, aggregation and/or 
precipitation in solution. It has been reported that multiple precipitation and 
centrifugation cycles often cause the QDs to aggregate and precipitate from 
solution, presumably due to the loss of some surface ligands60. Since most 
high-quality QDs are prepared by the high temperature organometallic route, 
these QDs are usually capped with hydrophobic ligands (such as TOPO) 
making them insoluble in aqueous system. However, for biological 
applications, water-solubility is essential and thus such hydrophobic QDs 
need to be surface modified to make them soluble in water. In this regard, a 
numbers of different approaches have been reported, which can be classified 
into three main methods: surface ligand exchange, silica encapsulation, and 
amphiphilic polymer or lipid micelle encapsulation, as shown in Fig. 1-11 16, 61. 
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Figure 1-11: (A) schematic representation of different possible route to 
transfer QDs from organic to aqueous medium. (B) Three general surface 
chemistries used to convert QDs from hydrophobic to hydrophilic16, 61. 
 
Ligand exchange is a useful method which uses small molecules or polymers, 
such as mercapto- caboxylic acids [HS-(CH2)n-COOH], dithiothreitol, 
dihydrolipoc acid, oligomeric, cross-linked dendrons and poly(ethylene glycol) 
(PEG), to replace the original ligands of QDs 3, 5, 62, 63. These ligands all have 
terminal functional groups to anchor to QD surface, while hydrophilic 
functional groups are pointing outwards to provide water solubility and other 
functional groups for further conjugation to specific biomolecules, such as 
DNA, non-antibody binding proteins (nABP) or Biotin. This method only 
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adds/displaces a thin layer of ligands on QD surface, producing little influence 
on the hydrodynamic diameter (HD) of the QDs, and thus very useful for 
further making QD-FRET based sensors which require compact QD 
structures. However, there are also obvious drawbacks of this method; the 
stability of the new ligand is often affected by the surround environment such 
as temperature, pH value or salt concentration. It has been reported that 
dithiol-based molecules can provide better stability over mono-thiol based 
molecules, and tridentate thiol ligand can provide even better stability over 
dithiol-based molecules, because of the stronger multi-dentate binding61, 64. 
 
Figure 1-12: Modular design of hydrophilic ligands with terminal functional 
groups used in this study64. 
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The Mattoussi group has designed a series of dihydroloic acid (DHLA) based 
ligands coupled with a poly(ethylene glycol) (PEG) linker and a terminal 
functional group. (Figure 1-12) Each ligand contains three main parts, anchor 
group (bidentate thiol group), hydrophilic segment (PEG chain) and terminal 
functional groups (biotin, carboxylic acid, or amine). Surface binding assays, 
cellular internalization and imaging experiments show that QDs capped with 
these ligands are stable over a broad pH range (e.g. 4~10) and accessible to 
simple bio-conjugation techniques such as protein conjugation of QDs driven 
by histidine coordination65. However, these ligands are directly bound to QDs’ 
surface metal ions, and a large excess of expensive ligands are used 
(ligand:QD molar ratio of ca. 105 :1) which often lead to a significant decrease 
of the QY of the QD64, 66. Another method recently developed by the Mattoussi 
is the photo-ligation method (Figure 1-13) where they found that irradiation of 
the thiolic acid (TA) based ligands by UV light prior to mixing with hydrophobic 
QDs was sufficient to promote ligand exchange. More recently they found that 
the photo ligation of the TA based ligands with the QDs can also be carried 
out simply by using sunlight. They have further probed the nature of the 
photochemical transformation of the TA-ligands and found that irradiation 
(using either a UV photo reactor or sunlight) altered the nature of the disulfide 
groups in the TA, yielding a different product mixture from the chemically 
reduced ligands. Irradiation of the ligand in solution generates a mixture of 
monomeric and oligomeric compounds. Ligation onto the QDs selectively 
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favors oligomers, presumably due to their higher coordination affinity onto the 
metal-rich QD surfaces. This optically controlled ligation of QDs combined 
with the availability of a variety of multidentate multifunctional TA-modified 
ligands opened up new opportunities for developing fluorescent platforms with 
great promises for use in imaging and sensor design.67 
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Figure 1-13: Schematic representation showing the cap exchange using 
preirradiated ligands. (A) Representation of the starting QDs and ligands 
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along with white light and fluorescence images of a two-phase mixture of 
TOP/TOPO-QDs in hexane and preirradiated TA-PEG750-OMe in methanol, 
immediately following mixing; four samples of distinct color QDs are shown. 
(B) Schematic representation of the QD ligation combined with white light and 
fluorescence images of the above two-phase solutions following phase 
transfer. (C) Schematics of the final hydrophilic PEG-capped QDs together 
with fluorescent images of these QDs in water. The dispersions were excited 
using hand-held UV lamp, with λex = 365 nm. The QD samples shown emit at 
540 nm (green), 570 nm (yellow), 590 nm (orange), and 630 nm (red).67  
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Figure 1-14: Sketch of the silanization method. The TOPO-capped CdSe/ZnS 
core/shell particles are dissolved in pure MPS, drawn in its hydrolyzed form 
for convenience in the figure. After basification, the MPS replaces the TOPO 
molecules on the surface. The methoxysilane groups (Si-OCH3) hydrolyze into 
silanol groups (Si-OH), and form a primary polymerization layer. Heat 
strengthens the silanol-silanol bridges by converting them into siloxane bonds 
and releasing water molecules. Then, fresh silane precursors containing a 
functional group (F = -SH, -NH2; -PO-(O
-)CH3) are incorporated into the shell 
and may tailor the nanocrystal surface functionality. In a last step (not shown) 
the remaining hydroxyl groups are converted in methyl groups; this last step 
blocks further silica growth68. 
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Another strategy shown in Figure 1-14, silica encapsulation, is to coat the QD 
surface with layers of silica which can also make the QDs soluble in water 69. 
This method is quite similar to the ligand exchange strategy, where 
hydrophilic silica replaces the original ligands of QDs, and functional groups 
such as COOH, NH2 and SH can be further introduced to conjugate functional 
biomolecules. However, QDs modified by this way normally have relatively big 
sizes which can limit their use in biology in situations that require compact 
sizes, e.g. FRET based biosensing. 
 
Figure 1-15:  (a) Structure of a multifunctional QD probe, showing the 
capping ligand TOPO, an encapsulating copolymer layer, tumor-targeting 
ligands (such as peptides, antibodies or small molecule inhibitors) and 
polyethylene glycol (PEG). (b) Chemical modification of a triblock copolymer 
with an 8-carbon side chain. This hydrophobic side chain is directly attached 
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to the hydrophilic acrylic acid segment and interacts strongly with the 
hydrophobic tails of TOPO70. 
 
Amphiphilic polymer encapsulation is to wrap a hydrophobic QD particle with 
amphiphilic polymers to make it water-soluble70, 71 (Figure 1-15). The 
amphiphilic polymer contains both hydrophobic and hydrophilic side groups. 
The hydrophobic side groups can interact with the hydrophobic ligands on the 
QD surface through van der Waals interactions and the exposed hydrophilic 
side groups provide water solubility 72, 73. In this case, these polymers just 
interact with hydrophobic ligands on the QD surface; they do not directly 
interact with the QD surface atoms (no change of the QD surface coordination 
environment). Therefore the resulting water-soluble QDs can often maintain 
their native high QYs. However, QDs modified by this way often have large 
sizes with hydrodynamic diameters typically greater than 25 nm22, 74, which 
could limit their applications in situations that require small sizes. 
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1.3.3.2 Surface modification of QRs 
 
Figure 1-16:  (a) A cartoon illustrating silanization of quantum rods. Cross-
linked silanes are priming molecules for the surface coating. (b) Chemical 
synthesis of Dual-Emitting Hybrid Nano thermometers. QRs were transferred 
into water using a poly(acrylic acid)-based amphiphilic random copolymer 
displaying an optimized ratio of hydrophobic alkyl chains, carboxylic acids and 
alkyl amines8, 75. 
Similar to QDs, high-quality QRs are also prepared to be only soluble in the 
organic solvents. It is necessary to design a surface modification to make 
them soluble in water and render them biofunctional. In this regard, a 
numbers of different approaches have been reported. However, conventional 
surface ligand exchange method is generally not suitable for Quasi-Type II 
QRs23 (e.g. CdSe/CdS) because cap-exchange with strongly coordinating 
hydrophilic ligands (e.g. thiol-containing ligands) lead to significantly 
quenched QR fluorescence. Therefore, two main methods have been used to 
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deal with QRs: silica encapsulation, and amphiphilic polymer or lipid micelle 
encapsulation as shown in Figure 1-16. QRs after silanization or 
encapsulation with an amphiphilic polymer shell are stable in aqueous buffer 
and biocompatible 8, 75.  
 
1.3.4 Bioconjugation of QDs  
QDs can be conjugated with specific biomolecules by several approaches as 
shown in Figure 1-17.  After coating QDs with amphiphilic polymers, 
biomolecules can be linked to the QD surface via functional groups (i.e. –
COOH, -OH, -NH2, maleimide) by covalent bonding
76. Alternatively 
biomolecules can also be directly linked to the QD surface by poly-Histidine-
tags if the QD surface is accessible to direct binding. This is a simple, rapid 
and straightforward method for QD-bioconjugation, producing QD-
bioconjugates with small hydrodynamic sizes. However, this method is not 
suitable for QD coated with dense surface capping ligands whose surface is 
not accessible. Furthermore, the biotin-avidin interaction is also a commonly 
used QD-bioconjugation approach, but the use of avidin or biotin-fuctionalized 
QDs will increase the size of QD-bioconjugate probe which will limit use in 
FRET analysis and cellular assays. Figure 1-17 illustrates an overview of the 
different bioconjugation methods between QDs and biomolecules. 
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Figure 1-17: Illustrative overview of the chemistry of core-shell QDs. Coatings 
for aqueous solubility are as follows: (i) amphiphilic polymer coating with 
carboxyl(ate) groups; (ii) amphiphilic polymer coating with PEG oligomers; (iii) 
dithiol ligand with a distal PEG oligomer; (iv) dithiol ligand with a distal 
zwitterionic functionality; and (v) dithiol ligand with a distal carboxyl(ate) group. 
Common R groups include carboxyl, amine, and methoxy, although many 
others can be introduced (e.g., see vi, x, xi). Methods for conjugating 
biomolecules of interest (BOI) are as follows: (vi) biotin-streptavidin binding; 
(vii) polyhistidine self-assembly to the inorganic shell of the QD; (viii) amide 
coupling using EDC/s-NHS activation; (ix) heterobifunctional crosslinking 
using succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC; 
structure not shown); (x) aniline-catalyzed hydrazone ligation; and (xi) strain-
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promoted azide–alkyne cycloaddition. The double arrows are intended to 
represent conjugation between the functional groups and, in principle, their 
interchangeability (not reaction mechanisms or reversibility)76. 
 
1.3.5 QD and QR in cell marking and labelling 
QDs have been successfully applied to label in vivo and in vitro systems, as 
well as in marking the structure of cells and proteins. The rationale here is that 
after conjugation of a specific antibody or small molecular ligand to the QD, it 
can specifically target/mark different intracellular organelles and/or skeletal 
systems, allowing for easy fluorescence detection via the specific coloured 
emission of the QD.  
 
Figure 1-18: Localization of NLS-qdots in the nucleus (A) or in the perinuclear 
region (B). In both panels, the top row represents the phase contrast image, 
while the central row represents the fluorescence image. The bottom row is 
an overlay of the top and central rows. In certain cases, such as the cell at the 
far left of panel A, NLS-qdots localized inside the nucleus reveal finer 
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structures such as nucleoli within the nucleus, one of which is indicated with 
the arrow. Scale bars: 10 µm77. 
 
Through transfection, Chen et al.77 managed to deliver a specific QD-marker 
molecule conjugate into the cell nucleus. In this experiment, they prepared a 
QD-peptide conjugate carrying the SV40 large T antigen nuclear localization 
signal (NLS) and transfected live cells with this conjugate. The movements of 
the QD-NLS conjugate from cytoplasm to the cell nucleus as well as its 
accumulation at the nucleus were monitored by fluorescence imaging shown 
in Figure 1-18. Besides live cell imaging, QD has been further applied to study 
the transportation pathway of endogenous proteins, cuticle proteins, cell 
matrixes and inside and outside of the cells.  
 
Silanized QRs conjugated with various biomolecules through surface amino, 
mercapto, or carboxyl functional groups have also been prepared. Since 
antibody-antigen affinity is one of the most specific biological interactions and 
widely used for fluorescence imaging, Fu et al.8 tested the conjugation of 
silanized particles with mercapto surface groups to anti-Her2 antibodies 
through a cross linker sulfo-SMCC as schematized in Figure 1-19. After 
incubating with the cells, the QR surface anti-Her2 antibody binds to the 
external domain of cancer cell surface over-expressed Her2, allowing for 
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specific targeting and fluorescence imaging of cancer marker Her2 on the cell 
surface in this case. 
 
 
Figure 1-19: Schemes for antibody bioconjugation of quantum rods and 
Immuno-fluorescence labelling of breast cancer cell marker Her2 on breast 
cancer cells SK-BR-3. The Her2 marker was labelled with mouse anti-Her2 
antibody and goat anti-mouse IgG F(ab’)2 conjugated quantum rods/dots. The 
right bottom images show that there is minimum binding of free nanocrystals 
to the anti-Her2 antibody treated cells. Scale bar is 20 µm8. 
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1.3.6 QDs in vivo imaging  
Because of the high complexity of bio-systems, an effective fluorescence 
probe should satisfy a number of requirements. For instance, they should 
possess a good photo-stability against photobleaching, cause minimum 
disturbance to the intrinsic function of the organism, and have a high 
fluorescent quantum yield, etc. As discussed above, QDs can satisfy most of 
such requirements and therefore, the development of effective QD based in 
vivo imaging probes have attracted a great deal of research interest 78. 
Dubertret et al.22 increased the stability and biocompatibility of the QD by 
coating it with polyethylene glycol (PEG)-functionalised ligands and 
successfully used it to track and observe the development stages of African 
frog embryo. Kim et al.79 injected the QD probes into the groin subcutaneous 
tissue of swine, and observed that the QDs could spread to the pre-lymph 
nodes for lymph nodes imaging. Gao et al.71 investigated the specific imaging 
with the QD probes in mice as shown in Figure 1-20. They conjugated the QD 
with an antibody that can specifically recognize prostate specific membrane 
antigen (PSMA), a biomarker that is over-expressed in prostate cancer 
tumours. Through the subcutaneous injection, the size and position of planted 
prostate cancer tumour could be observed clearly in mice from the QD 
fluorescence. The structural design involves encapsulating luminescent QDs 
with an ABC triblock copolymer and linking this amphiphilic polymer to 
tumour-targeting ligands and drug-delivery functionalities. What they found 
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was that there was no non-specific adsorption in the kidney and brain tissues 
slices, but some QD markers were swallowed into cells after adsorbed on the 
histocyte surface. The high specificity and effective endocytosis ability of the 
QD revealed here will undoubtedly provide a new approach in studying drug 
target in vivo. This work therefore laid the foundation for the QD to be applied 
in vivo studies. 
 
Figure 1-20: Spectral imaging of QD-PSMA Ab conjugates in live animals 
harboring C4-2 tumour xenografts. Orange-red fluorescence signals indicate a 
prostate tumour growing in a live mouse (right). Control studies using a 
healthy mouse (no tumour) and the same amount of QD injection showed no 
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localized fluorescence signals (left). (a) Original image; (b) unmixed auto 
fluorescence image; (c) unmixed QD image; and (d) super-imposed image71. 
After in vivo imaging, histological and immunocytochemical examinations 
confirmed that the QD fluorescence signals came from an underlying tumour. 
Note that QDs in deep organs such as liver and spleen were not detected 
because of the limited penetration depth of visible light71. 
In addition, QD can also be used for long term tissue optical imaging. Its 
biocompatibility can be enhanced via specific surface coating and engineering, 
making prolonged optical imaging of inside tissues possible. This is a property 
that the majority of fluorescent dye molecules cannot match. Morgan et al.80 
injected a near-infrared emitting CdMnTe/Hg QDs into a mice body, and 
confirmed it could be used for deep optical imaging of living organisms. 
However, the accumulation at the reticuloendothelial system and the influence 
of kidney filtration must be carefully considered before applying the QD in 
living body.  
 
1.3.7 QD based Multiplexed assay/labelling 
The fact that different coloured QDs can be excited by a single-colour light 
source yet each producing its specific, distinct colour emission make QDs 
excellent for developing multiplexed assays and labelling agents which can 
play a pivotal role in screening nucleic acid and protein. Jaiswal et al.81 used 
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different coloured QDs conjugated with antigens against nucleus and 
cytoplasmic microtubules respectively for specific intracellular imaging. Using 
a single laser excitation, they found that the two different coloured QDs 
stained different regions of the same cell, and could be distinguished clearly. 
Kaul et al.82 successfully labelled the WI-38 normal cells and U2OS cancer 
cells via their mortalin protein identity using QDs conjugated two different 
antibodies against such specific markers, allowing them to distinguish these 
two different cells using fluorescence microscopy. 
 
Figure 1-21:  (A) the four markers, all associated with EMT, are N-cadherin, 
EF (elongation factor)-1 , E-cadherin and vimentin, and their corresponding 
QD colors are 565, 605, 655 and 705 nm. The cell nuclei were counterstained 
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blue by DAPI, and the QD data were captured under blue excitation. (A left) 
Color fluorescence image of highly metastatic prostate cancer cells (clone 
ARCaPm); (A right) single-cell QD data obtained from image left.83 (B) 
Multicolour spatiotemporal strategy for labelling various subcellular 
compartments and structures with QDs and an example of a corresponding 
epifluorescence image.84 
 
Xing et al.,83 who used one colour of QD as an internal standard to target a 
housekeeping gene product that was expressed at a constant level. Four 
biomarkers—vimentin, N-cadherin, receptor activator of nuclear factor кB 
ligand, and E-cadherin—were labelled with secondary antibody conjugates of 
QD565, QD605, and QD655, respectively. An internal standard, elongation 
factor-1a, was labelled with QD705 (Figure 1-21A). They have achieved 
simultaneous staining of four different biomarkers with expression profiles 
consistent with western blot data. Moreover, QD staining provides spatial 
localization information (both inter- and intracellular), which is not possible 
with western blot or molecular biology techniques. Here, epifluorescence was 
used in combination with spectral imaging (vide infra). In general, more insight 
can be obtained from the detection of more biomarkers in parallel, suggesting 
a key role for the multiplexing advantages of QDs in diagnostic pathology. A 
report by Delehanty et al.84 demonstrated spatiotemporal multicolour labelling 
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of live A594 cells (human alveolar adenocarcinoma) by using mixed delivery 
techniques over several days (Fig. 1-21B). When combined with four narrow 
bandpass filters, these QD probes provided four distinct spectral windows for 
imaging each of the aforementioned cellular components with a single 
excitation at 457 nm.  
 
1.3.8 QD in drug target research.   
There is overwhelming evidence that the discovery and verification of new 
drug targets is a key source for developing new drugs. Uncovering the drug 
target based on interactions between bio-molecules is one of the most 
important approaches. Chan et al.85 noticed that the extremely high 
fluorescence stability of QD is an outstanding feature as compared to other 
organic dyes. Hence, it can be used to conduct long-term (from several 
minutes to hours) monitoring and tracking the interactions between bio-
molecules. Another advantage of QD is that it can observe many target 
molecules in or on the surfaces of the living cells simultaneously by using 
different coloured QDs. In this case, how they can implement the biological 
functions inside the cells and their correlations can be studied. Over the past 
decade, an increasing number of new types of quantum dots have been 
reported. What is more, the size, shape and internal structure of these QDs 
can be controlled precisely.86 These have provided a new path for the study of 
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receptor diffusion dynamics, ligand-receptor interactions, enzyme kinetics and 
so forth down to the single molecular level.5, 70, 87, 88 For example, Sandra et 
al.89 conjugated the 5-hydroxytryptamine to the quantum dots and used it to 
locate the receptor on the surface of cells successfully. At the same time, they 
examined the process how translocator proteins first drove the transmission of 
neurotransmitter when signal got through the intercellular space between 
adjacent nerve cells and then returned back to the cells. Recently, Lidke et 
al.87 marked the epidermal growth factor (EGF) with quantum dots, use the 
specific ones to combine with EGF receptor and activate the signal 
transduction of erbB/EG Mediator.  
Generally, to achieve the desired effect, one potent drug frequently needs to 
bind to its specific target molecules, while avoid binding to other non-target 
sites to avoid side effects. Combining different QDs with different drug target 
molecules is a superior way to detect the target sites simultaneously. Wood, 
K.V. et al.90 had managed to mark three different intracellular organelles with 
three different coloured QDs in a single cell, the microtubule by a green, the 
Golgi apparatus by orange-yellow and the nucleus by red fluorescence QDs. 
After excitation by a single wavelength laser, the three colours are appeared 
simultaneously. Besides, using effective single molecule active compounds as 
the probe is another essential way to look for drug target spots. The active 
molecule-QD conjugates can then bind to the target spots on the surface of 
cells, allowing for easy identification of drug targets via the specific QD 
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fluorescence signals. This can improve the susceptibility and specificity in 
searching for the drug target spots.  
The QD acting as an exceptionally promising fluorescent marker in organisms 
has been witnessed an increasing demand in the clinical drug applications. 
There is an pressing need to find out effective ways to enable drugs to enter 
and function in every target sites in the body, achieving the maximum 
therapeutic efficacy at the minimum dose range and without causing obvious 
toxic and side effects91. In this regards, the inorganic nanostructures (such as 
QDs) linked with bio-systems have attracted extensive interests because they 
combine the unique, size-dependent properties of nanomaterials and target 
specificity of biomolecules.  Despite a relatively large size, the bio-connected 
QD was found to behave similarly to fluorescent protein probe in imaging of 
living cells. No apparent steric hindrance and dynamic problems were 
observed 77.  
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1.4 . Fluorescence resonance energy transfer (FRET) 
 
1.4.1 FRET principle 
Fluorescence resonance energy transfer (FRET) is an energy transfer 
process which involves the non-radiative transfer of energy from a photo-
excited donor molecule to ground state acceptor molecule in close proximity 
(i.e. typically <10 nm), leading to lower energy emission by the acceptor not 
directly excited. This efficiency of the energy transfer process is strongly 
dependent on the distance between donor and acceptor, and hence is widely 
used in a wide range of biological applications, e.g. biosensing, probing 
specific biorecognication and conformational changes of biomolecules. To 
achieve highly efficient FRET interactions, the following key criteria are 
required: (i) the emission spectrum of the donor fluorophore must significantly 
overlap the absorption spectrum of the accepter fluorophore; (ii) the 
orientation of the two dipoles affects their coupling efficiency, donor and 
acceptor must be aligned as linear so that an acceptor dipole can be induced 
by the donor; (iii) the donor/acceptor separation distance should be small, 
typically no greater than 10 nm; (iv) the donor has a high quantum yield92, 93 
(Figure 1-22). 
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Figure 1-22: A schematic presentation of the FRET process. 92, 93 
The rate of energy transfer, k, for a single donor-acceptor pair separated by a 
distance r can be expressed by using the Förster formula94.  
𝑘𝐷−𝐴 =
𝐵 × 𝑄𝐷𝐼
𝜏𝐷𝑟6
= (
1
𝜏𝐷
) × (
𝑅0
𝑟
)
6
               (1) 
Where I is the integral of the spectral overlap function, and QD designates the 
quantum yield of the donor, R0 is the Förster distance, is excitation radiative 
lifetime of donor. B is given in the following equation: 
𝐵 =
[9000 × (𝑙𝑛 10)]𝑘𝑝
2
128𝜋5𝑛𝐷4𝑁𝐴
                    (2) 
B is a constant that is related to the refractive index of the medium, 
(Avogadro’s constant), and (the dipole orientation parameter). The value of 
the orientation factor, varies between 0 (for perpendicular alignment of the D-
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A dipoles) and 4 (for parallel dipoles); and for random oriented diploes, kp
2 = 
2/3. 
The FRET efficiency E is defined as: 
𝐸 =
𝑘𝐷−𝐴
𝑘𝐷−𝐴 + 𝜏𝐷−1
=
𝑅0
6
𝑅0
6 + 𝑟6
         (3) 
It is clear from the equation (3) that E is strongly dependent on the donor-
acceptor distance r. Specifically, E represents the fraction of excited photo 
energy that is transferred from the donor to the acceptor. 
 
 
Figure 1-23: the absorption spectra and emission spectra of donor and 
acceptor 94 
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FRET has long been an indispensable tool for probing molecular interactions. 
Method of FRET technology involves a single probe where two dyes (the 
quencher and the reporter) are in close proximity, e.g. < 10 nm. This 
technology can be used for bio-conjugate test to make sure the labeled 
protein or fluorescence protein has connected to the donor (QD). This is 
because a compact QD structure gives a small r value while the high QD 
fluorescence yields a large R0 value, both factors are strongly beneficial to 
improve E and hence FRET based sensitivity as E = 1/[1 + (r/R0)
6]. Since r is 
not only determined by the QD but also the associated bio-recognition 
molecule (binder) size, the use of small binders is also critical to improve 
FRET sensitivity95, 96. In order to make a good probe, the absorption spectrum 
of donor should have minimum overlap with that of the acceptor at the exciting 
wavelength (avoiding direct acceptor excitation, hence high background), and 
their emission spectra should have minimum overlap (ensuring easy 
separation of the donor and acceptor emissions), however, the donor 
emission should have strong overlap with the acceptor absorption spectrum 
for high FRET to happen 94. (Figure. 1-23) 
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1.4.2 QD for FRET investigation 
One example of such kinds of QD-bioconjugate probes are shown in Figure 1-
24. A luminescent QD can act as efficient energy donor and FRET to labelled 
DNA, protein and protease assembled on the QD surface. The bridging DNA 
chain is rigid and so it can control the distance between QD and acceptor (dye) 
precisely. This construct has been successfully used to investigate the 
distance dependent FRET in the QD-bioconjugate system, confirming that the 
QD-FRET system still obeys the Förster equation despite a relatively large 
size of the QD donor.97  
 
Figure 1-24: Schematic illustration of QD-FRET nanosensor for analysis of 
enzyme activity. a) QD-FRET sensor for the study of protease. b) QD-FRET 
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sensor for the study of protein kinase. c) QD-FRET sensor for the study of 
DNA polymerase. 97 
In this respect, Zhou, et al.98 found that functional thiols are very useful in QD-
bio-conjugation; where thiolated DNAs can directly self-assemble on to the 
mercapto-propionic acid (MPA) capped QD surface. Furthermore, it is 
possible to control the labelling position in the double-stranded DNA structure 
to conveniently control the separation distance between QD donor and dye 
acceptor to well within the R0 of the FRET pair, leading to high FRET 
efficiency at low Acceptor/Donor ratios. However, the above self-assembled 
QD-DNA system was not suitable for specific DNA detection due to strong 
non-specific adsorption. Later on, Zhou, et al.1 introduced a tri(ethylene glycol) 
linker in the QD surface coating ligands that eliminated the DNA non-specific 
adsorption, and the resulting QD-DNA conjugate was useful for both label and 
label free detection of DNA at low DNA probe/QD copy numbers. The 
schematics of the QD-FRET based sensing configurations are shown in 
Figure 1-25.  
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Figure 1-25: Schematic representation of the principles of the approaches for 
hybridization and label-free detection of DNA probes with a covalently coupled 
QD-DNA-T conjugate via a QD sensitized FRET signal1. 
 
In Figure 1-25(A), FRET from the QD to the labeled dye on DNA chain was 
used for detection of labeled DNA, while in (B) the specific intercalation of 
DNA intercalation dyes (ethidium bromide) within the formed dsDNA was 
used as acceptors for readout signal for label-free DNA detection. This design 
also allows the control of the separation distance between the QD donor and 
dye acceptor as well as the number of acceptors. 
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Zhan, et al65 introduced a two thioctic acid (TA) groups chemically link to a 
zwitterion moiety as surface coating ligands on QDs and further bio-
conjugated the QD to histidine-tagged proteins (mCherry). Moreover, the QD 
(donor) emission was quenched owing to FRET interactions with histidine-
tagged mCherry (Figure 1-26). The absorption data shown in Figure 1-26 (b) 
indicate that there is an increasing contribution to the measured spectra at 
586 nm, commensurate with the amount of added protein to the dispersion, 
which is attributed to the contribution of mCherry absorption. The composite 
photoluminescence spectra in Figure 1-26 (c) show that when the dispersions 
are excited at 400 nm (which coincides with the absorption valley of the 
protein) there is a progressive decrease in the QD emission concomitant with 
an increase in the contribution from mCherry when the molar concentration of 
the protein is increased. The absorption and fluorescence data confirm that 
conjugate formation has taken place. 
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Figure 1-26: Protein conjugation of QDs driven by histidine coordination. (a) 
Schematic representation of a self-assembled QD-mCherry conjugate 
detailing the structure of the different components; a CdSe-ZnS QD photo 
ligated with bis(TA)-ZW ligands is shown. (b, c) absorption and 
photoluminescence (PL) spectra collected from dispersions of QDs self-
assembled with mCherry at different molar ratios of 1:6, 1:9 and 1:15, along 
with the control samples of QDs and mCherry. The absorption spectra of the 
conjugates were normalized with respect to the value at 350 nm. The 
mCherry control spectrum was collected from a solution with the equivalent 
84 
 
mCherry concentration of 1:6 above. (d) Plot of FRET efficiency versus 
number of mCherry per QD conjugate.65 
 
Besides basic photo physical and biosensing studies, QD-FRET based 
systems have been shown to be useful in a wide range of other biorelated 
applications. The advantages of this technology are that, (i) it allows for in vivo 
studies of molecular interactions such as monitor physiological responses, live 
cell imaging and localization of FRET organelles; (ii) it can be easily linked to 
other instrumentation, e.g. being miniaturized for high-throughput assays of 
combinatorial products; (iii) it is relatively cheap to implement; (iv) 
measurement can be carried out very rapidly often done in a convenient 
separation-free format; (v) it can offer accurate measure of small changes in 
distance. A few disadvantages of FRET based methods include; (i) it can only 
work at relatively short donor-acceptor separation distances (e.g. < 10 nm), 
hence pose a strict limitation of on the size of the probes; (iii) it only gives 
information on the donor-acceptor distance; (iv) large excess of free 
fluorophores can also interfere with the energy transfer99-101. To be compatible 
with different QD-FRET sensing mechanisms, the QDs (donor) and labelled 
biomolecules (acceptor) need close enough, and the size of the biomolecules 
should fit for the QDs (e.g. small-molecule, peptide, protein, polymer, and 
DNA,).  
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1.5. Conclusion and aim of this project 
Quantum dots (QDs) and quantum rods (QRs) are a new type of fluorescent 
nanomaterial having unique size-dependent optical and electronic properties 
that are excellently suited for biomedical applications. These include size-
tunable, bright, narrow symmetric fluorescence emission, excellent optical and 
chemical stability, and large absorption cross sections, and excellent 
resistance against photo-degradation. By controlling the size and/or 
composition, it is possible to produce QDs with emissions covering from the 
UV to the near infrared range. They have a number of advantageous 
properties over the traditional organic dyes or fluorescent proteins in 
biomedical applications. They have been used to develop bioconjugate 
probes and showed promising applications in cell marking, bio-imaging, bio-
sensing, drug target and drug delivery research at the cellular and in vivo 
levels. A major limitation here is the potential toxicity and cytotoxicity of heavy 
metals contained in the QDs, and therefore the development of non-toxic QDs 
is imperative.  
Several different methods have been developed to synthesise the QDs. 
These can be roughly divided into two main classes: the organic phase and 
the aqueous phase synthesis. The advantages of the organic phase synthesis 
are that the resulting QDs have high fluorescence QY, excellent crystallinity 
with good size mono-dispersity and stability. However, it often suffers from 
drawbacks such as requiring toxic reagents, high costs, and hazardous 
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operating procedure. Moreover, the QDs are capped by hydrophobic ligands 
and water-insoluble, which have to be made water-soluble before being used 
in biological systems. In contrast, the aqueous phase QD synthesis does not 
require any toxic solvent, it is cheaper and easier to operate, and moreover, 
the resulting QDs are readily water-soluble so can be directly used in bio-
systems. However, most of these QDs have relatively low fluorescence QY, 
with limited chemical and photo stability.  
QDs and QRs are excellently suited for FRET based application because of 
their broad absorption and narrow symmetric emission, allowing wide choices 
of excitation wavelengths to minimise the direct excitation of the acceptor, 
leading to low background. Most QD-FRET systems use QD as the FRET 
donor and organic dyes as the acceptor. The FRET efficiency can be finely 
controlled by tuning the distance between the QD and dyes as well as the 
number of acceptor dyes attached to each QD. The QD can be conjugated to 
a wide range of functional molecules, e.g.  small-molecule, peptide, protein, 
polymer, and DNA, and the resulting QD-conjugates can act as novel FRET 
based sensing and imaging probes with broad ranges of biomedical 
applications. 
As discussed above, compact, water-soluble core/shelled QDs can be 
prepared easily via the ligand exchange method, which can be conveniently 
bio-conjugated with biomolecules for biosensing via a highly efficient self-
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assembly process with multi-Histidine-tagged biomolecules. However, there 
are still several challenges remained for the QD-FRET sensors 1) it can only 
work at relatively short donor-acceptor separation distances (e.g. < 10 nm); 
therefore, ligand exchange is better suited to make the required QDs than 
silica coating or amphiphilic polymer encapsulation. 2) Most current ligand 
exchange methods often produce significantly quenched QD, reducing the 
sensitivity of the resulting QD-FRET sensor.  
This project aims to address the following fundamental questions:  
1) to investigate why the cap-exchanged QDs often lose their fluorescence 
QYs;  
2) to investigate whether it is possible to develop an efficient cap-exchange 
method to allow post-exchanged QDs to retain their native QYs and high 
stability under biologically relevant conditions through improving and 
optimizing the ligand exchange procedures; ;  
3) to develop robust, sensitive ratiometric QD-FRET sensors for target 
proteins by combining such compact, bright QDs/QRs with small antibody 
mimetic proteins also known as non-antibody binding proteins (Affimers).  The 
Affimers are a new class of antibody mimetic proteins recently developed in 
our collaborator’s lab at the Faculty of Biological Sciences, University of 
Leeds. They have several advantageous properties over antibodies as target 
binders, including wide target choices; high binding affinity (low nM Kds), 
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rapid, cheap isolation, animal-free in vitro production (via bacteria expression) 
and excellent thermal-stability (Tm ≥80oC)102. More importantly, their much 
smaller molecular sizes (~1/10 of whole antibodies) are extremely well-suited 
for QD-FRET applications, allowing for significantly reduced donor-acceptor 
distance and hence improving sensitivity.  
4) In the long term, to develop robust QD-Affimer fluorescence probes for 
clinical diagnostics and cancer tissue imaging. In fact, robust, sensitive, 
specific detection of cancer markers in fixed cancer tissues has great value in 
clinical cancer diagnostics, but this is still challenging as there are no 
commercial diagnostic reagents available (including many antibody based 
reagents,) that can always provide unambiguous, reliable identification under 
current clinical setting. 
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Chapter 2 Synthesis of ligands  
 
In this Chapter, the synthesis of the surface capping ligands to be used in the 
preparation of robust, compact, biocompatible QDs/QRs probes in the 
following chapters are described. These compounds include several thioctic 
acid (TA) based ligands (TA-PEG750-OMe, TA-PEG2000-OMe, TA-Zwitterion, 
TA-PEG600-Biotin). The chemical structures of these ligands are shown in 
Figure 2-1. 
 
Figure 2-1: Chemical structures of TA-PEG750-OMe, TA-PEG2000-OMe, 
TA-Zwitterion, and TA-PEG600-Biotin. 
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2.1 Materials and Methods 
2.1.1 Materials 
Poly(ethylene glycol methyl ether) (average MW: 750; containing an average 
of ~15 PEG units, denoted as PEG~15 Acros organics); Poly(ethylene glycol 
methyl ether) (Average MW: 2000; containing an average of ~43 PEG units, 
denoted as PEG~43, Acros organics); Polyethylene glycol (PEG) with an 
average molecular weight of 600 (containing an average of ~13 PEG units, 
denoted as PEG~13); 11-Azido-3,6,9-trioxaundecan-1-amine (> 90% monomer 
purity), N,N-dimethyl-1,3-propanediamine (>99%), 1,3-propane-sultone (> 
99%), Triphenylphosphine (>98.5%), Dicyclohexylcarbodiimide (DCC, >99%), 
Dimethylaminopyridine (DMAP, >99%), Tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP.HCl, >98%), Triethylamine (>99%), Chloroform (> 
99.8%), Magnesium sulfate (>99%), Methanol (>99.9%), Potassium hydroxide, 
Methylene chloride (>98%), Sodium bicarbonate (>99.5%), Methanesulfonyl 
chloride (>99.7%), Sodium azide (>99.5%), Tri-phenylphosphine (>98.5%), 
Thioctic acid (TA, >99%), Ethyl acetate (>99.0%), and all other chemicals and 
reagents were all purchased from Sigma-Aldrich (Dorset, UK). These 
chemicals are purchased commercially from Sigma-Aldrich (Dorset, UK) and 
used without further purification unless stated otherwise. Solvents were 
obtained from Fisher Scientific (Loughborough, UK) and used as received. 
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2.1.2 Instrument and Methods1-3 
All moisture-sensitive reactions are performed under nitrogen atmosphere 
using oven-dried glassware. All dry solvents are dried by innovative 
technology prior to use, or are taken from sealed-bottles under nitrogen 
atmosphere. Evaporations are performed under reduced pressure on a rotary 
evaporator. Reactions are monitored by TLC on silica gel 60 F254 plates on 
aluminium and stained by iodine. Flash column chromatography was 
performed on silica gel 60 A (Merck grade 9385). 1H and 13C NMR spectra of 
the samples are recorded on Brucker DPX300 (500 MHz for 1H, 125 MHz for 
13C) in CDCl3. All chemical shifts are reported here in parts per million (ppm) 
and the coupling constants are reported in Hertz. Ultra-pure water 
(resistance >18.2 MΩ.cm) purified by an ELGA Purelab classic UVF system, 
was used for all experiments and making buffers. High resolution mass 
spectra (HR-MS) were obtained on a Bruker Daltonics MicroTOF mass 
spectrometer. Infra-red spectra were recorded on a PerkinElmer FT-IR 
spectrometer. UV-vis absorption spectra were recorded on a Varian Cary 50 
bio UV-Visible Spectrophotometer over 200-800 nm using 1 mL quartz 
cuvette with an optical path of 1 cm or on a Nanodrop 2000 
spectrophotometer (Thermo scientific) over the range of 200-800 nm using 1 
drop of the solution with an optical path length of 1 mm. All centrifugations 
were carried out on a Thermo Scientific Heraeus Fresco 21 microcentrifuge 
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using 1.5 mL microcentrifuge tubes at room temperature (unless stated 
otherwise).  
2.2 Ligand synthesis
1-8 
2.2.1 Synthesis of TA-PEG750-OMe and TA-PEG2000-OMe1 
The synthetic routes for TA-PEG750-OMe and TA-PEG2000-OMe were 
shown in Figure 2-2 
 
Figure 2-2: The synthetic route to TA-PEG750-OMe (n ≈ 15) and TA-
PEG2000-OMe (n ≈ 43). The reaction conditions are: (ia) MsCl, Et3N, THF; (ib) 
NaN3, NaHCO3, H2O; (ii) PPh3, EtOAc and 1 M HCl; (iii) thioctic acid, 
DCC/DMAP, CH2Cl2;  
Step 1: Synthesis of MeO-PEG750-N3 (compound 2) 
Monomethoxypolyetheylene glycol with an average molecular weight of 750 
(MeO-PEG750) (37.5 g, 50 mmol), THF (150 mL) and methanesulfonyl 
chloride (11.45 g, 100 mmol) were added in a 500 mL two-necked round-
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bottomed flask equipped with an addition funnel, septa and a magnetic stirring 
bar. Triethylamine (Et3N, 15 mL, 111 mmol) was loaded to the addition funnel. 
The reaction mixture was then purged with nitrogen and cooled to 0 °C in an 
ice bath. Triethylamine was then added dropwisely to the reaction mixture 
through the addition funnel (total addition time ~30 min). After that, the 
reaction mixture was allowed to warm up gradually to room temperature 
(~20 °C) and then stirred overnight. The product was checked by TLC on 
silica gel plate with CHCl3:MeOH = 10:1 (vol/vol) as elution solvent, Rf (MsO–
PEG750–OMe) = 0.65, Rf (HO-PEG750–OMe) = 0.35. After reaction was complete, the 
mixture was diluted with H2O (50 ml) and NaHCO3 (3.125 g, 37 mmol) was 
added. The resulting mixture was transferred to a separator funnel and 
extracted with CHCl3 (60 mL × 3). The combined organic phase was 
evaporated by dryness on a rotary evaporator, yielding slightly yellowish oil, 
40 g (48.3 mmol), 96.6% yields. 
The product from above reaction(40 g), sodium azide (7.75 g, 120 mmol), 
THF (50 mL), H2O (50 mL) and NaHCO3 (3.125 g, 37 mmol) were then added 
to 500 ml two-necked round-bottomed flask equipped with a distilling head 
using a round-bottomed flask as a solvent trap. The solvent trap was cooled 
with an ice-bath. The biphasic reaction mixture was heated under N2 to distil 
off the THF. The reaction mixture was then refluxed for overnight. After the 
reaction mixture was cooled to room temperature, it was transferred to a 
separator funnel. The product was extracted with CHCl3 (100 mL × 5). The 
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product was checked with TCL using CHCl3: MeOH =10:1 (vol/vol) as elution 
solvent, Rf (N3-PEG750-OMe) = 0.75. The combined organic layers were dried over 
Mg2SO4 (~20 g, ~30 min) with stirring. The Mg2SO4 was filtered off and the 
dried organic layer was evaporated to dryness on a rotary evaporator. A pale 
brown oil (24.93g, yield: 66.7%) was obtained. 1H NMR (500 MHz, CDCl3):  
(ppm), 3.35 (m, 5H, -OCH3 and N3-CH2-); 3.6-3.9 (m, 70H, CH2 in repeated 
PEG groups), 7.33 (s, 1H, impurity residue CHCl3). 
 
 
Figure 2-3: 1H NMR spectrum in CDCl3 of prepared MeO-PEG750-N3. 
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Synthesis of MeO-PEG2000-N3 (compound 2) 
Poly(ethylene glycol methyl ether) with an average molecular weight of 2000 
(MeO-PEG750) (30.0 g, 15 mmol), THF (150 mL) and methanesulfonyl 
chloride (3.82 g, 30 mmol) were added in a 500 ml two-necked round-
bottomed flask equipped with an addition funnel, septa and a magnetic stirring 
bar. Triethylamine (Et3N, 5 mL, 37 mmol) was loaded to the addition funnel. 
The reaction mixture was then purged with nitrogen and cooled to 0 °C in an 
ice bath. Triethylamine was then added dropwisely to the reaction mixture 
through the addition funnel (total addition time ~30 min). After that, the 
reaction mixture was allowed to warm up gradually to room temperature 
(~20 °C) and then stirred overnight. The mixture was then diluted with H2O 
(50 ml) and NaHCO3 (1.0 g, 10 mmol) was added. Sodium azide (2.60 g, 40 
mmol) was then added to 500 ml two-necked round-bottomed flask equipped 
with a distilling head with a round-bottomed flask as a solvent trap. The 
solvent trap was cooled with an ice-bath. The biphasic reaction mixture was 
heated under N2 to distil off the THF. The reaction mixture was then refluxed 
for ~8 hrs (or overnight). After the reaction mixture was cooled to room 
temperature, it was transferred to a separator funnel. The product was 
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extracted with CHCl3 (100 mL × 5). The product was checked with TCL using 
CHCl3: MeOH =5:1 (vol/vol) as elution solvent, Rf (N3-PEG2000-OMe) = ~0.5. Rf (HO–
PEG2000–OMe) = 0.3. The combined organic layers were dried over Mg2SO4 (~20 
g, ~30 min) with stirring. The Mg2SO4 was filtered off and the dried organic 
layer was evaporated to dryness on a rotary evaporator. A pale brown oil 
(27.8 g, yield: 85.2%) was obtained 1H NMR (500 MHz, CDCl3):  (ppm), 
3.35 (m, 5H, -OCH3 and N3-CH2-); 3.6-3.9 (m, 205H, CH2 in repeated PEG 
groups). 
 
 
Figure 2-4: 1H NMR spectrum in CDCl3 of prepared MeO-PEG750-N3 
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Step 2: Synthesis of OMe-PEG750-NH2 (compound 3) 
N3–PEG750–OMe (8.0 g, ~10 mmol), EtOAc (150 mL) and 1 M HCl (25 ml, 25 
mmol) were added into a 500 mL two-necked round-bottomed flask equipped 
with an addition funnel, septa and a magnetic stirring bar. Triphenyl-
phosphine (2.8 g, ~10 mmol) dissolved in 100 ml EtOAc was transferred to 
the addition funnel. The reaction vessel was purged with N2 and cooled to 
0 °C in an ice-bath while stirring. The triphenyl-phosphine solution was then 
added dropwisely under N2. The temperature was maintained to below 5 °C 
with an ice bath during the addition. Once the addition was complete, the 
reaction mixture was gradually warmed up to room temperature and stirred 
overnight under N2. The reaction mixture was then transferred to a separation 
funnel and the biphasic solution was separated. The aqueous layer was 
collected and washed with EtOAc (100 mL × 2). The aqueous layer was 
transferred to a round-bottomed flask and cooled in an ice bath. KOH (13.5 g) 
was then added slowly to the aqueous solution under magnetic stirring until 
the KOH was dissolved (pH > 10). The aqueous solution was transferred into 
a separation funnel and extracted repeatedly with CHCl3 (60 mL × 5). The 
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combined organic layer was dried over MgSO4 for 20 mins. After filting off 
MgSO4, the solvent was evaporated to dryness on a rotary evaporator, 
yielding a lightly yellow oil, 4.58 g, yield: 59.2%. Rfs (CHCl3:MeOH = 10:1, 
vol/vol) for Rf (N3-PEG750-OMe) = 0.75, Rf (NH2-PEG750-OMe) = 0.25. 
1H NMR (500 MHz, 
CDCl3),  (ppm), 2.87 (2H, -NH2), 3.35 (s, 3H, -OCH3), 3.6-3.9 (70H, m, CH2 
in repeated PEG unit), 7.33 (s, 1H, impurity residue CHCl3). 
 
 
Figure 2-5: 1H NMR spectrum of prepared MeO-PEG750-NH2. 
 
Synthesis of OMe-PEG2000-NH2 (compound 3) 
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N3–PEG2000–OMe (10.0 g, ~5 mmol), EtOAc (150 mL) and 1 M HCl (37.5 ml, 
37.5 mmol) were added into a 500 mL two-necked round-bottomed flask 
equipped with an addition funnel, septa and a magnetic stirring bar. Triphenyl-
phosphine (2.8 g, ~10 mmol) dissolved in 100 ml EtOAc was transferred to 
the addition funnel. The reaction vessel was purged with N2 and cooled to 
0 °C in an ice-bath while stirring. The triphenyl-phosphine solution was then 
added dropwisely under N2. The temperature was maintained to below 5 °C 
with an ice bath during the addition. Once the addition was complete, the 
reaction mixture was gradually warmed up to room temperature and stirred 
overnight under N2. The reaction mixture was then transferred to a separation 
funnel and the biphasic solution was separated. The aqueous layer was 
collected and washed with EtOAc (100 mL × 2). The aqueous layer was 
transferred to a round-bottomed flask and cooled in an ice bath. KOH (13.5 g) 
was then added slowly to the aqueous solution under magnetic stirring until 
the KOH was dissolved (pH > 10). The aqueous solution was transferred into 
a separation funnel and extracted repeatedly with CHCl3 (60 mL × 5). The 
combined organic layer was dried over MgSO4 for 20 mins. After filting off 
MgSO4, the solvent was evaporated to dryness on a rotary evaporator, 
yielding a lightly yellow oil, 5.12 g, yield: ~51.2%. Rfs (CHCl3:MeOH = 5:1, 
vol/vol) for Rf (N3-PEG2000-OMe) = 0.5, Rf (NH2-PEG2000-OMe) = 0.25. 
1H NMR (500 MHz, 
CDCl3),  (ppm), 2.87 (2H, -NH2), 3.52 (s, 3H, -OCH3), 3.6-3.9 (205H, m, 
CH2 in repeated PEG unit), 7.33 (s, 1H, impurity residue CHCl3). 
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Figure 2-6: 1H NMR spectrum of prepared MeO-PEG2000-NH2. 
 
Step 3: Preparation of TA-PEG750-OMe (Compound 4) 
NH2-PEG750-OMe (3.75 g, ~5.0 mmol), 4-(N,N-dimethylamino)pyridine (0.12 
g, ~1.0 mmol), N,N’-dicyclo-hexylcarbodiimide (1.06 g, ~5.0 mmol) and 
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CH2Cl2 (80 mL) were added into a 250 mL round-bottomed flask equipped 
with a magnetic stirring bar and an addition funnel. The mixture was kept at 
0 °C in an ice bath. Thioctic acid (1.03 g, ~5.0 mmol) dissolved in 30 mL of 
CH2Cl2 was transferred to the addition funnel. Thioctic acid solution was 
added dropwisely over 30 min under N2 while stirring. After the addition was 
complete, the reaction mixture was allowed to warm up to room temperature 
gradually, and the mixture was stirred overnight. The mixture was then filtered 
off through celite and the celite plug was rinsed with CHCl3. The solvent was 
then evaporated on a rotary evaporator, and the residue was added with 
saturated NaHCO3. The aqueous mixture was extracted with ether (100 mL x 
2). The aqueous layer was transferred to a separate funnel, and extracted 
with CH2Cl2 (100 mL x 2). The combined organic layer was dried over MgSO4, 
after filtration, the solvent was evaporated to yield the desired product as a 
yellow solid, weight 2.30 g, yield = 48.4%. TLC analysis (CHCl3: MeOH=10: 1 
(vol/vol) as elution) results, Rf (TA-PEG750-OMe) = ~0.6, whereas Rf (NH2-PEG750-OMe) 
= 0.25. 1H NMR (500 MHz, CDCl3),  (ppm): 1.45 (2H, m), 1.60 (m, 4H), 2.10 
(t, 2H); 2.50 (m, 2H), 3.08-3.30 (m, 3H), 3.40 (m, 5H, -OCH3 + (CO)-NH-CH2-), 
3.6-3.9 (m, 70H, CH2 in repeated PEG unit). 5.3 (s, 2H, CH2Cl2 residue 
solvent) 
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Figure 2-7: 1H NMR spectrum of prepared MeO-PEG750-TA. 
 
The TA-EG-OMe is m/z = 307.13 calculated by chemdraw software. For TA-
PEG750-OMe, its LC-MS analysis revealed a single UV absorption band with 
a retention time of ~31.9 seconds. The corresponding MS spectrum displayed 
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a series of species with m/z ratios separated by multiple numbers of 44 (the 
molecular weight of the EG unit):659.13, 703.13, 747.13, 791.13, 835.13 and 
879.13. The corresponding expected [M+1H]1+ peaks with PEG repeat 
number of 8, 9, 10, 11, 12, 13 were 660.13, 704.37, 748.46, 792.50, 836.61 
and 880.70., respectively Figure 2-8. 
 
 
Figure 2-8: HPLC-MS: found m/z 748.46 and 880.70, each repeat unit found 
m/z 44. 
Preparation of TA-PEG2000-OMe (Compound 4) 
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NH2-PEG2000-OMe (5.0 g, ~2.5 mmol), 4-(N,N-dimethylamino)pyridine 
(0.061 g, ~0.5 mmol), N,N’-dicyclo-hexylcarbodiimide (0.53 g, ~2.5 mmol) and 
CH2Cl2 (80 mL) were added into a 250 mL round-bottomed flask equipped 
with a magnetic stirring bar and an addition funnel. The mixture was cooled at 
0 °C in an ice bath. Thioctic acid (0.516 g, ~2.5 mmol) dissolved in 30 mL of 
CH2Cl2 was transferred to the addition funnel. Thioctic acid solution was 
added dropwisely over 30 min under N2 while stirring. After the addition was 
complete, the reaction mixture was allowed to warm up to room temperature 
gradually, and the mixture was stirred overnight. The mixture was then filtered 
off through celite and the celite plug was rinsed with CHCl3. The solvent was 
then evaporated on a rotary evaporator, and the residue was added with 
saturated NaHCO3, The aqueous mixture was extracted with ether (100 mL x 
2). The aqueous layer was transferred to a separate funnel, and extracted 
with CH2Cl2 (100 mL x 2). The combined organic layer was dried over MgSO4, 
after filtration, the solvent was evaporated to yield the desired product as a 
yellow solid, weight 2.77 g, yield = 50.3%. TLC analysis (CHCl3: MeOH=5: 1 
(vol/vol) as elution) results, Rf (TA-PEG2000-OMe) = ~0.33, whereas Rf (NH2-PEG2000-
OMe) = 0.25. 
1H NMR (500 MHz, CDCl3),  (ppm): 1.45 (2H, m), 1.60 (m, 4H), 
2.10 (t, 2H); 2.50 (m, 2H), 3.08-3.30 (m, 3H), 3.40 (m, 5H, -OCH3 + (CO)-NH-
CH2-), 3.6-3.9 (m, 205H, CH2 in repeated PEG unit), 5.3 (s, 2H, CH2Cl2 
residue solvent). 
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Figure 2-9: 1H NMR spectrum of prepared MeO-PEG2000-TA. 
 
For TA-PEG2000-OMe, its LC-MS analysis revealed a single UV absorption 
band with a retention time of ~31.8 seconds. The corresponding MS spectrum 
displayed a series of species with m/z ratios separated by multiple numbers of 
44 (the molecular weight of the EG unit): HPLC-MS: found m/z [M+1H]1+: 
771.02, each repeat unit found m/z 44. 
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Figure 2-10: HPLC-MS analysis of TA-PEG2000-OMe 
117 
 
2.2.2 The synthetic route to TA-ZW.2 
The chemical structures and synthetic routes for TA-ZW was shown in Scheme 2-11 
 
Figure 2-11: Scheme of the synthetic route to TA-ZW. Reaction conditions are: i) TA, 
Et3N, CH2Cl2, MsCl, N,N-dimethyl-1,3-propanediamine; ii) CHCl3, H2O, 1,3-
propanesultone [5] 
 
Step 1: Synthesis of TA-N, N-Dimethyl-1, 3-propanediamine.  
DL-Thioctic acid (3.0 g, ~15 mmol), triethylamine (1.47 g, ~15 mmol) and 30 mL 
CH2Cl2 were placed in three-necked bottom flask (250 mL). The mixture was cooled 
to 0°C in an ice-bath while being continuously flushed with N2 gas, the mixture was 
left stirring for 30 mins. Methanesulfonyl chloride (1.67 g, ~15 mmol) was added 
dropwisely with a syringe (1mL), and the mixture was slowly warmed up to RT by 
removing the ice bath and left stirring for 5 hrs. A mixture of N,N-dimethyl-1,3-
propanediamine (1.24, ~12 mmol) and triethylamine (0.61 g, ~6 mmol) in 20 mL 
CH2Cl2 was slowly added, followed by overnight stirring at room temperature under 
N2 atmosphere. Afterwards, the reaction mixture was then washed with water (30 mL 
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x 2) using a separating funnel, then with saturated Na2CO3 solution (100ml). The 
organic layer was dried over Na2SO4 and filtered. The solvent was evaporated, 
yielding this compound as yellow oil 1.48 g, yield 34.7%. 1H NMR (500 MHz, CDCl3): 
δ (ppm): 5.45 (s, 1H), 3.50-3.59 (m,1H), 3.30(m, 2H), 3.05-3.20 (m, 2H), 2.38-2.49 
(m, 1H), 2.38 (t, 2H, J = 6Hz), 2.20 (s, 6H), 2.17 (t, 2H, J=6Hz), 1.83-1.94 (m, 1H), 
1.57-1.72 (m, 6H), 1.38-1.52 (m, 2H), 5.3 (s, 2H, CH2Cl2 residue solvent). 
 
 
Figure 2-12: 1H NMR spectrum of prepared TA-N, N-Dimethyl-1, 3-propanediamine. 
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Step 2: Synthesis of TA-ZW. 
TA-N, N-Dimethyl-1,3-propanediamine (1.48 g, ~5.2 mmol) was dissolve in 20 mL 
dried TMF and purged with N2 for 30 mins, 1,3-propanesultone (1.0 g, ~8 mmol) was 
dissolve in 4 mL dried TMF was added at room temperature. The reaction mixture 
was left stirring continuously for 3 days. A turbidity instantly build up once 1,3-
propanesultone was injected due to limited solubility of the formed TA-Zwitterion in 
TMF. After that, the solvent was evaporated, yielding a pale yellow solid. The crude 
product was washed by chloroform 3 times (to remove any impurities) and the fully 
dissolved in H2O. The reaction yield was ~ 23% after purified by HPLC.  
1H NMR 
(300 MHz, CDCl3): δ (ppm) 3.60-3.70 (m,1H), 3.40-3.50 (m, 2H), 3.28-3.35 (m, 2H), 
3.20-3.28 (m, 2H), 3.10-3.20 (m, 2H), 3.10 (s, 6H), 2.90 (t, 2H), 2.40-2.50 (m, 1H), 
2.20 (t, 2H), 2.15 (m, 2H), 1.93-2.0 (m, 2H), 1.70 (m, 1H), 1.50-1.60 (m, 4H), 1.35-
1.40 (m, 2H).  HPLC-MS: TA-Zwitterion m/z is 412.15, calculated m/z for [M + H]+ = 
413.34. (Shown in Figure 2-14) 
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Figure 2-13: 1H NMR spectrum of prepared TA-ZW, 1H NMR (300 MHz, CDCl3): δ 
(ppm) 3.60-3.70 (m,1H), 3.40-3.50 (m, 2H), 3.28-3.35 (m, 2H), 3.20-3.28 (m, 2H), 
3.10-3.20 (m, 2H), 3.10 (s, 6H), 2.90 (t, 2H), 2.40-2.50 (m, 1H), 2.20 (t, 2H), 2.15 (m, 
2H), 1.93-2.0 (m, 2H), 1.70 (m, 1H), 1.50-1.60 (m, 4H), 1.35-1.40 (m, 2H). 
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Figure 2-14: HPLC-MS analysis spectra m/z for [M + H]+ = 413.34 
 
 
 
 
 
 
 
 
 
 
 
122 
 
 
2.2.3 Synthesis of TA-PEG600-Biotin  
The chemical structures and synthetic routes for TA-PEG600-Biotin was shown in 
Figure 2-15 
 
Figure 2-15: The synthetic route to TA-PEG600-biotin. Reaction conditions are: i) 
N,N’-dicyclohexylcarbodiimide, Biotin, NHS, DMF; ii) TA-PEG600-NH2, NHS-biotin, 
DMF, Et3N 
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Step 1 Synthesis of NHS-biotin. 
Biotin (2.0 g, ~8.2 mmol), NHS (0.94 g, ~8.2 mmol) and 100 mL DMF were placed in 
a round-bottomed flask (250 mL). The mixture was flushed with N2 gas, the mixture 
was left stirring for 30 mins. N,N’-dicyclohexylcarbodiimide (2.47 g, ~12 mmol) was 
added slowly to the mixture and left stirring overnight at room temperature under N2. 
A white precipitate was filtered out. The solvent was evaporated by using a rotary 
evaporator and filtered out by wash with ether. The white powder was dried under 
vacuum, weight 1.22 g, yield = 43.9 %.  
 
Figure 2-16: HPLC-MS spectrum of NHS-Biotin ([M+H] +, 342.2) 
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HPLCMS: found m/z 341.2, calculated m/z for [M + H]+ = 342.2. A further LC-MS 
analysis of the NHS-biotin revealed a single UV absorption band with a retention 
time of ~1.42 min. The corresponding MS spectrum displayed a peak with m/z value 
of 342.2, corresponding to the [M+H]+ (Figure 2-16) 
 
Step 2 Synthesis of TA-PEG600-biotin 
TA-PEG600-NH2 (0.29 g ~0.37 mmol), NHS-biotin (0.122 g, ~0.36 mmol) and DMF 
(8.0 mL) were added into a 20 mL round-bottomed flask equipped with a magnetic 
stirring bar and a septum. The reaction vessel was purged with N2 and cooled to 
0 °C in an ice-bath while stirring. Then triethylamine (0.50 mmol) was then added 
dropwisely under N2. Once the addition was completed, the reaction mixture was 
stirred overnight under N2 at room temperature. Once the reaction was complete, the 
reaction mixture was filtered by a paper filter and evaporated out DMF solvent. The 
pure TA-PEG600 was collected by HPLC-MS column, weight 0.185 g, yield = 51.3 %. 
1H NMR (300 MHz, CDCl3): δ (ppm) 6.79-6.98 (m,1H), 6.43-6.65 (m, 1H), 5.65-5.85 
(m, 1H), 4.92-5.12 (m, 1H), 4.47-4.63 (m, 1H), 4.33 (m, 1H), 3.5-3.9 (m), 3.40-3.50 
(m, 2H), 3.10-3.20 (m, 3H), 2.80-2.98 (m, 1H), 2.75 (d, 1H), 2.40-2.60 (m, 1H), 2.10-
2.30 (m, 4H), 1.80-1.96 (m, 1H), 1.60-1.80 (m, 8H), 1.40-1.60 (m, 4H), HPLC-MS 
found a series of peaks that were separated by 44 m/z units, corresponding to 
different PEG chain lengths in the mixed length PEG600 linker, e.g. 1048.0, 1004.8, 
959.6, 915.7, 871.7. The calculated corresponding [M+H]+ peaks for TA-PEGn-Biotin 
where n = 13, 12, 11, 10 and 9 were 1048, 1004, 959, 915 and 871, respectively. 
(Figure 2-18) 
 
125 
 
An HPLC-MS spectrum of TA-PEG600-NH2 is shown below. 
 
Figure 2-17: HPLC-MS spectrum of TA-PEG600-NH2. HPLC-MS found a series of 
peaks that were separated by 44 m/z units, corresponding to different PEG chain 
lengths in the mixed length PEG600 linker, e.g. 689.6, 733.7, 777.7, 821.7, and 
865.8 respectively. The calculated peaks for TA-PEGn-NH2 where n = 10, 11, 12, 13 
and 14. 
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Figure 2-18: HPLC-MS found a series of peaks that were separated by 44 m/z units, 
corresponding to different PEG chain lengths in the mixed length PEG600 linker, e.g. 
1048.0, 1004.8, 959.6, 915.7, 871.7. The calculated corresponding [M+H]+ peaks for 
TA-PEGn-Biotin where n = 13, 12, 11, 10 and 9 were 1048, 1004, 959, 915 and 871, 
respectively. 
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2.3 Summary 
In this chapter, the preparation of specific ligands to be used in making QD-
biosensors in the following chapters is described. First, I have synthesized a series 
of TA-based ligands, TA-PEG750-OMe, TA-PEG2000-OMe and TA-ZW to ensure 
the QD water solubility in further QD-sensor application. A TA-PEG600-Biotin 
functional ligand not only guarantees the QD water solubility but also provides a 
functional group for efficient conjugation to biomolecule (e.g. Neutravidin) was also 
synthesized. With the water-soluble functional ligands being prepared, the next step 
is to prepare QD-DHLA-based probes and investigate their FRET based sensing 
performances for specific biomolecule targets. 
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Chapter 3. An Ultra-efficient Cap-Exchange to 
Compact Biofunctional Quantum Dots for Sensitive 
Ratiometric Biosensing and Cell Imaging 
 
Abstract 
In this chapter, an ultra-efficient cap-exchange protocol (UCEP) to render 
commercial hydrophobic quantum dots (QDs) completely water-soluble using >50-
fold less of the air-stable Thioctic acid (TA) based functional ligands following a rapid 
in situ reduction by tris(2-carboxylethyl phosphine, TECP) is developed. The 
resulting water-soluble QDs are compact (Dh <10 nm), bright (retaining >90% of 
original fluorescence), resist nonspecific adsorption and display good stability in 
biological buffers even with high salt content (e.g. 2 M NaCl), making them well-
suited for cell imaging and ratiometric biosensing. A dihydrolipoic acid (DHLA)-
zwitterion capped QD prepared by the UCEP is readily biofunctionalized with octa-
histidine-tagged antibody mimetic proteins (also known as Affimers), allowing for 
rapid, ratiometric detection of its target protein down to 5 pM via the QD-sensitized 
Förster resonance energy transfer (FRET) readout signal. Moreover, compact biotin 
functionalized QDs were readily prepared by a facile, one-step cap-exchange 
process for ratiometric quantitation detection of 5 pM neutravidin as well as for 
fluorescence imaging of target model cancer cells. 
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3.1 Introduction 
Quantum dots (QDs) have been of significant research focus over the past two 
decades because of their unique, size-dependent, stable and bright fluorescence 
which makes them powerful tools in broad research areas such as energy, materials, 
biology, and medicine.1-7 Their broad absorption and stable, narrow symmetric 
emission are particularly well-suited for multiplexed sensing, bio-diagnostics, 
bioimaging, cell tracking and trafficking studies.3,4,8-18 In this regard, a robust, 
compact and biocompatible QD structure is paramount. However, since high quality 
QDs (e.g. CdSe/ZnS, CdSe/CdS/ZnS) are widely prepared by an organometallic 
route, they are naturally capped with hydrophobic ligands and are therefore water-
insoluble and bio-incompatible.1,2,8,9 To make such QDs biocompatible, three main 
approaches such as encapsulation with PEGylated phospholipids or 
amphiphilic/block copolymers,8,9,19 coating with silica,1 and cap-exchange are widely 
employed.2,4 The first two methods often produce stable but relatively bulky QDs 
(with typical hydrodynamic radius, Rh, >10 nm) which can limit their application in 
bioimaging particularly in crowded regions such as neuronal synapses,20 and more 
critically in Förster resonance energy transfer (FRET) based applications. This is 
because such Rh values are greater than the R0 (Förster radius) values of most QD-
dye FRET pairs (e.g. 4-7 nm) even prior to bio-conjugation. Given the reverse 6th 
power dependence of FRET efficiency (E) on the donor-acceptor distance (r): E = 
1/[1 + (r/R0)
6], such bulky QDs will lead to diminished E.21-24 In contrast, cap-
exchange often produces compact QDs which are better suited for FRET 
applications.11,13,24-33 In this regard, cap-exchange using dihydrolipoic acid (DHLA) 
based ligands is highly attractive because such ligands chelate strongly to the QD, 
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providing a compact, robust coating which also resists non-specific adsorption upon 
appending a poly(ethylene glycol) (PEG) or zwitterion terminal group.34-39 
Despite significant research, two limitations still remain to be solved for most current 
cap-exchange methods: 1) the requirement of using a large excess of ligand (with 
ligand:QD molar ratio, LQMR, of ca. 104-105, Table 3-1) which limits its use with 
precious or expensive ligands; and 2) the production of significantly quenched 
florescence over the parent hydrophobic QDs (with typical reduction of ca. 30-95%, 
depending on the QD types and cap-exchange procedures), which undoubtedly 
compromise their fluorescence applications.39-41 These limitations are mainly due to 
non-optimal conditions employed by current cap-exchange methods (e.g. reaction in 
two immiscible phases using non-/partially-deprotonated ligands which do not offer 
rapid QD-ligand transport, exchange and strong binding). Theoretically, a spherical 
4.5 nm red emitting (EM ~600 nm) CdSe/ZnS QD (Figure 3-3A) has a total surface 
area of 63.6 nm2. Assuming the QD is terminated with a full Zn2+ outer layer in stable 
Wurtzite structure with each Zn2+ occupying a surface area of 0.126 nm2 (Figure 3-
1), then the QD would contain 505 surface Zn2+ ions. Assuming each thiolate binds 
to one Zn2+ ion, then 505 single thiolate ligands (or 253 DHLA-based ligands, each 
containing 2 thiol groups and hence a footprint area of 0.252 nm2) would saturate the 
QD surface Zn2+ ions completely. Note this is the theoretical maximum number of 
ligands required for a 4.5 nm QD; the actual number could be smaller because the 
QD surface may not be fully terminated with a Zn2+ layer. Consistent with this, the 
Mattoussi group recently reported a footprint of ~0.5 nm2 for each TA-PEG1000-
benzaldehyde ligand on a CdSe/ZnS QD surface, about twice that of our estimate. 
This is reasonable considering the possible steric effect of the long PEG chain as 
well as the non-pure zinc layer nature of the QD surface.42 This simple calculation 
132 
 
reveals that only a tiny fraction (ca. ≤ 2%) of the DHLA-ligands used in current 
literature methods can actually bind to the QD, while the vast majority of ligands exist 
as free ligands. Given its strong Zn2+ binding affinity, such free DHLA-ligands may 
etch the ZnS protecting shell, generating surface defects (e.g. Zn2+/S2- vacant sites) 
that can effectively trap exciton carriers and compromise the QD fluorescence.30 This 
is supported by an observations that performing cap-exchange using Zn2+-metalated 
DHLA better preserved QD fluorescence than free DHLA, presumably as the 
introduced Zn2+ ions minimized the ZnS shell etching.43 
 
Figure 3-1: Schematic of a hexagonally packed Zn2+ outer layer (assuming ZnS 
being in its most stable Wurtzite structure) where a = b = 382 pm = 0.382 nm.  
Within the hexagon area, there are three Zn2+ ions (spheres, 1 in the middle + 6 × 
(1/3) one the corners). 
The total area of the hexagon = 6 × (1/2) a2 × sin60o = 3 × 0.3822 sin60o = 0.379 nm2 
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Therefore the surface area occupied by each Zn2+ = 0.379/3 = 0.126 nm2 
Based on this understanding, we hypothesize that reducing the number of the 
ligands to a level just sufficient for capping the QD surface Zn2+ ions should minimize 
any possible ZnS shell etching, allowing the cap-exchanged QDs to retain high 
fluorescence. To achieve this goal, it is vital to improve cap-exchange efficiency. We 
have recently demonstrated that the cap-exchange efficiency can be improved 
substantially by performing the reaction in homogenous solution using deprotonated 
DHLA-ligands,44 presumably due to the greatly improved QD-ligand transport/ 
exchange rates and enhanced binding affinity. Despite success, it is still a laborious 
and delicate to handle because the DHLA based ligands need to be freshly prepared 
as they are air-sensitive and susceptible to oxidization to the thioctic acid (TA) form, 
which would result in loss of QD binding affinity.38 By contrast, the photo-ligation 
method reported by the Mattoussi group can work directly with the air-stable TA form 
of ligands,37-39,41 however, the requirement for a large excess of ligands (ca. LQMR = 
2-4 ×104, see Table 3-1) can limit its application with precious or expensive custom 
ligands. An efficient cap-exchange method that can work with a minimal amount (ca. 
LQMR < 1000) of air-stable ligands without involving any complicated 
separation/purification steps and without compromising the fluorescence of cap-
exchange QDs would be extremely valuable to broaden and enhance QD based 
biomedical applications.  
 
Herein we report an ultra-efficient cap-exchange protocol (UCEP) that can satisfy 
such requirements.  It is based on a rapid reduction of TA-based ligands to their 
DHLA form by tris(2-carboxylethyl)phosphine (TCEP). After deprotonation of the thiol 
groups, the resulting in situ reduced DHLA-ligands are directly used to initiate cap-
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exchange with hydrophobic CdSe/ZnS or CdSe/CdS/ZnS QDs in homogenous 
solution. We show that the UCEP can provide complete QD water-solubilization at a 
LQMR of as low as 200:1, ~50-500 folds lower than most literature protocols (Table 
3-1). Moreover, the resulting QDs are compact (with typical hydrodynamic radius, Rh 
<5 nm), retaining >90% of their original fluorescence and resist non-specific 
adsorption, making them powerful probes for FRET based ratiometric sensing and 
cancer cell imaging. 
 
3.2 Experiment details 
3.2.1 Chemicals and Reagents 
CdSe/ZnS core/shell QD with EM of 600 nm was purchased commercially from 
PlasmaChem GmbH (Berlin, Germany). The QD was supplied as dry powders 
capped with mixed ligands of trioctylphosphione oxide (TOPO), hexadecylamine and 
oleic acid. Three different colored CdSe/CdS/ZnS core/shell/shell QDs in toluene 
(CANdots, EMs = ~610, 575 and 525 nm, quantum yield > 40%) were purchased 
from Strem Chemicals (Cambridge, UK). tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP.HCl, >98%), chloroform (> 99.8%), methanol (>99.9%), sodium 
bicarbonate (>99.5%), Dulbecco's modified Eagle's medium (DMEM), fetal bovine 
serum (FBS), penicillin, typsin-EDTA, Dulbecco’s phosphate buffered saline (D-PBS) 
and other chemicals were all purchased from Sigma-Aldrich (Dorset, UK) and used 
as received without further purification unless stated otherwise. Solvents were 
obtained from Fisher Scientific (Loughborough, UK) and used as received. Ultra-pure 
water (resistance >18.2 MΩ.cm) purified by an ELGA Purelab classic UVF system, 
was used for all experiments and making buffers. The target protein, yeast SUMO 
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(SUMO) protein and the anti-SUMO Affimers (nABP) were expressed in BL21 (DE3) 
cells using isopropyl ß-D-1-thiogalactopyranoside (IPTG) induction and purified by 
Ni-NTA resin (Qiagen) affinity chromatography according to the manufacturer’s 
instructions. And all the target protein and anti-SUMO Affimers were provide by 
Darren Tomlinson’s group in School of Chemistry and Astbury Structure for 
Molecular Biology, University of Leeds.  The detailed experimental procedures were 
described in our recent publication.50  
 
3.2.2 Instrument and methods 
The QD purification was performed by Amicon ultra-centrifugal filter tubes with a cut-
off MW of 30,000. All fluorescence spectra were measured on a Spex Fluoro Max-3 
Spectrofluorometer (fluorescence linear response up to 5000000 cps) using a 0.70 
mL quartz cuvette under a fixed excitation wavelength (EX) of 450 nm. This 
wavelength corresponds to the absorption minimum of the acceptor dye, minimizing 
the direct excitation of the dye acceptor.1 An excitation and emission bandwidths of 5 
nm and a scan rate of 120 nm/min over 480-800 nm range were used. Confocal 
fluorescence imaging was recorded on Zeiss LSM-510 inverted laser scanning 
confocal microscope was done by Rongjun Chen’s group in Department of Chemical 
Engineering, Imperial College London. They using at 488 nm excitation and 
collecting emission at above 570 nm. Flow cytometry was recorded on a BD 
LSRFortessa cytometer. The samples were excited at 488 nm and the emission was 
collected in the 570-585/42 nm band and the results were analysed using the 
FlowJov10 software. 
 
136 
 
 
 
3.2.3 Experimental Procedures36 
3.2.3.1 Preparation of water-soluble QDs by ligand exchange 
Preparation of DHLA-Zwitterion ligand capped QDs (QD-ZW) 
Typical ligand exchange procedures for preparing QD-ZW is as follows: commercial 
hydrophobic CdSe/ZnS or CdSe/CdS/ZnS QD (1 nmole, 20 μL in hexane) was 
precipiated by adding 500 μl EtOH followed by centrifugation to remove any free 
TOPO ligands. The QD pellet was then dissolved in 50 μl CHCl3 and then added with 
20 μl EtOH to make solution A. TA-ZW (0.10 M, 2 μL in H2O) was reduced to DHLA-
ZW by mixing with TCEP.HCl (0.10 M, 2 μL in H2O) for 10 mins. After which NaOH 
(0.10 M in EtOH, 12 μL) was added to fully deprottonate the DHLA thiol-groups and 
to neutralise acid groups in TCEP.HCl (each containing 4 acid groups) to make 
solution B. After that, the above solutions A and B were mixed in a new Eppendorf 
tube for 1-3 mins with occasional shaking by hand, after which H2O (50 μL) was 
further added to the reaction mixture. The QD was found to rise to the top aqueous 
phase, leaving the bottom CHCl3 layer effectively colourless, indicating full QD 
water-solubilization. The top aqueous layer was then carefully separated from the 
bottom CHCl3 layer and transfered to an Amicon ultra-centrifugal tube equipped with 
a 30,000 MW cut-off filter membrane and centrifuged for 1 min at 3000 rpm. The 
residue was then washed with H2O (200 μL) and followed by a brief centrifugation. 
The process was repeated three times with to remove any unbound free ligands, 
yielding a stable, and water soluble QD stock solution. The stock QD concentration 
was determined by UV-vis absorption spectra using their first exciton peak and the 
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respective extinction coefficient using our previously established procedures 
before.31, 33 
 
The ligand exchange procedure for QD-PEG750-OMe 
QD (1 nmol, 20 μL in hexane) was first precipitated by adding 500 μl EtOH followed 
by centrifugation to remove unbound free TOPO ligands. The QD precipitate was 
then dissolved in 30 μL hexane and then added with 10 μL EtOH to make solution A. 
TA-PEG750-OMe (0.189 M in EtOH, 1.06 μL) was reduced by 1 molar equivalent of 
TCEP (0.10 M, 2 μL in H2O) for ~10 mins, and then NaOH (0.10 M in EtOH, 12 μL) 
was added to make solution B. After that, solutions A and B were mixed for 1-3 mins 
under agitation, then H2O (20 μL) was further added and the QD will move to lower 
aqueous layer, leaving the top organic layer colourless. The aqueous layer was 
transfered to an Amicon ultra-centrifugal tube equipped with a 30,000 MW cut-off 
filter membrane. After centrifugation and washing with H2O three times as above to 
eliminate the free ligand, a stable, biocompatible QD-PEG750 was obtained.  
Preparation of DHLA-PEG750-OMe and DHLA-PEG600-Biotin mixed ligand 
capped QDs (QD-biotin70/100/150) 
Commercial hydrophobic CdSe/ZnSe/ZnS core/shell/shell QD (1 nmole, 20 μL in 
hexane) was precipitated by adding 500 μL EtOH followed by centrifugation to 
remove any free TOPO ligands. The QD pellet was then dissolved in 100 μL CHCl3 
and then added with 50 μL EtOH to make solution A. TA-PEG600-Biotin (0.10 M in 
EtOH, 0.7 μL, 1 μL, 1.5 μL) was reduced to DHLA-PEG600-Biotin by mixing with 1 
molar equivalent of TCEP.HCl (0.10 M, 0.7 μL, 1 μL, 1.5 μL in H2O) for 10 mins. 
After which NaOH (0.10 M in EtOH, 4.2 μL, 6 μL, 9 μL) was added to fully 
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deprottonate the DHLA thiol-groups and to neutralise acid groups in TCEP.HCl (each 
containing 4 acid groups) to make solution B. TA-PEG750-OMe (0.10 M in EtOH, 10 
μL) was reduced to DHLA-PEG750-OMe by mixing with TCEP.HCl (0.10 M, 10 μL in 
H2O) for 15 mins. After which NaOH (0.10 M in EtOH, 60 μL) was added to fully 
deprotonate the DHLA thiol-groups and to neutralise acid groups in TCEP.HCl (each 
containing 4 acid groups) to make solution C. After that, the above solutions A and B 
were mixed in a new Eppendorf tube for 10 mins with occasional shaking by hand, 
after which solution C was further added to the reaction mixture for 15 mins more. 
After which H2O (50 μL) was further added to the reaction mixture. The QD was 
found to rise to the top aqueous phase, leaving the bottom CHCl3 layer effectively 
colourless, indicating full QD water-solubilization. The top aqueous layer was then 
carefully separated from the bottom CHCl3 layer and transferred to an Amicon ultra-
centrifugal tube equipped with a 30,000 MW cut-off filter membrane and 
centrifugated for 1 min at 3000 rpm. The residue was then washed with H2O (200 μL) 
and followed by a brief centrifugation. The process was repeated three times with to 
remove any unbound free ligands, yielding a stable, and water soluble QD stock 
solution.  
 
3.2.3.2 Protein preparation, purification and labelling 
The anti-SUMO Affimer (5 mg/ml, 12.5 µL in PBS, MW = 13,267) in a 
microcentrifuge tube was first mixed with Alexa 647 NHS-ester (50 µg in 2 µL DMSO) 
and then 5 µL NaHCO3 (0.5 M, pH = 8.3) and 7.5 µl PBS (10 mM phosphate, 150 
mM NaCl, pH 7.4) were added and thoroughly mixed at room temperature for 2 h 
(dye: protein molar ratio ≈ 8:1). After that the reaction mixture was loaded on a small 
139 
 
G25 gel filtration column using PBS as eluting solution on natural flow. The first 
eluted blue band (corresponding to the labelled anti-SUMO Affimer) was collected 
and its absorption spectrum was recorded. Using the extinction coefficients of the 
Alexa-647 dye (nm = 239,000 M
-1cm-1) and Affimer (nm =7904 M
-1cm-1) and the 
CF280nm of 0.03 for Alexa-647 dye, the average dye labelling ratio on per Affimer was 
calculated as 1.08. The stock protein concentration was 86 µM.55 
Similarly, the SUMO protein was labelled with Alexa-647 NHS ester using the same 
procedures under a dye: protein molar ratio of 6.4. After purification by using a G25 
column as above, the average number of dyes labelled on each protein was 
determined as 0.80. The labelled protein stock concentration was 32.7 µM. 
Neutravidin was also labelled with Alexa-647 NHS ester using the same procedures 
under a dye: protein molar ratio of 7. After purification by using a G25 column as 
above, the average Alexa-647 dye label per protein was determined as 1.67. 
 
3.2.3.3 Cell culture and cell based studies (done by Rongjun Chen’s group) 
The following works were done by Rongjun Chen’s group in Department of Chemical 
Engineering, Imperial College London. HeLa adherent epithelial cells derived from 
human cervical carcinoma were grown in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) and 100 U mL-1 
penicillin. The HeLa cells were trypsinized using trypsin-EDTA and maintained in a 
humidified incubator with 5% CO2 at 37 
oC. 
Laser scanning confocal microscopy 
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2 mL of HeLa cells (1.5 × 105 cells mL-1) were cultured for 24 h followed by the 
treatment with 1 mL of the serum free DMEM with or without of the QD samples (50 
nM). After incubation for 4 h, the cells were washed three times with Dulbecco’s 
phosphate buffered saline (D-PBS). Hoechst 33342 was added to a final 
concentration of 5 µg mL-1 for nuclei staining. The cells were then imaged by laser 
scanning confocal microscopy (Zeiss LSM-510 inverted laser scanning confocal 
microscope, Germany). The QD was excited at 488 nm and the emission above 570 
nm was collected.  
3.2.3.4 Flow cytometry and free biotin competition (done by Rongjun Chen’s 
group) 
1 mL of HeLa cells (3 ×105 cells/mL) were cultured in 6 well plates for 24 h followed 
by treatment with 1 mL of serum-free DMEM with or without QD (50 nm). After 4h 
incubation, the cells were washed three times with Dulbecco's Phosphate Buffered 
Saline (D-PBS). After cell detachment using 0.5 mL of Trypsin-EDTA, 0.5 mL of 
serum-free DMEM was added to each well and the samples were centrifuged in 2 
mL microcentrifuge tubes for 5 minutes at 1000 rpm. The supernatant was discarded 
and replaced with 0.5 mL of serum-free DMEM. The samples were filtered using 
Flowmi™ cell strainers (40 µm) and analysed in 5 mL Falcon plastic tubes using BD 
LSRFortessa cytometer. The samples were excited at 488 nm and the emission was 
collected in the 570 - 585/42 nm band. The results were analysed using FlowJo v10 
software. 1 mL of HeLa cells (3 ×105 cells/mL) were cultured in 6 well plates for 24 h, 
followed by 1 h treatment of one set of triplicates with 10 mM free biotin in serum-
free DMEM. 1 mL of serum-free DMEM with QD (50 nM) with or without free biotin 
(10 mM) were then added to the wells which had been pre-treated with free biotin or 
incubated normally, respectively. After a 4 h incubation, the cells were washed three 
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times with PBS. After cell detachment using 0.5 mL of Trypsin-EDTA, 0.5 mL of 
serum-free DMEM was added to each well and the samples were centrifuged in 2 
mL microcentrifuge tubes for 5 minutes at 1000 rpm. The supernatant was discarded 
and replaced with 0.5 mL of serum-free DMEM. The samples were filtered using 
Flowmi™ cell strainers (40 µm) and analysed in 5 mL Falcon plastic tubes using BD 
LSRFortessa cytometer. The samples were excited at 488 nm and the emission was 
collected in the 586/16 nm band. The results were analysed using FlowJo v10 
software. 
 
3.2.3.5 Gel electrophoresis 
2 or 5 µL of a DHLA-ZW capped CdSe/ZnS core/shell QD (QD-ZW, EM ~600 nm) 
prepared at a LQMR of 200, 500 and 1000, respectively was mixed with 18 or 15 µL 
of 60% glycerol in H2O. A QD-Affirmer assembly was also prepared by mixing the 
QD-ZW prepared at a LQMR of 500 with 10 molar equivalent of the His8-tagged 
Affirmer. The resulting QD-Affimer conjugate was treated the same way as the 
above QD-ZW samples. Then 20 uL of each sample was loaded onto a 0.75% 
agarose gel in TAE buffer pH8.3. Gel was run at 100 mV for ~30 min and QD was 
visualized under a UV illumination ( = 365 nm). 
 
 
 
 
 
 
142 
 
 
 
 
3.3 Results and discussion 
 
3.3.1 Ultra-efficient cap-exchange protocol with CdSe/ZnS core/shell QD 
Chart 1: Chemical structures of the Thioctic acid (TA)-based ligands used in this 
study. 
 
 
Our UCEP procedure is shown schematically in Figure 3-2(A). First, TA-based 
ligands with different terminal functional groups (e.g. PEG750, zwitterion, PEG600-
biotin) were synthesized (see Chapter 2 for details).34,36,41 Next, the TA-ligand (e.g. 
TA-ZW) was reduced quantitatively to its DHLA form by 1 mole equivalent of 
TCEP.HCl in a mixed solvent of ethanol/water (1:1 v/v). The reduction happened 
rapidly (ca. ~5 mins) and could be directly visualized by eye (via the disappearance 
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of yellow color that originates from the dithiolane ring), yielding a clear colorless 
solution. Then six DHLA-ligand molar equivalents of NaOH (in ethanol) was added to 
fully deprotonate the DHLA di-thiol groups to enhance their QD binding affinity.43 Six 
molar equivalents of NaOH were used because each DHLA-based ligand contains 
two thiol groups and each TCEP.HCl molecule contains 4 acid groups. The in situ 
reduced ligand solution was then added directly into a QD solution (in CHCl3), 
forming a homogenous solution. After brief shaking, the QDs were found to rapidly 
rise (< 1 min) to the top aqueous layer (note, the mixed CHCl3/EtOH/H2O solution 
itself did not phase separate in the absence of the QD and/or ligands), indicating the 
formation of hydrophilic QDs. It became clearer after adding more water followed by 
a brief centrifugation (60 s, 20000×g), where all QDs were found in the top aqueous 
layer, leaving the bottom CHCl3 layer colorless (Figure 3-2(B)), indicating full QD 
water-solubilization. The aqueous layer was then transferred to a centrifugal filtration 
tube with a 30,000 MW cutoff membrane. After three rounds of centrifugation and 
washing with H2O to remove unbound free ligands, a stable well-dispersed QD stock 
aqueous solution was obtained. 
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Figure 3-2:  (A) Schematic procedures of our UCEP to compact, biocompatible 
DHLA-based ligand capped QDs. (B) Photograph of a CdSe/ZnS QD (EM ~ 600 nm) 
after cap-exchange with DHLA-ZW under different ligand:QD molar ratio, top layer: 
water, bottom layer: CHCl3. (C) Fluorescence spectra of a CdSe/ZnS QD prior to (10 
nM in CHCl3, TOPO) and after cap-exchange with DHLA-ZW (10 nM in H2O) under 
different LQMRs without and with heating (LQMR is indicated for each sample; H 
stands for heating). (D) Comparison of the relative fluorescence intensity of the 
above QDs (data shown as mean ± standard deviation, n = 3). 
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First, we investigated how LQMR affected the cap-exchange process using the most 
widely used hydrophobic CdSe/ZnS QD capped with mixed trioctylphoshine/ 
trioctylphoshine oxide ligands (TOP/TOPO) (EM ~600 nm, ~4.5 nm core diameter, 
Figure 3-3) and the DHLA-zwitterion (ZW) ligand (Chart 1).  
 
Figure 3-3:  (A) TEM image of the TOP-TOPO capped CdSe/ZnS core/shell QD 
(EM ~ 600 nm) used in this study prior to ligand exchange. It has an average crystal 
diameter of ~4.5 nm. (B) TEM image of the CdSe/ZnS core/shell QD after ligand 
exchange with the DHLA-ZW at a ligand: QD molar ratio of 500:1. It has an average 
crystal diameter of ~4.6 nm. 
When cap-exchange was performed at a LQMR of  200, all of the CdSe/ZnS QDs 
were fully transferred to the aqueous phase (shown as a brownish colour in the top 
aqueous layer), leaving the bottom CHCl3 layer colorless. In contrast, the CHCl3 
layer still contained some un-transferred QDs at a LQMR of 100, indicating that 200 
is the minimum ratio required for complete QD water-solubilization (Figure 3-2(B)). 
This LQMR is ~2 orders of magnitude lower than most literature protocols (Table 3-
1), demonstrating its ultra-efficiency.32,34-36,40,41,43,45 Moreover, this LQMR number 
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actually matched well to our estimation that a maximum of 253 DHLA-ligands would 
be sufficient to cap all the Zn2+ sites on the QD surface. Deprotonation of the DHLA 
thiol groups was essential for a successful cap-exchange. The use of TCEP reduced 
DHLA-ZW ligand directly without thiol group deprotonation produced no observable 
QD phase transfer at LQMR = 200, all the QDs were found to remain in the organic 
phase. This result agrees well with the report that thiolates bind much more strongly 
to Zn2+ ions than free thiols.43 The use of NaOH deprotonated TCEP only in the 
absence of DHLA-ZW ligand also produced no observable QD phase transfer, 
confirming that it was the DHLA-ZW ligand, but not TCEP, that was responsible for 
the rapid and efficient QD phase transfer observed here. 
We subsequently investigated how fluorescence of the cap-exchanged CdSe/ZnS 
QD was affected by the LQMR. At a LQMR of 200, the cap-exchanged QD 
effectively retained the native fluorescence of the parent hydrophobic QD in CHCl3 
(~96%, Figure 3-5). This relative fluorescence intensity retained was reduced to ~92% 
at 500 and further to ~63% at 3000 (Figure 3-2(C)). The observation that the higher 
the LQMR the lower the retained QD fluorescence agreed well with our hypothesis, 
suggesting that excess free ligands were indeed responsible for the quenched 
fluorescence of cap-exchanged QD. Besides, heating was also found to impact the 
retained QD fluorescence. For example, at a LQMR of 3000, heating at ~70 oC for 1h 
produced a water-soluble QD displaying half the intensity of its non-heating 
counterpart (Figure 3-2(D)). Further increasing the LQMR to 6000 with 1 h heating 
yielded an even more severely quenched QD, retaining just ~10% of the original 
fluorescence. These results indicated that heating could accelerate the ZnS shell 
etching by free DHLA-ZW ligands. This effect was exacerbated under high LQMRs 
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with large excesses of free ligands, leading to efficient etching of the ZnS shell and 
hence severe quenching of the QD fluorescence. 
Table 3-1: A comparison of cap-exchange conditions and retained fluorescence for 
some DHLA-based ligand capped QDs. h photo-irradiation; DHLA-F: DHLA 
modified with functional group. 
LQMR      Time  QD type          Ligand    Retained original  Ref 
(in 10
3
 )                                                                                              QD fluorescence (%)  
~42  ~2h  CdSe/ZnxCd1-xS DHLA-PEG-NH2 46-62   
35
 
~40  2.5h  CdSe/CdS DHLA-PEG  ~8   
45
 
~40  2.5h  CdSe/CdS/ZnS DHLA-PEG  ~26   
45
 
~41  2h  CdSe/ZnS DHLA-Zn
2+
  28-57   
43
 
~10  ~2h  CdSe/ZnS DHLA   3.4-53*   
46
 
~40  60 min (h) CdSe/ZnS Bis(LA)-ZW  50-70   40 
~22-50  ~20 min (h) CdSe/ZnS LA-PEG/NH2/F  50-70   
39
 
40-60  ~30 min (h) CdSe/ZnS LA-PEG/F  50-70   37 
10-100  2h  InP/ZnS DHLA   11   
47
 
98   ~over night  CdSe/ZnS DHLA-F  40-57%   
48
 
0.2-0.5  ~1 min  CdSe/ZnS DHLA-PEG/ZW 95     This work 
0.6  ~1 min  CdSe/ZnSe/ZnS DHLA-ZW  96     This work 
* The retained QD fluorescence varied significantly for different colored QDs. 
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Importantly, the DHLA-ZW capped CdSe/ZnS QD prepared here (abbreviated as 
QD-ZW) was highly stable in phosphate buffer saline (PBS, 10 mM phosphate, 150 
mM NaCl, pH 7.4) and over a broad pH range (e.g. 6-10) and even with high salt 
conditions (e.g. 2 M NaCl, Figure 3-4). This figure confirmed that the QD-DHLA-ZW 
prepared at LQMR of 200:1 is stable for at least 4 weeks in PBS over pH 4-10 and 
even under high salt conditions of 2 M (NaCl). Such stability is comparable to the 
QD-DHLA-ZW prepared by photoligation and other literature methods. The stability 
of the QD-ZW prepared at a LQMR of 200 is comparable to those reported in 
literature, despite being prepared using 50-500 fold less ligands.39,41 This result 
agreed well with our estimation that ~200 DHLA-ZW ligands were sufficient to 
saturate all of the QD surface Zn2+ ions, producing stable biocompatible QDs. 
Performing cap-exchange in homogenous solution (CHCl3/EtOH/H2O) also greatly 
accelerated the process: complete transfer of the QD into the aqueous phase was 
observed in < 1 min, which was much faster (ca. 20-500 fold) than most literature 
methods using two immiscible phases (Table 3-1). The greatly improved cap-
exchange efficiency was attributed to the greatly enhanced QD-ligand exchange and 
transfer rates in homogeneous solution as well as greatly enhanced affinity between 
the QD and DHLA-ZW ligands after thiol deprotonation.  
 
 
149 
 
 
Figure 3-4: Photographs of the 100 nM CdSe/ZnS core/shell QD-DHLA-ZW 
(maximum EM = ~606 nm) upon exposure to a UV lamp ( = 350 nm) prepared by 
the UCEP at a Ligand:QD molar ratio (LQMR) of 200 at different post-preparation 
intervals (1 h, 1 day, 1 week and 4 weeks from top to bottom panels). The solution 
conditions are H2O (A), PBS (pH 7.4, B), PBS with pH adjusted to 4 (C), 7 (D), 10 
(E), 13 (F), and with NaCl concentration of 1M (G) and 2M (H), respectively. 
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Besides DHLA-ZW, the UCEP can be readily applied to other DHLA based ligands 
such as DHLA and DHLA-PEG750, where a LQMR of 200 was also found to be 
sufficient to water-solubilize the CdSe/ZnS QD completely (Figure 3-5).  
 
Figure 3-5:  (A) Fluorescence spectra of the CdSe/ZnS core/shell QD before (red) 
and after ligand exchange with DHLA-ZW (blue) and DHLA-PEG750 (pink) at a LQ-
MR of 200:1 (B) Comparison of the relative fluorescence intensity for the above QDs.     
 
Moreover, all cap-exchanged QDs retained > 95% of their original fluorescence. This 
is attributed to the ultra-efficient and gentle cap-exchange conditions (short exposure 
to homogenous solution at room temperature) with minimal free ligands that can etch 
the ZnS protective shell. As a result, the ZnS shell may be effectively intact after cap-
exchange, allowing the QD to retain native fluorescence. Such a gentle yet robust 
approach is particularly well-suited for core/shell QDs with relatively thin ZnS shells 
(which is the case for most commercial CdSe/ZnS QDs) whose fluorescence is 
known to be highly sensitive to environmental conditions (e.g. oxidation, precipitation 
etc.) and can be especially badly affected after cap-exchange with strongly 
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coordination ligands.30,49 A further dynamic light scattering analysis44 of the 
CdSe/ZnS QD after cap-exchange with the DHLA-ZW under different LQMRs 
revealed that compact (ca. Dh < 9 nm) water-soluble QDs with uniform narrow size 
distribution were obtained at LQMR of ≥500. Those prepared under lower LQMRs 
showed some minor aggregation or clustering (Figure 3-6, Table 3-2). The different 
QD sizes were further verified by a gel electrophoresis analysis:44 the QD prepared 
at 200 LQMR apparently showed evidences of aggregation and exhibited lower gel 
mobility (larger sizes) than those prepared at 500 or 1000, while the latter two QDs 
displayed identical gel mobility (Figure 3-6). Thus the gel mobility results were fully 
consistent and in perfect agreement with those expected from their different Rhs 
measured by DLS. Together, these results indicate that not all of the added DHLA-
ligands may have bound to the QD or the dithiolates in each DHLA may simply 
chelate to one Zn2+ ion rather than bind to two separate Zn2+ ions on the QD surface. 
Therefore a DHLA-ligand: QD surface Zn2+ molar ratio of ~1:1 (rather than the 
original estimate of 1:2) is required to produce compact, aggregation-free QDs 
suitable for practical biomedical applications. 
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Figure 3-6: Hydrodynamic diameter (volume, Dh = 2Rh) distribution histograms of a 
CdSe/ZnS core/shell QD (EM ~ 600 nm) before (A, in hexane) and after cap-
exchange with DHLA-ZW under different LQMRs: 200 (B); 300 (C); 500 (D); 1000 
(E). Data were fitted by the Gaussian function: (A-C) appeared to contain two 
different sizes while D and E contained just one species. (F) A typical gel 
electrophoresis diagram of this QD after cap-exchange with DHLA-ZW at a LQMR of 
200 (lane 1 and 2); 500 (lane 3 and 4), 1000 (lane 5 and 6) and 500 after assembly 
with a His8-tagged Affimer at a protein:QD molar ratio of 10:1 (lane 7 and 8). The 
sample volumes were for 5 L for lane 1, 3, 5 and 7 and 2L for lane 2, 4, 6 and 
8.The histograms were fitted by double Gaussian (normal) distribution.  
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Table 3-2. Hydrodynamic diameters (volume, Dh) of the CdSe/ZnS QD before and 
after cap-exchange with DHLA-ZW under different LQMRs. The polydispersity index, 
PDI, is obtained by PDI = FWHM/Dh. 
QD samples Average D
h
 (nm) D
h
 (nm, %) FWHM (nm) PDI 
QD-TOPO 6.2 4.4±0.1 (41%) 2.1±0.3 0.48 
7.4±0.6 (59%) 4.4±0.8 0.59 
QD-ZW (200) 23.2 17.1±0.3 (42%) 8.0±0.9 0.47 
27.5±2.1 (58%) 15.9±2.8 0.58 
QD-ZW (300) 17.2 12.5±0.2 (43%) 6.2±0.6 0.50 
20.8±1.6 (57%) 12.5±2.2 0.60 
QD-ZW (500) 8.9 8.9±0.1 (100%) 2.7±0.1 0.30 
QD-ZW (1000) 8.6 8.6±0.1 (100%) 3.87±0.2 0.45 
 
The original QD and the cap-exchanged QDs at low LQMRs (<500) appear to have 
bimodal size distributions (e.g. containing two species). In this case, the average Dh 
was calculated by: Dh = Dh1 × A1% + Dh2 × A2%.  
Where Dh1 and Dh2 are the Dh values, and A1% and A2% are the percentage areas 
(abundance %) of the two species obtained from the bimodal Gaussian fit. The 
resulting data are summarised in Table 3-2.  
Assuming 8.6 nm corresponds to the Dh of an isolated individual QD-ZW particle, 
then its hydrodynamic volume:  
Vh = (4/3) π (Dh/2)
3 = (4/3) π (8.6/2)3 = 333 nm3.  
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Using the Dh values obtained from the Gaussian fits given in Table 3-2, the average 
particle hydrodynamic volume Vh for the QD cap-exchanged with the DHLA-ZW 
ligand at a LQMR of 200 and 300 is calculated as:  
Vh (200) = (4/3) π (23.2/2)
3 = 6535 nm3.  
Vh (300) = (4/3) π (17.2/2)
3 = 2663 nm3.  
Therefore the Vh (200) and Vh (300) values are ~20 and ~8 times that of an isolated 
QD-ZW particle, respectively, suggesting that the QD forms small clusters or 
assemblies each containing a few to ~20 QDs after cap-exchange with the DHLA-
ZW ligands under these low LQMRs of <500.   
3.3.2 Ultra-efficient cap-exchange protocol with CdSe/CdS/ZnS QD 
Besides the CdSe/ZnS core/shell QD, the UCEP was readily extended to different 
colored CdSe/CdS/ZnS core/shell/shell QDs with λEMs = 525, 575 and 606 nm, 
respectively. These QDs have more robust fluorescence because their fluorescent 
cores were protected by two layers of inorganic shells. Cap-exchange carried out at 
a LQMR of 200 with the DHLA-ZW ligand was be able to completely water-solubilize 
all these three different colored CdSe/CdS/ZnS QDs. Moreover, all three water-
soluble CdSe/CdS/ZnS QDs also retained >95% of their respective original 
fluorescence (Figure 3-7), demonstrating the excellent robustness of the UCEP 
approach. It was noticed that although a LQMR of 200 was able to water-solubilize 
the CdSe/CdS/ZnS QDs, their long term stability was limited, and the QDs eventually 
precipitated from the aqueous solution in a week. Increasing the LQMR to 600 
produced highly stable, biocompatible QDs that remained visibly clear without any 
noticeable changes of physical appearance or fluorescence for several months. This 
is likely due to the larger sizes of the CdSe/CdS/ZnS (e.g. EM = 606 nm) over the 
155 
 
CdSe/ZnS QD (Figure 3-7 and 3-8), and hence more ligands are required to cap all 
its surface Zn2+ ions to ensure high stability.  
 
Figure 3-7:  (A, B) Photographs of aqueous solutions of three different coloured 
CdSe/CdS/ZnS core/shell/shell QDs with λEMs of 606, 575 and 525 nm respectively 
after cap-exchange with DHLA-ZW at a LQMR of 200 under day light (A) and a 
hand-held UV-lamp (365 nm, B) illuminations. (C) Fluorescence spectra of the three 
QDs (10 nM) before (in CHCl3) and after cap-exchange with DHLA-ZW (in H2O) at a 
LQMR of 200. The intensity of the 606 nm emitting QD was reduced by 3 fold in 
order to display in the same graph. (D) Comparison of the normalised fluorescence 
intensity for each QD before and after cap-exchange with DHLA-ZW (the QD 
intensity in CHCl3 prior to cap-exchange was set to 100). 
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Figure 3-8:  (A) Zeta potential test of the CdSe/CdS/ZnS core/shell/shell QD after 
ligand exchange with the DHLA-ZW at a ligand: QD molar ratio of 600:1. The Zeta 
potential value is -41.4 mV. (B) TEM image of the CdSe/CdS/ZnS core/shell/shell 
QD after ligand exchange with the DHLA-ZW at a ligand: QD molar ratio of 600:1. 
This QD appears somewhat eclipse, with long and short axis of ~8.2 and ~6.0 nm 
respectively. 
 
Despite the increase of LQMR, this ratio is still 20-150 folds lower than most other 
methods reported in literature (Table 3-1). More importantly, all these water-soluble 
QDs prepared by the UCEP retained >95% of their respective original fluorescence. 
In contrast, most literature methods often reported ca. >50% fluorescence reduction 
even for such photo-chemically robust CdSe/CdS/ZnS or CdSe/ZnxCd1-xS alloyed 
shell QDs after cap-exchange with DHLA-based ligands (Table 3-1). This is 
presumably because the large excesses of metal-free DHLA-ligands existing in 
these literature methods (due to high LQMRs) effectively etched the protective shells 
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during the relatively long cap-exchange process, significantly compromising the shell 
quality and hence fluorescence of post-exchange QDs. 
 
3.3.3 QD-Affimer for ratiometric biosensing 
The excellent fluorescence, compact structure and robust stability in biologically 
relevant buffer of the UCEP prepared QDs make them extremely attractive for 
FRET-based applications. This is because a compact QD structure gives a small r 
value while the high QD fluorescence yields a large R0 value, both factors are 
strongly beneficial to improve E and hence FRET based sensitivity as E = 1/[1 + 
(r/R0)
6]. Since r is not only determined by the QD but also the associated bio-
recognition molecule (binder) size, the use of small binders is also critical to improve 
FRET sensitivity. Here, small antibody mimetic proteins (also known as Affimers, first 
reported as Adhirons)47 were employed as binders for target proteins. Compared to 
the widely used antibodies, Affimers have the advantages of high thermal stability 
(typically Tm ≥80 
oC), excellent binding affinity (nM-pM) and specificity, animal-free 
production (via bacterial expression) and ease of incorporating site-specific 
functional tags (e.g. His8, cysteine) for controlled bioconjugation with maximal 
binding site accessibility.50-52 More importantly, their small sizes (MW ~12 kDa, <10% 
that of a whole antibody) is especially attractive for FRET based applications, 
allowing for significantly reduced r value and thereby improving sensitivity. To 
demonstrate this potential, an Affimer that specifically recognizes the yeast small 
ubiquitin-like modifier (SUMO) protein was employed as a proof of concept for 
detecting its target SUMO protein. The SUMO proteins play an important role in a 
number of cellular process which include nuclear-cytosolic transport, transcriptional 
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regulation, apoptosis, protein stability and response to stress, making them useful 
diagnostic markers for genotoxic stress, cancer development and proliferation.50  
First, we studied the QD-Affimer conjugation via a convenient, highly efficient His8-
tag-metal affinity based self-assembly.3 The C-terminal His8-tagged Affimer was 
reacted with an Alexa-647-NHS ester dye, yielding an average labeling of 1.06 
Alexa-647 dyes per Affimer (see experiment section above). The labeled Affimers 
were then mixed with a DHLA-ZW capped CdSe/CdS/ZnS QD (EM ~606 nm) at 
different molar ratios (but with a constant total Affimer:QD molar ratio of 12 by 
adjusting the label/unlabel Affimers to minimize the possible change of QD 
fluorescence quantum yield upon protein conjugation).3 The resulting fluorescence 
spectra (EM = 450 nm, corresponding to the absorption minimum of the Alexa-647 
dye to minimize dye direct excitation) revealed a progressively quenched QD 
fluorescence and simultaneously enhanced Alexa-647 FRET signal (at ~667 nm) 
with the increasing dye/QD ratio, consistent with the QD-sensitized Alex-647 dye 
FRET mechanism3 (Figure 3-9＆3-10). This result confirmed the successful QD-
Affimer conjugation. The QD-Alexa-647 FRET pair has good spectral overlap with a 
relatively large R0 value of ~6.4 nm (Figure 3-9). By using E obtained from QD 
fluorescence quenching (E = 1 - IDA/ID, where ID and IDA are the QD intensity in the 
absence and presence of the acceptor) and a single QD in FRET interaction with N 
identical acceptors model (E = 1/[1 + r6/N*R0
6)],25 the average QD-dye distance r 
was found to be ~6.5 nm (Figure 3-10), matching well to the sum of the Affimer size 
(~3 nm)50 and radius of the CdSe/CdS/ZnS QD core ~3.5 nm (Figure 3-8), 
confirming the formation of compact QD-Affimer conjugate. 
 
159 
 
 
 
Figure 3-9: Photophysical properties of the QD donor and the Alexa 647 acceptor. 
(A) Normalized fluorescence emission spectrum of the QD606 (red), and the 
normalized absorption spectrum (Black) of the Alexa 647 labeled Adhiron. (B) 
Spectral overlap function of the Alexa 647 and QD600 FRET pair. 
 
Where PLD() is the normalised QD fluorescence intensity at ; A() is the acceptor 
absorption coefficient at . 
The integral of the spectral overlap: I = 1.32 × 1016 (nm4.cm-1.M-1) 
 
Assuming a media refractive index of 1.45, and random orientation of the dipoles of 
the FRET pair (where K2 = 2/3). The quantum yield of the CdSe/ZnSe/ZnS 
core/shell/shell QD, QQY, was determined as ~40%, then the Förster radius (R0, in 
the unit of Å) of the above QD-dye FRET pair (at 1:1 molar ratio) can be calculated 
via the following equation:56 
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R0 = (8.79 × 10
-5 nr
-4 × QQY × K
2 × I)1/6  
     = (8.79 × 10-5 × 1.45-4 × 0.40 × (2/3) × 1.32 × 1016)1/6  
     = 64 Å 
     = 6.4 nm 
 
Figure 3-10:  (A) Fluorescence spectra of a DHLA-ZW capped CdSe/CdS/ZnS 
core/shell/shell QD (EM = 605 nm) after self-assembly with different molar ratios of 
Alexa-647 labelled Affimer (with total Affimer: QD molar ratio fixed at 12). (B) The 
apparent FRET efficiency E (obtained by QD fluorescence quenching) as a function 
of labelled Affimer: QD molar ratio. The scheme beneath showing the FRET process 
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Next we exploited their use in target protein detection. Here DHLA-ZW ligand 
capped CdSe/ZnSe/ZnS QD each conjugated with 12 copies of unlabeled anti-
SUMO Affimer (His8-tagged) was mixed with different amount of the target SUMO 
protein (Alexa-647 labeled).50 The resulting fluorescence spectra (Figure 3-11) 
clearly showed that, with the increasing SUMO concentration, the QD fluorescence 
was greatly quenched while the Alexa 647 FRET signal was enhanced 
simultaneously. This result was fully consistent with a mechanism of QD-sensitized 
Alexa-647 FRET induced by the specific Affimer-SUMO binding. A plot of the 
integrated fluorescence intensity ratio between the Alexa-647 FRET (from 650-750 
nm) and the QD (560-650 nm), IDye/IQD, versus the SUMO concentration yielded a 
positive linear relationship over 0-500 pM (R2 = 0.957), suggesting the QD-Affimer 
conjugate is suitable for ratiometric quantitation of pM levels target proteins. The 
positive linear increase of the I667/I606 ratio with the increasing SUMO concentration 
matched exactly what was expected for the multiple acceptors FRET to a single QD 
donor model,25,32 suggesting that all SUMO proteins were bound in the same 
orientation on the QD surface (with the same QD-dye distance). 
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Figure 3-11:  (A) Fluorescence spectra of the QD-Affimer (final CQD = 0.50 nM) after 
incubation with different concentration of the target SUMO protein (Alexa-647 
labeled) in PBS containing 1 mg/ml of bovine serum albumin. Inset shows the 
amplified FRET signals over 650-725 nm and the PBS and PBS+10 nM labeled 
SUMO protein backgrounds. (B) A plot of the integrated fluorescence intensity ratio 
(IDye/IQD) between the dye (over 650-750 nm) and QD (over 560-650 nm) versus the 
SUMO protein concentration fitted to a linear function. Inset shows the response 
over 0-50 pM and green line indicates the limit of detection (background +3σ). (C) A 
schematic presentation of the QD-Affimer for detection of labeled target SUMO via 
QD-sensitized Alexa-647 FRET readout strategy. 
A significant advantage of FRET-based sensing over others is ratiometric readout 
signal with internal self-calibration function and is therefore insensitive to 
instrumental noise and/or signal fluctuations, allowing for highly reliable, accurate 
quantitation.21,24 Moreover, the signal of 10 pM SUMO protein was well-separated 
from the background (by >3 × standard deviation, 3σ, as indicated by a broken line in 
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Figure 3-11 B inset), suggesting this sensor is capable of detecting 5 pM target 
SUMO protein. Such sensitivity places it among the very best for QD-FRET sensors 
for direct protein detection (Table 3-3).  
 
Table 3-3. Comparison of the sensing performance of some QD-FRET sensors for 
direct target detection using fluorescence spectroscopy without target amplification. 
Sensing  Target      LOD (nM) Dynamic         Reference 
Mechanism      limit  range (nM) 
QD-FRET  Thrombin   10   10-1000             [57] 
QD-MB FRET  Thrombin   1  1-500              [58] 
ET quenching  Thrombin    10  10-210              [59] 
QD-FRET  Mucin-1   250  250-2000             [60] 
Electrochemical Thrombin   ~ 1    1-1000              [61] 
Tb-complex QD FRET PSA    0.05-0.27 0.05-21              [62]* 
QD-FRET  SUMO protein   0.5  0.10-150 This work 
QD-FRET  SUMO protein (labeled) 0.005  0.005-1 This work 
QD-FRET  Neutravidin (labeled)  0.005  0.005-50 This work 
* The sensitivity (LOD) is dependent on the sizes of the antibody or antibody fragment used as 
target binder. 
The reasons for the excellent sensitivity here are two folds: 1) our UCEP allows for 
the water-soluble QD to retain native high fluorescence (hence large R0 value); 2) the 
small size of the Affimer binder (hence compact QD-Affimer conjugate) leads to short 
QD-dye distance r. Both factors are strongly beneficial for improving E and hence 
sensitivity. Importantly, the QD-Affimer sensor was highly robust; it gave an excellent 
positive linear detection of target SUMO protein in the presence of large excesses of 
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a non-target protein, bovine serum albumin (BSA, 1 mg/mL, see Figure 3-12). It also 
specifically detected the target SUMO protein even in 50% of human serum (Figure 
3-13), demonstrating an excellent sensing robustness. It should be noted that, 
despite a number of different QD-FRET sensors being reported in literature, most 
sensing tests were carried out in “clean” buffers, few have demonstrated robust 
sensing in clinically relevant media, e.g. 50% human serum,16,32 especially for QDs 
capped with small-molecule ligands. The fact that the QD-Affimer sensor can work 
robustly in 50% human serum demonstrates an excellent potential for possible 
clinical applications.  
 
Figure 3-12:  (A) Fluorescence spectra of the self-assembled QD-Affimer (unlabelled, 
specific for SUMO protein, 10 nM) conjugate after incubation with different amounts 
of Alexa 647 labelled SUMO protein target in the presence of 1 mg/mL bovine serum 
albumin. (B) A plot of the I667/I606 as a function of SUMO protein concentration, data 
was fitted to a linear function: y = 0.0024 + 0.0014x, R2 = 0.9778. 
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Figure 3-13: Fluorescence spectra of the self-assembled QD-Affimer (unlabelled, 
specific for SUMO protein, 10 nM) conjugate after incubation with Alexa 647 labelled 
SUMO protein targets (300 nM) under different conditions: (A) prior to and (B) after 
human serum background correction. The figure clearly shows that the self-
assembled QD-Affimer sensor prepared here is highly robust; it can specifically 
detect its target protein even under complex conditions such as 50% human serum. 
 
The ability of detecting unlabeled protein target is more useful for biodiagnostics 
because target labeling may not be feasible for naturally occurring proteins in 
biological samples. To investigate this potential, we first conjugated each 
CdSe/CdS/ZnS QD with 1 copy of the anti-SUMO Affimer (via His8-tag self-
assembly) and then blocked the QD with 20 copies of a control Affimer (His8-tagged) 
that showing no binding affinity to the SUMO protein.50 An Alexa-647 labeled SUMO 
protein was used as FRET reporter. The final assay concentration of the QD and 
labeled SUMO reporter was fixed at 0.5 nM each. Introducing the unlabeled SUMO 
protein would compete with the labeled SUMO protein reporter binding to the QD-
Affimer conjugate, reducing the number of labeled proteins binding to the QD and 
resulting in the QD fluorescence recovery (Figure 3-14). A plot of the resulting I606/I667 
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versus the unlabeled SUMO concentration revealed a good positive linear 
relationship over 0-10 nM range (R2 = 0.977) with 500 pM being clearly detectable 
(Figure 3-14). The label-free sensitivity is lower than that of label detection (ca. 5 
pM), presumably because each QD is conjugated with only 1 copy of the Affimer 
binder versus 12 copies in labeled detection which may enhance the Affimer-SUMO 
binding affinity via multivalency effect. Moreover, not all target Affimers on the QD 
surface may have bound to the labelled protein reporters due to their natural binding-
dissociation equilibrium, thus some of the introduced unlabeled SUMO proteins may 
simply bind to the unbound free Affimers on the QD surface without displacing the 
reporter proteins. Nevertheless, the label-free sensitivity reported herein is 
comparable or better than most other QD-FRET based protein sensors (Table 3-3). 
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Figure 3-14:  (A) Fluorescence spectra of the QD-Affimer conjugate (0.5 nM) mixed 
with Alexa-647 labeled SUMO protein reporter (0.5 nM) in the presence of different 
amounts of unlabeled SUMO protein. (B) A plot of I606/I667 as a function of the 
unlabeled SUMO concentration: data over 0-10 nM were fitted by a linear function. 
The scheme below shows the assay principle (the protein circled being the anti-
SUMO Affimer while all others are non-SUMO binding Affimers). 
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3.3.4 Preparation of QD-biotin for biosensing and cancer cell imaging 
Besides making stable QDs using non-directly bioactive DHLA-ligands, biotin-
functionalized QDs were readily prepared by in one step using mixed DHLA-
PEG600-biotin/DHLA-ZW or DHLA-PEG750 ligands. Tuning the ratio of the DHLA-
PEG600-biotin ligand to DHLA-ZW or DHLA-PEG750 spacer ligand ratio allowed for 
control of the QD surface biotin valency. The resulting CdSe/CdS/ZnS QD-biotin 
(each having ~100 DHLA-PEG600-biotins with the rest being DHLA-ZW ligands, 
denoted as QD-biotin100) was employed for detection of neutravidin (NAV, each 
labelled with 1.7 Alexa-647 dyes) by exploiting the extremely strong bio-specific 
interaction between biotin and NeutrAvidin (NAV) (dissociation constant: Kd ~10
-15 M). 
With the increasing amount of NAV being added to the QD-biotin100 (0.5 nM QD), the 
QD fluorescence was progressively quenched while the Alexa-647 FRET signal was 
enhanced concurrently before reaching saturation at ~50 nM (Figure 3-15). This 
result conform the specific biotin-NAV binding brought the Alexa-647 label to the 
close proximity with the QD, producing efficient QD-sensitized Alex-647 FRET. This 
was validated by a control experiment where the QD capped with DHLA-ZW ligands 
only without DHLA-PEG600-biotin displayed no detectable FRET signal under 
identical conditions (Figure 3-16). A plot of the I667/I607 ratio versus NAV 
concentration gave a good positive linear calibration over 0-50 nM range (R2 = 0.982, 
Figure 3-15B). Moreover, 5pM NAV was clearly distinguished from the background, 
suggesting a detecting limit of 5 pM and confirming it is among the most sensitive 
QD-FRET protein sensors (Table 3-3). The signal saturation at ≥50 nM NAV 
suggests that all of the QD surface biotins have bound to NAV, matching well to the 
total biotin content expected for 0.5 nM QD-biotin100. 
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Figure 3-15:  (A) Fluorescence spectra of QD-biotin100 (0.5 nM) mixed with different 
amounts of Alexa-647 labeled neutravidin (NAV). (B) Relationship between the 
I667/I607 ratio and NAV concentration. Data over 0-50 nM were fitted by the linear 
function: Y = 0.01037 + 0.0084X, R2 = 0.982 (inset showing the data over 0-0.3 nM) 
 
Figure 3-16: (A) Fluorescence spectra of 0.5 nM QD-biotin100 (purple); 0.5 nM QD-
ZW + 50 nM Alexa-647 labelled neutravidin (abbreviated as NAV, black); 0.5 nM 
QD-biotin100 + 50 nM NAV (red) and 50 nM NAV only (blue). (B) Comparison of the 
I667/I607 intensity ratio of the QD-Biotin100 only (QD only), QD-ZW+NAV and QD-
biotin+NAV obtained from the spectra shown in (A).    
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Using the labeled NAV as FRET reporter, the QD-biotin/NAV was further exploited 
for label-free detection of biotin. This was based on the fact that free biotin can 
effectively compete with the QD-biotin100 for binding to NAV, reducing the amounts of 
NAV binding to the QD and hence the QD to Alexa-647 FRET efficiency. Indeed 
significant QD fluorescence recovery together with concurrently reduced Alex-647 
FRET signal was observed with the increasing free biotin concentration. Moreover, 
10 nM biotin was positively detected (Figure 3-17), suggesting the QD-biotin sensor 
can detect low nM level of unlabeled biotin, a small molecule target.  
Besides a high affinity binding to NAV, biotin is an important vitamin (known as 
vitamin H) necessary for cell growth, the production of fatty acids, and the 
metabolism of fats and amino acids. A number of cancer cells over-express biotin 
receptors on their surfaces, making biotin an attractive ligand for cancer cell 
targeting.51-53 Thus we further investigated the potential of using the QD-biotin in 
cancer cell imaging. Here two QD-biotin samples with valencies of ~70 and ~150 per 
QD respectively (the rest being the DHLA-PEG750 ligand) were prepared and 
incubated with the human cervical cancer (HeLa) cells which are known to over-
express biotin receptors.51,53 The resulting confocal fluorescence images revealed 
that cells incubated with the QD-biotin displayed the higher fluorescence than the 
DHLA-PEG750 capped control QD (red channel, Figure 3-18). This result showed 
that biotin modification on the QD enhanced the uptake by HeLa cells, presumably 
via biotin receptor mediate endocytosis. Interestingly, most intracellular QDs 
appeared to be located close to the cell nuclei (stained by Hoechst and displayed in 
blue) without enter the nuclei. A flow cytometry analysis further revealed that the 
strongest QD fluorescence was observed for cells incubated with the QD-biotin150, 
followed by QD-biotin70, and then the control QD (Figure 3-19). This result is fully 
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consistent with the confocal fluorescence imaging, demonstrating the good potential 
of the biotinylated QD in targeted cancer cell imaging. 
 
Figure 3-17: (A) Fluorescence spectra of QD-biotin100 (0.5 nM) + Alexa-647 
labelled NAV (50 nM) in the presence of different concentrations of free biotin. (B) A 
plot of the corresponding I608/I667 ratio versus free biotin concentration. The 10 nM 
free biotin produced a clearly distinguishable signal from the background, suggesting 
that the QD-biotin/NAV system is suitable for label-free detection of low nM level of 
free biotin. 
 
 
 
 
 
 
 
550 600 650 700 750
0.0
0.2
0.4
0.6
 
 
I 
(1
0
6
 c
p
s
)
/nm
 0 nM
 1 nM
 5 nM
 10 nM
 20 nM
 50 nM
 100 nM
 200 nM
0 50 100 150 200
0
5
10
15
20
25
30
35
 
 
I 6
6
7
/I
6
0
8
C/nM
(A) (B)
172 
 
 
Figure 3-18: Confocal fluorescence images of HeLa cells after 4 h treatment with 50 
nM of the DHLA-PEG750 ligand capped control QD (top panel) and two QD-biotin 
samples containing ~150 (middle panel) or ~70 (bottom panel) biotins per QD. From 
left to right, the images are displayed as QD fluorescence image (red), DAPI 
fluorescence (staining the nuclei, blue), optical image DIC and the merged 
fluorescence and optical images.   (This work is done by Rongjun’s group in imperial)    
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Figure 3-19:  (left): Typical cell fluorescence distribution histograms of HeLa cells 
measured by flow cytometry after 4 h incubation with the DMEM medium only (A) 
and DMEM medium supplemented with 50 nM of the control QD (B), QD-biotin70 (C) 
or QD-biotin150 (D). The media cell fluorescence intensities (a.u.) were 1218, 3255, 
Fluorescence Intensity (a.u.) 
(A)
(B)
(C)
(D)
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4194, and 5071, for A, B, C and D respectively. A significant increase (by ca. 56%) 
of cell median fluorescence (marked by broken lines for each treatment) was 
observed for HeLa cells after treatment with the QD-biotin150 over the control QD 
(capped with DHLA-PEG750 only, note the logarithmic scale of the intensity). This 
result was consistent with the higher fluorescence intensities observed from the 
confocal fluorescence image shown in Figure 3-18 (This work is done by Rongjun’s 
group in imperial) 
 
Figure 3-20: Comparison of the median fluorescence intensity of HeLa cells after 
incubation with the DMEM medium only (Control); 1 h incubation with EMEM 
medium followed by 4 h incubation with EMEM medium contianing 50 nM of QD-
Biotin150 (QD); and 1h incubation with DMEM medium suplemented with 10 mM free 
biotin followed by 4 h incubation with DMEM medium containing 50 nM of QD-
Biotin150 and 10 mM free biotin (QD + free biotin). A signficant decrease of ca. 53% 
of cell median fluorescnece intensity (from 5700±560 to 2690±280) was obtainted by 
the presence of free biotin.  
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3.4 Conclusion 
In summary, an UCEP that allows for rapid, complete water-solubilization of the 
widely used hydrophobic CdSe/ZnS and CdSe/CdS/ZnS QDs using 50-1000 folds 
less amounts of the DHLA-based ligands over most literature methods has been 
developed. It readily produces compact, biocompatible QDs with excellent stability in 
biological buffers and effectively retaining the native parent QD fluorescence (>90%). 
The resulting QD is readily bioconjugated with His8-tagged Affimers for robust, 
sensitive detection of 5 pM of a specific target protein and works robustly in clinical 
relevant media (50% human serum). The UCEP also allows for readily one-step 
preparation of biotinylated QDs for sensitive biosensing and cancer cell imaging. 
Compared to other QD cap-exchange methods reported in literature, the UCEP has 
four notable advantages: 1) using far fewer ligands (by 50-1000 fold) which is 
extremely valuable for precious, expensive or difficult to access ligands; 2) it is a 
rapid procedure; 3) it is easy to operate (using air-stable compounds and rapid in situ 
reduction at ambient condition); and 4) it shows no compromise of the post cap-
exchange QD fluorescence. Therefore, we believe this UCEP will impact significantly 
in broad QD-based biomedical research field, including biosensing, bioimaging, drug 
delivery, clinical diagnostics and therapeutics, and most importantly in areas 
involving the use of QD-FRET based readout strategies. 
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Chapter 4. Photon induced fluorescence recovery of 
cap-exchanged quantum rod for ultra-sensitive 
ratiometric biosensing 
 
 
Abstract 
In this chapter, a stable, water-soluble rod-shaped fluorescence semiconductor 
nanocrystal (CdSe/CdS core/shell quantum rod, QR) was made by an efficient cap 
exchange protocol. However, in most cases the fluorescence of the cap-exchanged 
QR was almost quenched, hindering their biomedical applications. Herein I have 
solved this problem by discovering a simple method that allows for efficient recovery 
of the QR quantum yield, making them suitable for biological applications. The 
resulting water-soluble QRs are compact (Dh < 20 nm), bright (recovering to >67% of 
original fluorescence), resisting nonspecific adsorption and displaying good stabilities 
in biological buffers, making them well-suited for ratiometric biosensing. After tris(2-
carboxylethyl phosphine, (TECP) reduction, a dihydrolipoic acid-zwitterion ligand 
(DHLA-ZW) capped QR was self-assembled with (His8)-tagged anti-yeast SUMO 
non-antibody binding proteins (Affimers), allowing for ratiometric detection of its 
target protein down to 5 pM via the QR-sensitized Förster resonance energy transfer 
(FRET) readout signal. Furthermore, compact biotin functionalized QRs are prepared 
by a facile, one-step cap-exchange process for ratiometric quantitation of labelled 
neutravidin down to 5 pM. Such sensitivity is among the very best for QR-FRET 
based biosensors. These stable, bright QR-based probes have many potential 
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applications where they can be advantageous over the more widely sued quantum 
dots as biological labels. These include larger absorption cross section, higher 
extinction coefficient and individual particle brightness, higher quantum yield and a 
bigger stokes shift and a bigger particle size that can be functionalized with more 
functional/binding moieties. 
 
4.1 Introduction 
Fluorescent semiconductor nanocrystals, also known as “quantum dots, rods, and 
wires”, have been intensely investigated over the past twenty years because of their 
unique, size-dependent, stable and bright fluorescence properties which have board 
applications in energy, materials, biology, and medicine1-12.  
Despite significant recent progress, high quality QRs are typically synthesised by the 
organometallic route based on reactions performed in coordinating organic 
solvents13. Approaches capable of preparing high quality QRs with accurate control 
of size and aspect ratios have also been reported. However such nanocrystals are 
capped with hydrophobic surface ligands, making them only soluble in organic 
solvents such as hexane, toluene or chloroform, and hence biologically incompatible. 
For applications like biosensing and bio-imaging, the QRs need to be soluble in 
aqueous solutions and compatible with clinic diagnostic biological media. 
Encapsulation of QRs with amphiphilic ligands1 is one of the methods that is often 
used to make the QR soluble in aqueous solution and retain its photo-physical 
properties. Although the resulting QRs can be suitable for bioimaging, but they have 
limited use in biosensing and Förster resonance energy transfer (FRET) applications 
because of the significantly increased hydrodynamic diameters arising from the QR 
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encapsulation (Dh > 20 nm) 14-21. As discussed in the previous chapters, for sensitive 
biosensing and FRET based applications, the QR-bioconjugate should have short 
separation distance between the QR and the functional label on the target and 
binder molecules (e.g. the non-antibody binding protein (Affimer), Yeast SUMO 10, 
and its specific target protein (Yeast SUMO 28b)) used in this chapter. Whereas, 
ligand exchange (LE), a frequently used methodology to replace the native 
hydrophobic ligands with hydrophilic ones to promote the QR water-solubility and 
biocompatibility,22, 23 is better suitable for FRET applications because of the resulting 
smaller Dhs. 
As in the previous QD chapter, we also use the small dithiol-containing ligands such 
as dihydrolipoic acid (DHLA) and DHLA based compounds (DHLA-PEG600-Biotin) 
to perform the QR ligand-exchange, owing to their ability to form a stable and thin 
coating (small hydrodynamic diameters) on the QR surface. DHLA is made from TA 
(lipoic acid) by reducing its S-S bond of 1,2-dithiolane ring using tris(2-
carboxylethyl)phosphine (TCEP). The reduced DHLA-ligands are directly used to 
initiate cap-exchange with hydrophobic CdSe/CdS QRs in homogenous solution 
similar to the previous QD chapter. This method allows for complete water-
solubilisation of commercial hydrophobic QRs (CdSe/CdS) at a ligand: QR molar 
ratio of as low as 1000:1. Despite success in making the QR water-soluble, a major 
problem we found here is that the post cap-exchange Quasi-Type II QRs have 
almost totally lost their fluorescence property. To address this problem, we have 
discovered a new simple method that allows the QR to recover its fluorescence up to 
90% of its original value. Moreover, the water-solubilized QRs retain compact sizes, 
resist nonspecific adsorption of proteins and display good stabilities in biological 
buffers. Furthermore, such QRs can be readily conjugated with a His8-tagged Affimer 
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(Yeast SUMO10) for specific detection of 5 pM of its protein target (Yeast SUMO28b) 
via the QR-sensitized dye FRET signal in the presence of large excess of a non-
target protein (ca. 0.1 mg/ml BSA (bovine serum albumin)). Additionally, biotinylated 
QRs are prepared by a facile, one-step cap-exchange process that can be used for 
ratiometric quantitation of labelled NeutrAvidin down to 5 pM. 
 
4.2 Experiment details 
4.2.1 Chemicals and Regents 
CdSe/CdS core/shell QR (EM max ~556 nm, CANdots, quantum yield >60%) was 
supplied as a hexane solution. The QR was coated with hydrophobic organic 
molecules. CdSe/CdS/ZnS core/shell/shell QDs in toluene (CANdots, EM = ~610 nm, 
quantum yield > 40%) were purchased from Strem Chemicals (Cambridge, UK). 
lipoic acid (LA, > 99%), tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP.HCl, >98%), chloroform (> 99.8%), ethanol (>99.9%), methanol (>99.9%), 
sodium bicarbonate (>99.5%), Dulbecco’s phosphate buffered saline (D-PBS) and 
other chemicals were all purchased from Sigma-Aldrich (Dorset, UK) and used as 
received without further purification unless stated otherwise. Solvents were obtained 
from Fisher Scientific (Loughborough, UK) and used as received. Ultra-pure water 
(resistance >18.2 MΩ.cm) purified by an ELGA Purelab classic UVF system, was 
used for all experiments and making buffers. All moisture-sensitive reactions are 
performed under nitrogen atmosphere using oven-dried glassware. All solvents are 
dried by innovative technology prior to use, or are taken from sealed-bottles under 
nitrogen atmosphere. Evaporations are performed under reduced pressure on a 
rotary evaporator.  
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4.2.2 Experimental Procedures 
4.2.2.1 Preparation of water-soluble DHLA-Zwitterion ligand capped QRs (QR-
ZW) by ligand exchange 
 
Chart 1: Chemical structures of the lipoic acid (LA)-based ligands used in this study. 
 
Our ligand exchange procedure is shown in Figure 4-2. The synthesis, purification 
and characterization of the LA-Zwitterion and LA-PEG600-Biotin ligands were 
described in Chapter 218-20. A typical ligand exchange procedure for preparing of 
DHLA-ZW ligand capped QR (abbreviated as QR-ZW) is as follows: the hydrophobic 
CdSe/CdS QR (0.2 nmole, 10 μl in hexane) was precipitated by adding 500 μl EtOH 
(or MeOH) followed by centrifugation to remove any free TOPO ligands. The QR 
pellet was then dissolved in 200 μl CHCl3 and then added with 100 μl EtOH to make 
solution A. The LA-ZW ligand (0.10 M, 2 μl in H2O) was reduced to DHLA-ZW by 
mixing with TCEP.HCl (0.10 M, 2 μl in H2O) for 15 mins. After which NaOH (0.10 M 
in EtOH, 12 μl) was added to fully deprotonate the DHLA thiol-groups and to 
neutralise acid groups in TCEP.HCl (each containing 4 acid groups) to make solution 
B. The above solutions A and B were then mixed in a new Eppendorf tube for 1-5 
mins with occasional shaking by hand. After that, the reaction mixture was 
centrifuged (1000 rpm for 10 seconds) and all the QR was precipitated at the bottom 
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of the Eppendorf tube as a pellet, leaving the supernatant (CHCl3, EtOH and H2O 
homogeneous solution) effective colourless. The supernatant was then carefully 
removed and the QR pellet was sonicated in a mixed CHCl3 (500μl) and EtOH (200μl) 
solution to break up the QR-ZW pellet. After that, the tube was centrifuged for 1 min 
at 3000 rpm to collect the QR pellet and the clear supernatant was discarded. The 
process was repeated twice to remove any unbound free ligands, the QR pellet was 
finally added with H2O (100 μl), yielding a stable, and water soluble QR stock 
solution. The stock QR concentration was determined by UV-vis absorption spectra 
using their first exciton peak at 550 nm and the respective extinction coefficient (2.56 
x 105 L mol-1 cm-1) using our previously established procedures before24, 25. 
4.2.2.2 The ligand exchange procedure to make water soluble QR-ZW,-PEG600-
biotin (1:1000 ratio for DHLA-ZW, 1:200 ratio for DHLA-biotin) 
A typical ligand exchange procedure is as follows: QR (0.2 nmol, 10 μl in toluene or 
hexane) was first precipitated by adding 500 μl EtOH or MeOH and centrifuged to 
remove any free TOPO ligands. The QR precipitate was then dissolved in a 100 μl 
CHCl3 followed by addition of 60 μl EtOH to make solution A. LA-ZW (0.10 M, 2 μl in 
H2O) and LA-PEG600-Biotin (0.01 M, 4 μl in EtOH) were mixed with TCEP (0.10 M, 
2.4 μl in H2O) for 15-20 mins to reduce the LA-ZW and LA-PEG600-Biotin into 
DHLA-ZW and DHLA-PEG600-Biotin, after that NaOH (0.10 M in EtOH, 14.4 μl) was 
added to fully deprotonate the DHLA thiol-groups and to neutralise acid groups in 
TCEP to make solution B. After that, the above solutions A and B were mixed in a 
new Eppendorf tube for around 1 min with occasional shaking by hand. The QR was 
found precipitated to the bottom of the tube. After removal of clear supernatant, 
washing and centrifugation steps to remove any free DHLA based ligands as above, 
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the QR pellet was dissolved in pure H2O (50 μl), yielding a stable QR stock aqueous 
solution.  
4.2.2.3 Yeast SUMO protein preparation, purification and labelling 
The target protein, yeast SUMO (SUMO) protein and the anti-Yeast SUMO Affirmer 
were expressed in BL21 (DE3) cells using isopropyl b-D-1-thiogalactopyranoside 
(IPTG) induction and purified by Ni-NTA resin (Qiagen) affinity chromatography 
according to the manufacturer’s instructions. All the target protein and anti-SUMO 
Affimers were provide by the Tomlinson group at Faculty of Biological Sciences, 
University of Leeds. The detailed experimental procedures were described in our 
recent publication26. The anti-SUMO Affimer (5 mg/ml, 12.5 µl in PBS, MW = 13,267) 
in an Eppendorf tube was first mixed with Atto 594 NHS-ester (30 µg in 2 µl DMSO) 
and then 5 µl NaHCO3 (0.5 M, pH = 8.3) and 7.5 µl PBS (10 mM phosphate, 150 mM 
NaCl, pH 7.4) were added and thoroughly mixed at room temperature overnight (dye: 
protein molar ratio ≈ 5:1). After that the reaction mixture was loaded on a small G25 
gel filtration column using PBS as eluting solution on natural flow. The first eluted 
blue band (corresponding to the labelled anti-SUMO Affimer) was collected and its 
absorption spectrum was recorded. (Figure 1) Using the extinction coefficients of the 
Atto-594 dye (nm = 120,000 M
-1cm-1) and Affimer (nm=7904 M
-1cm-1) and 
the CF280nm of 0.51 for Atto-594, the average dye labelling ratio on per Affimer was 
calculated as 0.35. The stock protein concentration was determined as 8.4 µM27. 
Similarity, the SUMO protein was labelled with Atto-594 NHS ester using the same 
procedures under a dye: protein molar ratio of 5. After purification by using a G25 
column as above, the average number of dyes labelled on each protein was 
determined as 0.25. The labelled protein stock concentration was 10 µM. 
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Figure 4-1: Picture of Yeast SUMO10 Affimer and Yeast SUMO28b target protein 
labelled by Atto-594 go through G25 column.  
 
4.2.2.4 NeutrAvidin Protein labelling 
Neutravidin (28.8 µl, MW = 60000 g/mol, ɛ = 1.66 at 1mg/mL, c = 10 mg/mL) in an 
Eppendorf sample tube was added Atto 694 NHS-ester 50 µg (Mw ≈ 1358 g/mol, 
nm = 120,000 M
-1cm-1) dissolved in 2 µl DMSO, and the CF280nm of 0.51 for 
Atto-594 and 7.5 µl PBS (10 mM phosphate, 150 mM NaCl, pH 7.4) were added and 
mixed together at room temperature for 8 h (reaction ratio of protein : dye ≈ 1: 8). 
After that, the mixture was separated on a small G25 gel filtration column using PBS 
as eluting solution on natural flow. The first eluted blue band (the labelled 
Neutravidin) was collected the dye labelling ratio was calculated by following our 
earlier established procedures, yielding a dye: neutravidin ratio of 0.67. The stock 
protein concentration was 4.6 µM. 
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4.3 Results and discussion 
 
4.3.1 Preparation and investigation of water soluble QR-ZW 
First we studied how ligand: QR molar ratio (LQMR) affected the cap-exchange 
process using the hydrophobic CdSe/CdS QR capped with mixed 
trioctylphoshine/trioctylphoshine oxide ligands and the DHLA-zwitterion (ZW) ligand 
(Chart 1). When cap-exchange was performed at a LQMR of  1000, all of the 
CdSe/CdS QRs were fully transferred to the aqueous phase (shown as a yellow 
colour in the top aqueous layer), leaving the bottom CHCl3 layer colourless (Figure 
4-2). Those prepared under lower LQMRs showed some minor aggregation or 
clustering (Figure 4-2, 3). Thus a LQMR of 1000:1 was determined as the minimum 
ratio to allow full CdSe/CdS QR water-solubilization. A further dynamic light 
scattering (DLS) analysis of the CdSe/CdS QR after cap-exchange with the DHLA-
ZW revealed that compact (ca. Dh =13.5 ± 2.6 nm, mean ± ½ FWHM) water-soluble 
QRs with uniform narrow size distribution was obtained at LQMR of 1000 (Figure 4-
3). Then we investigated the crystal size of QR (EM ~550 nm) before and after LE 
procedure by Transmission electron microscopy (TEM) (Figure 4-4).  The QR 
appeared as uniform rod shaped nanocrystals of ~3.6 nm wide and ~23 nm in length. 
No observable change of the shape or size of the QRs were observed after the cap-
exchange.  
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Figure 4-2: A picture of our approach to transfer of the hydrophobic CdSe/CdS QRs 
(EM ~ 550 nm)  into aqueous media by ligand exchange with DHLA-ZW ligands at 
LQMR =1000:1. The LA-ZW ligands, after TCEP reduction and NaOH deprotonation, 
are used directly to initiate ligand exchange with hydrophobic QRs in a homogenous 
solution of CHCl3/EtOH/H2O.  
 
Figure 4-3: Size distribution diagrams measured by dynamic light scattering (DLS) 
for the CdSe/CdS core/shell QR (EM ~ 550 nm) after cap-exchange with DHLA-ZW 
under LQMR: 1000. Mean size is 13.5 nm, and ½ FWHW is 2.7 nm. 
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Figure 4-4:  (A) TEM image of the TOP-TOPO capped CdSe/CdS core/shell QR 
(EM ~ 550 nm) used in this study prior to ligand exchange. It has an average wide of 
~3.6 nm and length of ~23 nm. (B) TEM image of the CdSe/CdS core/shell QR after 
ligand exchange with the DHLA-ZW at a ligand: QR molar ratio of 1000:1.  
 
Theoretically, a cylinder 3.6 nm wide and 23 nm length green emitting (EM ~550 nm) 
CdSe/CdS QR (Figure 4-4) has a total surface area of 300.6 nm2 (Figure 4-5). 
Assuming the QR is terminated with a full Cd2+ outer layer in stable Wurtzite 
structure with each Cd2+ occupying a surface area of 0.15 nm2 (Figure 4-6), then the 
QR would contain a maximum of 2004 surface Cd2+ ions. Assuming each thiolate 
binds to one Cd2+ ion, then 2004 single thiolate ligands (or 1002 DHLA-based 
ligands, each containing 2 thiol groups and hence a footprint area of 0.30 nm2) would 
saturate the QR surface Cd2+ ions completely. This result may indicate that all of the 
added DHLA-ligands have bound to the QR and each DHLA may have chelatd to 
two Cd2+ ions. Thus a QR surface Cd2+:DHLA-ligand ratio of ~2:1 is needed to 
produce compact, isolated individual biocompatible QRs. The observation that a 
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LQMR of 1000:1 can promote a complete phase transfer and formation of stable 
water-soluble QRs may indicate that all of the added DHLA-ligands have bound to 
the QR. 
 
 
Figure 4-5: the calculation of QR total surface area. 
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Figure 4-6: Schematic of a hexagonally packed Cd2+ outer layer (assuming CdS 
being in its most stable Wurtzite structure) where a = b = 416 pm = 0.416 nm. 
Within the hexagon area, there are three Cd2+ ions (spheres, 1 in the middle + 6 × 
(1/3) one the corners). 
The total area of the hexagon = 6 × (1/2) a2 × sin60o = 3 × 0.4162 sin60o = 0.449 nm2 
Therefore the surface area occupied by each Cd2+ = 0.449/3 = 0.150 nm2 
 
Despite the success in the phase transfer and formation of stable water-soluble QR, 
a major problem here was that the post ligand-exchange QR displayed a significantly 
reduced fluorescence quantum yield (QY) compared to the parent QR in organic 
phase, typically retaining <5% of original fluorescence even the same LE method as 
the QD described in chapter 3 was used. In contrast, the CdSe/ZnS or 
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CdSe/CdS/ZnS QDs typically retained >96% of their original quantum yields as 
described in chapter 3 (Figures 4-7, 8) 
 
 
Figure 4-7: Pictures of 1 nmol Type I QDs and 0.2 nmol Quasi-Type II QRs in H2O 
and CHCl3 under sunlight ambient and UV light. (A) Picture of 1 nmol core/shell/shell 
Type I QD600 in H2O after LE method and 1 nmol original QD600 in CHCl3, (B) 
Picture of 0.2 nmol core/shell Quasi-Type II QR550 in H2O after LE method and 0.2 
nmol original QR550 in CHCl3 
28. 
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Figure 4-8:  (A) Emission spectra of 1 nmol CdSe/CdS core/shell QRs organic 
ligand capped in CHCl3 (black) and DHLA-ZW capped in H2O (red). After LE, the QR 
was almost totally quenched compared to original QR before LE (original QR 
fluorescence intensity at 556 nm I556≈ 3.5*10
6 cps, DHLA-ZW capped QR I556 ≈ 
0.1*106 cps). (B) The picture of 0.2 nmol DHLA-ZW capped QR dissolved in H2O 
under ambient and UV light. 
 
The reason behind this problem is likely due to the different band structures of the 
QR and QD used here. The CdSe/ZnS or CdSe/CdS/ZnS QDs used in chapter 3 are 
both type I QDs whose exciton carriers are fully confined within the core of the 
core/shell structure, so any changes to the shell as a result of the ligand exchange 
do not affect its fluorescence significantly. (Figure 4-7, 4-9) However, the CdSe/CdS 
QR used here has a Quasi-type II band structure, whose excited electron can spread 
across the whole core and shell structures29. Ligand exchange with the strongly 
chelating DHLA-based ligands may produce cation/anion vacant sites on the shell 
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which can trap the exciton carriers to prevent their emissive recombination30, leading 
to greatly quenched fluorescence. Particularly, the excited electron can spread 
throughout of the whole core/shell structure in the CdSe/CdS QR, making its 
fluorescence be strongly dependent on surface properties and hence highly sensitive 
to cap-exchange28.(Figure 4-9) This represents a major challenge/problem for 
realising the full potential for QR based biomedical applications which are all relied 
on its fluorescence property. Here we have developed a simple but effective 
approach to solve this problem. 
 
 
Figure 4-9: Schematic representation of energy – level alignment by selection core 
and shell materials. (A) A CdSe/ZnS core/shell type I QD with both electron and hole 
are confined within the core; (B) A CdSe/CdS quasi-Type II QR with the electron 
being spread in both core and shell structure28. 
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4.3.2 Photon-induced fluorescence recovery of the QR-ZW 
In order to make the QR reach its full potential in biomedical applications, we 
discovered a simple method to recover the QR fluorescence after LE. The 
schematics of our process for transferring the hydrophobic ligand (TOPO) capped 
QRs (soluble in CHCl3) into water-soluble ones capped with DHLA-ZW ligand is 
shown in Figure 4-10. 
 
Figure 4-10: A schematic of our approach to transfer of the hydrophobic QRs into 
aqueous media by ligand exchange with DHLA-ZW ligands. The LA-ligands, after 
TCEP reduction and NaOH deprotonation, are used directly to initiate ligand 
exchange with hydrophobic QRs in a homogenous solution of CHCl3/EtOH/H2O. 
Photograph of a CdSe/CdS QR (EM ~ 550 nm) under ambient and UV light before 
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(left) after ligand exchange with DHLA-ZW (right, top layer: H2O; bottom layer: 
CHCl3).  
Because the QRs were practically non-emissive immediately after the ligand 
exchange when the ligand: QR molar ratios (LQMRs) used were higher than 1000:1. 
(1000:1 was minimum LQMR required for the complete transfer of the oil-soluble 
QRs into the aqueous phase) (Figure 4-2, 4-4, 4-11) As shown in Figure 4-8, the 
original QR fluorescence intensity was reduced by >97% after LE (reduced from ca. 
3.5 x106 to ≈ 0.1 x106 cps). The dramatic decrease of QR fluorescence was 
observed immediately after ligand exchange with DHLA-ZW. This effect cannot be 
eliminated even when minimum ligands (LQMR of 1000: 1) were used in the cap-
exchange to minimum the shell etching using the same principle as described in 
Chapter 3. Interestingly, we found that the fluorescence of the QR-ZW can recover 
automatically when being stored under ambient conditions. To the best of our 
knowledge, this fluorescence automatically recovery for post cap-exchanged QDs or 
QRs has not been reported previously in literature.  
In order to investigate what is the main cause of fluorescence recovery, we made a 
batch of three identical QR-ZW samples fully dispersed in H2O and exposed them 
under different light conditions: sunlight, UV light (a UV lamp typically used for 
imaging the TLC plate) or total darkness wrapped with aluminium foil. (Figure 4-11) 
The QRs exposed to UV light was found to recover its fluorescence very rapidly, 
gaining ~86% of its original fluorescence in 5 hours, whereas the fluorescence of the 
QR stored under ambient light conditions recovered more slowly, gaining ~60% of its 
original fluorescence in 1 week (Figure 4-12). Presumably because the UV light has 
higher energy than normal sunlight. In contrast, the QR-ZW sample stored in total 
darkness (in a fridge) has the lowest fluorescence recovery rate. Since the sample 
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was occasionally taken out from fridge for fluorescence checking, during which it was 
also exposed to the ambient sunlight in a very short time which may have led to the 
slow fluorescence recovery. (Figure 4-11) Nevertheless, it remained very dim even 
after 1 month. Based on these results, we concluded that the ambient room light and 
more effectively the UV light can provide enough energy to the QR for fluorescence 
recovery.  
 
Figure 4-11:  (A) Photographs showing a rapid fluorescence recovery of CdSe/CdS 
core/shell QR-ZW (maximum EM = ~550 nm, 2 μM) prepared immediately by ligand 
exchange at a ligand: QR molar ratio of 1000:1 after upon exposure to a laboratory 
TLC UV lamp ( = 350 nm) at different time intervals. The top layer is H2O and 
bottom layer is CHCl3. (B) Fluorescence auto-recovery of a QR-ZW sample (1 μM in 
H2O) upon exposure to the ambient sunlight over a course of 7 days. (C) A QR-ZW 
(2 μM in H2O) stored in a fridge in darkness with occasional exposure to the sunlight 
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(due to taken out for inspection) shows very slow fluorescence recovery over 4 
weeks. All the QR samples were prepared at a LQMR of 1000:1. 
 
 
Figure 4-12:  (A) Fluorescence spectra of the CdSe/CdS core/shell QR before LE in 
CHCl3 (black) and after LE with DHLA-ZW at a LQ-MR of 1000:1 in H2O after 
treatment by UV light (blue) and sunlight (pink). (B) Comparison of the relative 
fluorescence intensity for the above QRs. 
 
In order to confirm that the QR fluorescence recovery is induced by the light energy, 
another experiment has been done. As shown in Figure 4-13 (A), no fluorescence 
recovery was observed for a water soluble QR-ZW sample that was wrapped in an 
aluminium foil and kept in total darkness for two weeks. Upon exposure this sample 
to the ambient light for 5 days, significant fluorescence recovery was observed. After 
fluorescence recovery, the two samples (parent QR in CHCl3 and QR-ZW in H2O) 
cannot be easily distinguished when being exposed to UV light ( = 350 nm) as 
202 
 
shown in Figure 4-13 (B). Moreover, the water-soluble QR in H2O can recover to ~86% 
of its original fluorescence intensity in CHCl3 (Figure 4-12). In addition, two parallel 
water soluble QR-ZW samples before and after the light treatment can also be easily 
distinguished by the naked eye from the photograph shown in Figure 4-13 (C): the 
light treated QR (right) looks much brighter than the non-treated one (left). Overall, 
all of the cap-exchanged QRs can recover to > 60% of their original fluorescence 
after ‘light activation’ (Figure 4-12). 
 
Figure 4-13:  (A) After LE, the QR-ZW (2 μM) was fully transferred to the upper H2O 
phase, leaving the bottom CHCl3 layer colorless in an Eppendorf tube. Photograph of 
the tube sample exited by a hand-held UV lamp after being wrapped in aluminium 
foil and stored in total darkness for two weeks showed no fluorescence. After this, 
the sample was exposed to the ambient sunlight for 5 days, and then excited by the 
UK lamp where the QY was recovered. (B) Comparison of the same concentration 
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(both 1.5 μM) original QR in CHCl3 and light treated QR-ZW in H2O under UV light ( 
= 350 nm, left panel) radiation and normal ambient sunlight situation (right panel). 
(C) Two parallel water soluble QR-ZW samples (both at 2 μM) before and after light 
treatment can be easily distinguished by eye under ambient conditions, the light 
treated QR (right) looks much lighter and brighter than other one (left). 
Another interesting finding is that dilution of the QR-ZW sample can also increase 
the fluorescence recovery speed. A 10-fold dilution of the QR-ZW sample (e.g. from 
a stock concentration of 2 μM to 0.2 μM) by adding H2O to the sample tube greatly 
increased the rate of the fluorescence recovery, where 4 hour exposure of the 
sample to the sunlight produced a fluorescence recovery comparable to the more 
concentrated stock sample for at least 3 days (Figure 4-14). This is presumably 
because the volume of the diluted QR sample is much bigger than the concentrated 
one, hence it is able to absorb a greater number of photons to initiate fluorescence 
recovery (i.e. the number of excitation photon is the limiting factor for the QR 
fluorescence recovery) (Figure 4-14). Therefore, dilution of the post LE QR sample 
appears to be an efficient way to make stable, bright and water-soluble QRs with 
light treatment. This result further confirmed that light can help the quenched QR to 
recover its fluorescence. 
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Figure 4-14:  (A) Photos of a 2 μM QR-ZW stock in H2O (100 μl) recorded under a 
UV lamp ( = 350 nm) after exposure to ambient light for 0 hour, 3 days, 1 week and 
2 months. (B) Photos of a 10-fold diluted QR-ZW (0.2 μM, 500 μl) in H2O recorded 
under a UV light ( = 350 nm) after exposure to ambient light for 0 hour, 4 hours, 2 
days and 2 months respectively. Schematic procedures of the QR QY recovery by 
light treatment for the concentrated sample (A) and diluted sample (B). 
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After the QR has already recovered its fluorescence for 2 weeks, the quantum yield 
(QY) test has been done. The method for QY determined used here is a comparative 
method, which involves the use of a standard sample of known QY value. In this 
regard, Rhodamine 6G which dissolved in EtOH, under 480nm excitation was used 
as the reference standard (QY = 0.95)31. The QR QY was calculated by the equation: 
𝑌𝑢 = Ys ∗ (
Fu
Fs
) ∗ (
As
Au
) 
Yu: quantum yield for QRs, Ys: quantum yield for Rhodamine 6G (0.95), Fu: 
integrated fluorescence intensity (I = 18794950) for QRs at 480nm, Fs: integrated 
fluorescence intensity (I = 57441080) for Rhodamine 6G at 480nm, As: Absorbance 
(A = 0.010) of Rhodamine 6G at 480nm, Au: Absorbance (A = 0.013) of QRs at 
480nm. 
 
Figure 4-15:  (Left) the Plot of fluorescence intensity test of QR (integrate 
=18794950) and Rhodamine 6G (integrate =57441080). (Right) the plot of UV 
absorption test after eliminates H2O and EtOH background. The concentration of QR 
and Rhodamine 6G in UV-absorption test and fluorescence test are same. 
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Using the above data, the QY of QR-ZW sample after treatment with the ambient 
sunlight is thus determined as 24.6% (Figure 4-15), and this result is recorded 
instantly without further exciting the QR sample which have found to further brighter 
the QRs until the fluorescence intensity keep stable. After excited sample for more 
than 30 mins in fluorimeter, the fluorescence intensity will further increase. (See 
Figure 4-16)  This light activated QR is suitable for further FRET biosensing 
application.  
 
4.3.3 QR-Affimer for ratiometric biosensing 
After light activation, the stability of QR-ZW sample was also investigated. The 
fluorescence spectra of two QR-ZW samples in H2O and phosphate buffer saline 
(PBS, 10 mM phosphate, 150 mM NaCl, pH 7.4) were recorded. Interestingly, as 
shown in Figure 4-16, the florescence intensity of the QR-ZW sample was found to 
increase after each fluorescence recording and finally plateaued in ~60 mins. As 
shown in Figure 4-16 (A, B), the intensity of 1 nM QR-ZW in H2O increased from 
4000000 cps to 8500000 cps in 60 mins, after which it showed little change. Similar 
behaviour was also obverted for the 0.1 nM QR-ZW sample in PBS buffer, where its 
intensity increased from 1250000 cps to 2000000 cps in 30 mins and then plateaued 
out afterwards. This result may indicate that the QR-ZW sample used here has yet to 
reach full fluorescence recovery; hence it can further absorb the excitation light to 
trigger further fluorescence recovery till maximum is reached. The 1 nM QR gave too 
high a florescence intensity (>8 x 106 cps) which is beyond the linear response of the 
fluorimeter. Whereas the 0.1 nM QR gave a highly respectable florescence intensity 
of ~ 2 x 106 cps, making it suitable for sensitive biosensor detection. To minimise the 
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signal change due to different excitation scans, all sensing samples were scanned 
for ~5 runs till its florescence intensity became stable. 
 
Figure 4-16: (A) Fluorescence spectra of 1 nM QR550-DHLA-ZW in H2O stability test 
in 90 mins. (B) A plot of 1 nM QR550-DHLA-ZW Fluorescence intensity in H2O time 
dependent. (C) Fluorescence spectra of 0.1 nM QR550-DHLA-ZW in PBS buffer 
stability test in 60 mins. (D) A plot of 0.1 nM QR550-DHLA-ZW fluorescence intensity 
in PBS buffer time dependent. 
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The high fluorescence and compact structure in biologically relevant buffer of the LE 
prepared QRs make them extremely attractive for FRET-based applications. The fact 
that the QRs  have recovered to retain > 60% of their native fluorescence (Figure 4-
12) after exposure to ambient for 2 months make them especially attractive for ultra-
sensitive biosensing and biomedical applications. Herein, the QR was combined with 
the non-antibody binding protein (Affimer) to develop protein biosensors using same 
principles as the QD-biosensor described in chapter 3. The same Affimer and its 
target small ubiquitin-like modifier (SUMO) protein playing an important role in a 
number of cellular processes, such as nuclear-cytosolic transport and transcriptional 
regulation were used. The Affimer against Yeast SUMO protein were selected and 
prepared the Tomlinson group at the Faculty of Biological Sciences, University of 
Leeds26. The nABP was modified by His8-tag at N-terminal, allowing it to self-
assemble on the QR surface Cd2+ ions32. As mentioned in Chapter 3, the Affimers 
are especially well-suited for FRET based biosensing because of their small 
molecular sizes, allowing significantly reduced donor-acceptor distance and hence 
achieving high FRET efficiency and sensitivity. 
First we studied the QR-Affimer self-assembly by mixing the Atto-594 labelled 
Affimer with the QD-ZW (EM ~550 nm) at different molar ratios. The resulting 
fluorescence spectra (EX = 450 nm, corresponding to the absorption minimum of the 
Atto-594 dye to minimize dye direct excitation) revealed a progressively quenched 
QR fluorescence and simultaneously enhanced Atto-594 FRET signal (at ~625 nm) 
with the increasing dye/QR ratio, consistent to the QR-sensitized Atto-594 dye FRET 
mechanism32 (Figure 4-17). This result confirmed the successful QR-Affimer 
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conjugation. Because the average dye labelling ratio on per Affimer was low (at 0.35), 
the observed the FRET signal was also weak. 
 
 
Figure 4-17:  (A) Fluorescence spectra of the QR550-ZW (100 pM QR) after 
incubation with different concentration of Atto-594 labelled Yeast SUMO Affimers in 
PBS (B) A plot of the I625/I550 ratio versus the Yeast SUMO nABP concentration fitted 
to a linear function: R2 = 0.8596. (C) Schematic show of the QR self-assembled by 
labelled Affimer via the FRET readout strategy. 
 
After that, the QR-Affimer bio-conjugate was further tested for biosensing function by 
binding to its specific target protein (Yeast SUMO 28b). Here the QR-ZW each 
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conjugated with 40 copies of unlabelled anti-SUMO Affimer (His8-tagged) was mixed 
with different amount of the target Yeast SUMO28b protein (Atto-594 labelled)26. The 
resulting fluorescence spectra (Figure 4-18) clearly showed that, with the increasing 
target binding Yeast SUMO28b concentration, the QR fluorescence was greatly 
quenched while the Atto 594 FRET signal was enhanced simultaneously, in 
agreement with the expectation that the specific Affimer-SUMO binding would bring 
the Atto-594 label close to the QR, producing QR-sensitized Atto 647 FRET signal. A 
plot of the peak intensity ratio (direct excitation background corrected) of the Atto-
594 FRET (at 625 nm) to that of the QR (at 549 nm), I625/I549, versus the Yeast 
SUMO28b concentration gave a good positive linear relationship over 0-2000 pM (R2 
= 0.904) with a detect limit of as low as 5 pM, suggesting the QR-Affimer conjugate 
is suitable for ratiometric quantitation of pM level target proteins. The positive linear 
increase of the I625/I549 ratio with the increasing SUMO concentration matched 
exactly what was expected for the multiple acceptors FRET to a single QR donor 
model.24, 33 
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Figure 4-18:  (A) Fluorescence spectra of the QR-ZW-Affimer (0.1 nM QR and 4 nM 
nABP) after incubation with different concentration of Atto-594 labelled Yeast SUMO 
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in PBS. (B) Fluorescence spectra amplify wavelength from 600nm to 650nm (C) A 
plot of the I625/I549 ratio versus the SUMO concentration from 0 to 5000 pM and 0 to 
20 pM. (D) A plot of the I625/I549 ratio versus the SUMO concentration from 0 to 50 
pM. And the schematic show of the QR-Affimer for detection of labelled target SUMO 
via QR-sensitized Atto-594 FRET readout strategy. 
 
After confirming that the QR-Affimer can detect the labelled target SUMO protein, 
label free test was also done. The ability of detecting unlabelled protein target is 
more useful for bio diagnostics because target labelling may not be feasible for real 
situations. To investigate this potential, we first conjugated each CdSe/CdS QR with 
1 copy of the anti-SUMO Affimer (via His8-tag self-assembly) and then blocked the 
QR with 40 copies of a control Affimer (His8-tagged) that showed no binding affinity 
to the Yeast SUMO28b protein26. An Atto-594 labelled Yeast SUMO28b protein was 
used as FRET reporter (with CQR = CSUMO = 0.1 nM) similar to that described in 
Chapter 3. Adding different concentration of unlabelled Yeast SUMO28b protein 
should compete with the labelled Yeast SUMO28b protein binding to the QR-Affimer, 
reducing the number of labelled Yeast SUMO28b binding to the QR and resulting in 
the QR fluorescence recovery (Figure 4-19). A plot of the resulting fluorescence 
intensity ratio I549/I625 versus the unlabelled Yeast SUMO28b concentration showed 
that, with the increasing unlabelled target Yeast SUMO28b concentration 
(particularly at > 50 pM), the QR fluorescence was greatly enhanced while the Atto 
594 FRET signal was decreased simultaneously, in agreement with the expectation 
that the unlabelled SUMO protein would compete and displace the Atto-594 labelled 
SUMO protein from binding to the QR. The label-free sensitivity (ca. 50 pM) is lower 
than that of the label detection (ca. 5 pM), presumably because each QR here is 
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conjugated with only 1 copy of the Affimer binder versus 40 copies in labelled 
detection which may enhance the Affimer-SUMO binding affinity via multivalency 
effect. Moreover, not all labelled Yeast SUMO protein reporters may have bound to 
the QR-Affimer conjugates due to their natural binding-dissociation equilibrium, thus 
some of the introduced unlabelled SUMO proteins may simply bind to the unbound 
free Affimers on the QR surface without displacing the reporter proteins. 
Nevertheless, the label-free sensitivity achieved here is comparable or even better 
than most other QD-FRET based protein sensors (see Chapter 3). 
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Figure 4-19:  (A) Fluorescence spectra of the QR-Affimer conjugate (0.1 nM) mixed 
with Atto-594 labelled SUMO protein reporter (0.1 nM) in the presence of different 
amounts of unlabelled Yeast SUMO28b protein. (B) A plot of I549/I625 as a function of 
the unlabelled SUMO concentration: data over 0-10 nM range and 0-50 pM. The 
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scheme below shows the assay principle (the protein circled being the anti-SUMO 
Affimer while all others are non-SUMO binding Affimer). 
4.3.4 Preparation of QR-biotin for biosensing 
After demonstration the ability of making stable and fluorescence recovered QR-ZW 
samples, biotin-functionalized QRs were further prepared in one step using mixed 
DHLA-PEG600-biotin/DHLA-ZW. Tuning the ratio of the DHLA-PEG600-biotin ligand 
to DHLA-ZW spacer ligand ratio allowed for control of the QR surface biotin valency. 
The preparation procedures of the mixed ligand cap-exchanged QRs were described 
in experiment section. After that, the QRs prepared at a LQMR of 1000:1 with DHLA-
ZW and 200:1 with DHLA-PEG600-biotin were exposed to ambient light conditions to 
allow fluorescence recovery over 1 week, gaining ~60% of its original fluorescence. 
Such QR-biotin sample was found to be stable and suitable for detection of 
neutravidin via the strong biotin-neutrAvidin interaction. (Figure 4-20)  
 
 
Figure 4-20:  (A) Fluorescence spectra of the CdSe/CdS core/shell QR before LE 
(black) and after LE at a LQ-MR of 1000:1 with DHLA-ZW and 200:1 with biotin after 
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ambient light treatment for 1 week (red). (B) Comparison of the relative fluorescence 
intensity for the above QRs. 
 
Similar to the QR-ZW sample, the QR-biotin sample prepared at a LQMR = 1000:1 
with DHLA-ZW and 200:1 with DHLA-PEG600-Biotin was also found to be sufficient 
to completely water-solubilize the CdSe/CdS QR to form a stable, water-soluble QR-
biotin sample.  
 
Figure 4-21:  (A) Fluorescence spectra of 1 nM QR-biotin in PBS containing 0.1 
mg/ml of BSA tested over a 90 min period. (B) A plot of the QR-biotin fluorescence 
intensity versus time: a ~7 fold fluorescence enhancement was observed over a 
course of 30 mins and then plateaued out afterwards.  
 
The stability of the CdSe/CdS QR (EM = 550) capped with mixed ligands of DHLA-
ZW and DHLA-PEG600-Biotin was first investigated. Similar to the QR-ZW above, its 
fluorescence was also found to be time dependent in PBS buffer containing 0.1 
mg/mL of BSA. As shown in Figure 4-21, its florescence also increased after each 
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scan over the first 30 mins and then plateaued out, where a very significant 6.7 fold 
increase of intensity was observed (increasing from ca. 4.5 x105 to 3 x106 cps).  
Based on this result, further sensing experiment was carried out by performing 
repeated scans of QR-biotin sample for 30 min till its florescence no longer showed 
significant changes, the same way as the QR-Affimer sensing above. A further TEM 
imaging reveals that the prepared QR-biotin sample retained the same crystal size 
and shape as the parent QR (Figure 4-22), similar to that observed with the QR-ZW 
sample above. 
 
 
Figure 4-22: (A) TEM image of the CdSe/CdS core/shell QR after LE with the DHLA-
ZW at a ligand: QR molar ratio of 1000:1 and DHLA-PEG600-biotin at a ligand: QR 
molar ratio of 200:1 (B) of the same TEM image under higher magnification. The QR 
has an average width of ~3.6 nm and length of ~23 nm. 
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After that, the QR-ZW/PEG600-biotin probe (abbreviated as QR-biotin200) was 
further tested for its biosensing application of its specific target protein (NeutrAvidin) 
by exploiting the extremely strong bio-specific interaction between biotin and 
Neutravidin (Kd ~10-15 M). Here the QR-biotin200 was mixed with different 
concentration of the Atto 594 labelled NeutrAvidin and the resulting fluorescence 
spectra were shown in (Figures 4-23). With the increasing NeutrAvidin concentration, 
the QR fluorescence was greatly quenched while the Atto 594 FRET signal was 
enhanced simultaneously, in agreement with the expectation that the specific biotin-
NeutrAvidin binding would bring the Atto-594 dye close to the QR, producing QR-
sensitized Atto-594  FRET signal. A plot of the peak intensity ratio of the Atto-594 
FRET (at 623 nm) to that of the QR (at 543 nm), I623/I543, versus the NeutrAvidin 
concentration revealed a detect limit of as low as 5 pM, suggesting the QR-biotin 
conjugate is suitable for quantitation of low pM levels of the target NeutrAvidin. The 
sensing specificity was supported by a control experiment where mixing the Atto-594 
labelled neutravidin (100 nM) with the QR capped with DHLA-ZW ligand only but 
without DHLA-PEG600-biotin ligand displayed almost no quenching of the QR 
fluorescence. The resulting direct excitation corrected I623/I543 ratio was only 0.0042, 
< 10% of the ratio observed for the QR-biotin200 with 1 nM neutravidin, despite the 
former neutravidin concentration was 100 fold higher than the later. This result 
clearly demonstrates that the observed FRET signal here is due to the specific 
biotin-neutravidin binding, and not due to non-specific adsorption (Figure 4-23 (D)).  
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Figure 4-23:  (A) Fluorescence spectra of the QR -biotin200 (0.5 nM QR) after 
incubation with different concentration of Atto-594 labelled NeutrAvidin in PBS 
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containing 0.1 Mg/mL of BSA. (B) Amplified fluorescence spectra from 600 to 650 
nm. (C) A plot of the I625/I543 ratio versus the NeutrAvidin concentration from 0 to 
1000 pM and 0-100 pM. (D) Fluorescence spectra of the 1 nM QR-ZW (without 
biotin) after mixing with 100 nM labelled Avidin (black): no QR-fluorescence 
quenching was observed. Moreover, the resulting I625/I543 ratio was only 0.0042 after 
correction of direct excitation background. Schematic show of the QR-Biotin for 
detection of labeled target Neutravidin via QR-sensitized Atto-594 FRET readout 
strategy. 
 
4.4 Conclusion 
A rapid and highly efficient LE method that allows for complete water-solubilisation of 
the hydrophobic CdSe/CdS QR similar to that reported in Chapter 3 has been 
developed. It readily produces compact, biocompatible QRs with excellent stability in 
PBS buffers. Moreover, a novel method for effective recovery of the QR fluorescence 
to >60% of its original value using a light activated method has been discovered. The 
resulting fluorescence recovered QR can be readily conjugated with His8-tagged 
Affimers for sensitive detection of 5 pM of a specific target Yeast SUMO28b protein. 
The highly efficient LE method has been successfully employed for one-step 
preparation of biotinylated QRs which can be for sensitive detection of neutravidin 
down to low pM level. Compared to other QR biosensors reported in literature, our 
method has three notable advantages: 1) it is a rapid procedure to make stable, 
biocompatible QRs with a minimum LQMR as low as 1000:1; 2) it is easy to operate 
(using air-stable compounds and rapid in situ reduction at ambient condition); 3) a 
novel light activation strategy can make the almost totally quenched (<3% original 
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fluorescence intensity) QR recover to retain > 60% of its original fluorescence, 
making such QRs attractive for broad biomedical applications. Therefore this novel 
light activation method discovered herein will impact significantly in broad QR-based 
biomedical research field, including biosensing, bioimaging, clinical diagnostics, and 
most importantly in areas involving the use of QR-FRET based readout strategies. 
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Chapter 5. General conclusions and future work 
suggestions 
 
5.1 General conclusions 
 
Firstly, In order to prepare of robust, compact, biocompatible QDs/QRs probes, a 
series of surface capping hydrophilic thiolated TA-based ligands, (such as TA-
PEG750-OMe, TA-PEG2000-OMe and TA-Zwitterion and TA-PEG600-Biotin) were 
successful synthesised and characterized in chapter 2. These ligands are very useful 
for further QD-DHLA-based bioconjugate application, Especially for DHLA-PEG750-
OMe and DHLA-Zwitterion ligands, the PEG units and +/- electron charged zwitterion 
part not only provide an effective ‘shield’ to improve the QD stability but also resist 
biomolecule non-specific absorption which make QD/QR well suitable for further 
his8-tagged nABPs/target SUMO protein FRET based ratiometric biosensor 
application. Besides, the biotin functional groups at the end of the PEG600 chain 
enable to formation of QD-biotin-Neutravidin conjugate also well suitable for cancer 
cell imaging. By using these TA-based ligands. Several achievements in QD/QR-
bioconjugate sensing systems have been successfully developed. 
Secondly in chapter 3, a successful development of a simple ultra-efficient cap 
exchange procedure (UCEP) was developed by a rapid reduction of TA-based 
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ligands to their DHLA form by tris(2-carboxylethyl)phosphine (TCEP). After 
deprotonation of the thiol groups, the resulting in situ reduced DHLA-ligands are 
directly used to initiate cap-exchange with hydrophobic type I CdSe/ZnS core/shell 
and CdSe/CdS/ZnS core/shell/shell QDs in homogenous solution which were 
prepared by using 50-1000 folds less amounts of the DHLA-based ligands over most 
literature reported. We show that the UCEP can provide complete QD water-
solubilization at a LQMR of as low as 200:1. These biocompatible QDs exhibited an 
excellent stability in biological buffers (PBS with 0.1 mg/ml BSA), effectively retaining 
the native parent QD fluorescence (> 90%), and small hydrodynamic diameters (< 10 
nm). the resulting QDs are readily bio-conjugated with His8-tagged Affimers for 
robust, sensitive detection of 5 pM of a specific target protein, the QD-bio probe can 
works robustly in clinical relevant media (50% human serum). The UCEP also allows 
for readily one-step preparation of biotinylated QDs for sensitive biosensing, 
sensitive detection of 5 pM of NeutrAvidin as well. 
Thirdly in Chapter 4, the UCEP method is also suitable for Quasi-Type II CdSe/CdS 
QRs, and provides complete QR water-solubilization at a LQMR of as low as 1000:1. 
After UCEP in preparing QR, it was totally quenched, but we found a simple photon-
induced method to make QR fluorescence recovery their native parent QR 
fluorescence (>60%), small hydrodynamic diameters (< 15 nm) and sensitive for 
further biosensing application. Furthermore, these QRs also have excellent stability 
in PBS buffers, the resulting QDs are readily bio-conjugated with His8-tagged 
Affimers for robust, sensitive detection of 5 pM of a specific target protein. The UCEP 
also allows for readily one-step preparation of biotinylated QRs for sensitive 
biosensing, sensitive detection of 5 pM of NeutrAvidin as well. 
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Finally, a more stable, specific, robust, and sensitive compact QD/QR-bioconjugate 
probes were prepared by new UCEP. This procedure has several advantages: (a) it 
is a rapid procedure to make water soluble QR/QD in a few minutes; (b) it is easy to 
operate (using air-stable compounds and rapid in situ reduction at ambient 
condition); (c) this method can save lots of expensive excess ligands; (d) after ligand 
exchange QDs retaining the native parent QD fluorescence (>90%); (e) Light 
activation method can make useless totally quenched QR recover fluorescence 
properties up to > 60% of original fluorescence intensity. (f) After UCEP method QDs 
and QRs can keep stable in water phase for at least 3 months. The high stability, 
specificity together with excellent robustness and sensitivity QD-Affimer, QD-biotin, 
QR-Affimer and QR-biotin sensor will have good potential for a wide biomedical 
research field, including biosensing, bioimaging, drug delivery, clinical diagnostics 
and therapeutics. 
5.2 Future research 
Although the water-soluble QRs prepared by our ligand exchange method using the 
DHLA-ZW ligands are stable and resisting the non-specific absorption, making them 
attractive for biosensing, some further work in the following areas are nonetheless 
necessary. 
Firstly, the mechanisms by which the Quasi-Type II QR’s fluorescence is quenched 
upon ligand exchange and why its fluorescence can be recovered after light 
activation should be investigated in details. This information can be obtained by 
performing transient absorption spectra as well as fluorescence lifetime 
measurement. The mechanism of fluorescence recovery of QR is worth further 
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investigation. It might find new applications in super-resolution imaging similar to 
PALM. 
Secondly, both the QR-Atto-594 labeled SUMO and QR-Atto-594 labeled 
NeutrAvidin FRET pairs appear to give extremely low FRET signal despite significant 
quenching of the QR fluorescence. This result appears to contrast significantly with 
those of the QD560-Atto-594 FRET pair reported in literature where much higher 
FRET signals were reported despite the QD560 and the QR used here have very 
similar emission spectra. The reasons behind this phenomenon are also worthy of 
investigation. 
Thirdly, after confirming the specific binding between the QR-biotin and NeutrAvidin, 
a label free detection of neutravidin as well as free biotin should also be done. This 
can be based on the same strategy as those employed in the QD-detection where 
free biotin can effectively compete with the QR-biotin200 for binding to labeled 
NeutrAvidin, reducing the amounts of labelled NeutrAvidin binding to the QR and will 
hence the QR to Atto 594 FRET efficiency.  
Fourthly, nucleic acid aptamer could be a useful choice, allow for detection of a wide 
range of different target.  
Finally, Multiplex detection of several different targets simultaneously by several 
different coloured QD/QRs, each encoding a unique target binder, that maybe further 
improve sensitivity and clinical detection. 
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